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ABSTRACT
The study of the molecular organisation of specialised synaptic 
structures has been considerably advanced by the development of methods 
for the isolation of synaptic subfractions enriched in synaptic plasma 
membranes (SPM), synaptic junctional complexes (SJC's) and postsynaptic 
densities (PSD's). The present thesis deals with one important aspect 
of this organisation, namely the synthesis of SPM proteins and its 
modulation by selected chemical agents.
SPM, mitochondrial and myelin-enriched fractions of comparable purity to
published data have been isolated from adult rat brain. An in vivo -
35method for monitoring incorporation of L-( S)methionine into the protein
of these fractions has been developed. This involved injection of
35flooding concentrations of L-( S)methionine into the lateral ventricle 
via a pre-implanted cannula. Since the precursor specific activity is 
known and constant for at least 45 minutes the incorporation rates can 
be reliably measured over this period.
The effects of two anaesthetics, halothane and pentobarbitone, on brain 
protein sy nthesis were investigated. Halothane (3%) produced a gross 
inhibition of protein synthesis in total forebrain and SPM, myelin and 
mitochondrial fractions. Pentobarbitone produced no such inhibition at 
doses of 60 or 75 mg/Kg body weight. L-DOPA was also found to inhibit 
incorporation rates by close to 30% in total forebrain and mitochondrial 
protein in hyperthermic animals (body temperature 39-40°C). Other 
subcellular fractions were less affected by the drug.
Thyroid hormone deficiency during brain development impairs brain 
structure and function including synapse formation. The present study 
showed that hypothyroidism decreased protein yields in SPM, myelin and 
mitochondrial fractions and impaired synthesis of SPM and myelin 
protein. The rates of incorporation into total forebrain and 
mitochondrial protein were not significantly affected. SDS 
polyacrylamide gej, electrophoresis and fluorographic studies tentatively 
showed that the relative rates of synthesis of specific polypeptides 
were altered in thyroid deficient animals. r :
. ' :
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1. INTRODUCTION
The central nervous system is made up of a vast network of neurones 
each of which interacts at many specific sites with other neurones. 
These sites of interaction are synaptic junctions. Thus the 
synaptic region, although constituting only a small area of the 
neurone, is of great importance.
In the early 1960's Gray and Whittaker (1962) and De Robertis 
et al. (1962) independently found that particles which structurally 
resembled nerve endings in intact tissue were present in crude 
mitochondrial preparations. Their identity was confirmed by 
extensive electron micrographie and enzyme distribution studies. 
These nerve ending particles were named synaptosomes.
Since the development of methods for their isolation synaptosomes 
have provided an invaluable tool for the study of synaptic function. 
Subsequently methods have been established for isolation of synaptic 
subfractions such as the synaptic plasma membrane (SPM), synaptic 
junctional complex (SJC) and postsynaptic density (PSD).
The synaptic plasma membrane is intimately involved in both 
regulating the release and actions of neurotransmitters and in the 
formation and maintenance of synaptic connections. Little, however, 
is known of the synthesis of SPM proteins or of their function. The 
aim of the work presented in this thesis, therefore, has been to 
examine the synthesis of SPM proteins and some factors which may 
affect this.
1.1 Isolation of Synaptic Subfractions
1.1.1 Synaptic Plasma Membrane Fractions
Several procedures for the isolation of SPM from mammalian brain 
have been published (Cotman and Matthews, 1971; Morgan et al. 1971; 
Gurd, et al., 1974; Johes and Matus, 1974). These methods involve 
the initial isolation of a crude mitochondrial fraction by 
differential centifugation. A synaptosomal fraction may then be 
obtained by density gradient centrifugation. This is followed by a 
period of hypotonic lysis to release the synaptosomal contents and
—13-
density gradient centrifugation to obtain a fraction enriched in 
synaptic membranes. (Figs. 1.1 and 1.2).
Subsequent treatment of this fraction with detergents yields junctional 
or postsynaptic density fractions (Figs. 1.3 and 1.4). The exact 
procedures, however, differ between individual methods.
The starting material for the isolation of synaptic membrane fractions is 
usually a 10% (w/v) homogenate of brain tissue in either a 0.32 M or 10% 
(w/w) sucrose solution (homogeniser clearance 0.25 mm). The homogenate 
is subjected to differential centrifugation to produce a crude 
mitochondrial fraction which may be used as the parent fraction for 
isolation of SPM (Jones and Matus, 1974). Alternatively a synaptosome- 
enriched fraction can be isolated from the crude mitochrondrial faction 
by discontinuous density gradient centrifugation. (Morgan et al., 1971; 
Cotman and Matthews, 1971; Gurd et al., 1974). The aim of this is to 
minimise the contamination of subsequent fractions by non-synaptosomal 
components.
The similarity in buoyant densities of synaptosomes and potential 
contaminants makes adequate resolution on this basis difficult (Table
1.1). Although most microsomes are removed during differential 
centrifugation there is some residual microsomal contamination in the 
crude mitochondrial fraction. Gurd et al. (1974) reported a reduction in 
the microsomal contamination in this fraction from more than 50% to less 
than 15%. This was achieved by washing the crude mitochondrial pellet 
three times. Levitan et al. (1972) and Tamir et al. (1974) claim to have 
achieved similar results by reducing the centrifugation time and force in 
the preparation of the P^ fraction.
Cotman (1972) suggested that the use of Ficoll gradients, which maintain 
an isotonic environment, should maximise the difference in buoyant 
density between components. Morgan et al. (1972) reported that 
synaptosomes prepared in this way had lower proportions of myelin, glial 
and ^nal fragments than similar fractions prepared on sucrose gradients. 
They did, however, observe higher levels of mitochondrial contamination 
which is difficult to explain in view of Cotman's suggestion that 
resolution of components may be improved under these conditions.
-14-
TABLE 1.1
Buoyant densities of some brain subcellular fractions
Fraction
Synaptosomes
Microsomes
Mitochondria
Myelin
Glial membranes
Buoyant density 
in sucrose (g/ml)
1.13-1.17
1.13-1.182 
1.15-1.187 
1.10
1.121-1.167
Reference
Whittaker, 1968 
Cotman et al.,1971
Il If It
Autilio et al., 1964 
Cotman et al., 1971
-15-
FIG. 1.1
Isolation of SPM
(Cotman and Matthews, 1971)
10% (w/v) brain homogenate in 0.32M sucrose
llOOg^^, 5 min
Crude nuclear fraction
17,000g^^, 10 min
Crude mitochondrial fraction 
Resuspend in 0.32M sucrose
sample in 0.32M sucrose 
7.5 )
) % Ficoll in 0.32M sucrose
13.0 )
64,000g^^.
PzB
45 min 
Synaptosome Fraction 
Dilute with 4 Vol 0.32M sucrose 
50,000g^^, 30 min 
Synaptosome pellet 
Resuspend in 0.32M sucrose 
Add 5 Vol 6mM Tris, pH8,l 
Lyse for 90 min at 4®C 
25,000ggy, 20 min 
Resuspend pellet in 0.32M sucrose 
Apply to gradient
60,000gav
sample 
25
32.5 
35 % sucrose (w/w)
38
, 90 min 
Dilute with. 4 Vol. . O.lrnM EDTA 
50,000g^^* 30 min 
Resuspend pellet in 0.32H sucrose
SPM.
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FIG. 1.2
Isolation of SPM
(Jones and Matus, 1974)
10% (w/v) homogenate in 10% (w/w) sucrose
800g , 20 min__________  av
P^ Crude nuclear fraction
10,000g , 20 minav
P^ Crude mitochondrial fraction 
Resuspend in 5 mH Tris, pH8.1 
Lyse for 1 h at 0®C 
Add 2 vol 48% (w/w) sucrose
myelin_
SPM
mitochondria
10% (w/w) sucrose
28.5% (w/w) sucrose
Sample in 32% (w/w) sucrose
60,000g^y, 110 min
Dilute interfaces with 3 vol 0.1 mM EDTA
80,000g^y, 20 min
Resuspend pellets in 10% (w/w) sucrose
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In addition to possibly improving the resolution from contaminants 
synaptosomes prepared on Ficoll gradients are more susceptible to lysis 
which is an important factor in the preparation of SPM (Morgan et al., 
1972). Sucrose has also been reported to cause non-specific association 
between membranes (Day et al., 1971) which, again, would be minimized by 
the use of Ficoll gradients.
Tamir et al. (1974) claim to have improved their yield of synaptosomes 
by using a linear gradient (10-18%) of sodium diatrizoate. They 
attribute this to the improved separation of synaptosomes from 
mitochondria in this medium.
Recent evidence using monoclonal antibodies has suggested that even in
synaptosome-enriched fractions only 20% of synaptosomes bind a putative
neurone-specific antibody (Reichardt and Matthew, 1982). These workers
suggest that this may indicate high levels of contamination even in
relatively ’purified* synaptosome fractions. Once the parent fraction
has been isolated it is necessary to lyse the synaptosomes in order to
release the synaptoplasm and synaptic organelles. This is achieved by
homogenisation in a hypotonic alkaline buffer such as 5-6 mM Tris, pH8.1
(Cotman and Matthews, 1971; Jones and Matus, 1974), 5 mM HEPES, pH8.4 or
1 mM phosphate/0.1 mM EDTA, pH/.5 (Gurd et al., 1974). The pH of the
lysis medium is critical. By examining the distribution of
+ +
acetycholinesterase, (Na ,K )ATPase and cytochrome c oxidase on a 
continuous sucrose gradient Cotman and Matthews (1971) demonstrated that 
only at pH values above 8.0 was there adequate separation of the membrane 
marker enzymes from the mitochondrial marker cytochrome c oxidase.
Lysis is usually carried out at 0°C for periods varying from 30 minutes 
(Jones and Matus, 1974) to 90 minutes (Cotman and Matthews, 1971; Mena 
et al., 1980). The particulate fraction may then be pelleted prior to 
application to the gradient (Cotman and Matthews, 1971; Gurd et al., 
1974).
Some workers have attempted to minimise mitochondrial contamination by 
including a procedure which selectively increases the density of 
mitochondria, thereby enabling better resolution from synaptic membranes. 
This can be achieved by incubating the lysed synaptosomal fraction with 
the dye iodonitrotétrazolium violet (INT) which results in the succinate
-18-
TABLE 1.2
Reported yields of protein in synaptic subfractions isolated from rat brain
Yield
(mg protein/g tissue)
Reference
SPM 0.12"
1.5-2.0
3.0 
5.0^
2.5-3.3 
0.2-0.25
1.0 
3.0 
2.75
0.3-0.5^ 
2.9
Morgan et al., 1971 
Cotman and Matthews, 1971 
Cotman and Taylor, 1972 
Levitan et al., 1972 
Davis and Bloom 1973 
Gurd et al., 1974 
Jones and Matus, 1974 
Cotman et al., 1974 
Therien and Mushynksi, 1976 
Smith and Loh, 1977 
Nièto-Sampedro et al., 1981
SJC 0.10-0.15
0.15-0.20
0.012-0.004
0.242^
0.46
Cotman and Taylor, 1972 
Davis æid Bloom, 1973 
Therien and Mushynski, 1976 
Webster and Klingman, 1979 
Nieto-Sampedro et al., 1982a
PSD 0.025
0.100-0.150
0.078
Cotman et al., 1974 
Cohen et al., 1977 
Gurd et al., 1982
Triton X-100 6.8
Na^cholate 4,8
Na^deoxycholate 1.7
N-lauroyl sarcosinate 0,4
Matus and Taff-Jones, 1978
1. Yield reported as mg protein/brain,
2. SPM isolated from mouse brain*
3. SJC’s isolated from chick forebrain,
4. Yield reported as mg protein/100#g SPM
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dehydrogenase catalysed deposition of the reduced dye, formazan, within 
the mitochondria. (Cotman and Taylor, 1972; Davis and Bloom, 1973; 
Nieto-Sampedro et al., 1981a).Using 1 mg INT/g brain tissue (wet weight) 
Nieto-Sampedro et al. (1981a) found that the mitochondrial contamination 
of the SPM fraction was 10-13% of the SPM protein.
The lysed fraction is then applied to a discontinuous sucrose gradient 
of typical composition 0.6M, 0.8M, l.OM, 1.3M sucrose (Gurd et al.,
1974) or 25, 32.5, 35, 38% (w/w) sucrose (Cotman and Matthews, 1971).
The gradients are then centrifuged at 53-60,000^^^ for 1.5-2 hours in 
a swing-out rotor.
Jones and Matus (1974) used a sedimentation-floatation gradient for 
isolation of SPM in which the lysed crude mitochondrial fraction was 
mixed with a high concentration sucrose solution and formed the bottom . 
step (32% (w/w) sucrose) of a three step gradient (overlayed with 28% 
and 10% (w/w) sucrose solutions). Salvaterra and Matthews (1980) adapted 
this technique for use with a fixed angle rotor. They reported that this 
reduced the centrifugation time from 110 minutes to about 35 minutes and 
also increased the yield of SPM although they did not quote value for 
this.
After centrifugation the fractions can be collected from the gradient 
either by aspiration or by use of a tube cutter. The fractions are then 
diluted and pelleted. Cotman and Matthews (1971) recommended using a
0.1 mM EDTA solution for this step.
The yield of SPM protein obtained reflects the method of isolation used. 
Those schemes entailing many steps generally produce lower yields of SPM 
protein (e.g. Morgan et al., 1971; Gurd et al., 1974). Most workers, 
however, have reported yields of SPM protein as being between 1 and 5 
mg/g tissue (wet weight). (See Table 1*2)
1.1.2 Synaptic Junctional Complex Fractions
Fiszer and De Robertis (1967) demonstrated that it is possible to 
solubilize the extra-junctional membrane by treating SPM fractions with 
Triton 2^-100 (0.1%, v/v) leaving the area of junctional contact intact.
-20-
FIG. 1.3
Isolation of synaptic junctional complexes
(Cotman and Taylor, 1972)
SPM (4 mg/ml) In 
2 mM Blclne, pH7.5
Add solution of Triton X-100 (4 mg/ml),
2 mM EDTA, 2 mM Blclne, pH7.5
Incubate at 4°C or room temperature for 10 min
Apply to gradient
64,000gav
sample 
1.0 ) 
1.2 )
1.4 )
1.5 )
, 75 min
M sucrose
Collect Interfaces and dilute with water 
Pellet at 100,000g^, 30 min.
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Electron microscopic evidence showed that the pre- and postsynaptic 
densities and their associated membranes survived the detergent 
treatment.
A considerable amount of work has been carried out to establish routine 
methods for the isolation of synaptic junctional fractions (Cotman 
et al., 1971b; Cotman and Taylor, 1972; Davis and Bloom, 1973; Therien 
and Mushynski, 1976; Webster and Klingman, 1979; Nieto-Sampedro et al, 
1982a). (See Fig. 1.3) Generally the isolated SPM fraction is subjected 
to solubilization in a Triton X-100 solution at either a Triton X-100: 
protein ratio of 1:1 or 2:1 (w/w) (Cotman and Taylot, 1972) or 0.2-0.4% 
Triton X-100 (Davis and Bloom, 1973; Webster and Klingman, 1979). The 
detergent is usually buffered with a low concentration of Tris 3mM at 
pH7.2-7.5 (Cotman et al., 1971b). Solubilization is conducted at 0-4°C 
or room temperature (Cotman and Taylor, 1972) and the solubilized 
fraction is either applied directly to a discontinuous sucrose gradient 
of composition l.OM, 1.2M, 1.4M, 1.5M sucrose (+50jjM CaCl^, pH7.0, Cotman 
and Taylor, 1972) or pelleted to give the detergent insoluble fraction 
(Davis and Bloom, 1973).
All of these workers have noted the improvement in structural integrity 
of the junctions when calcium is included in the isolation media.
Addition of CaCl^ to the Triton X-100 solution, however, results in a 
significant decrease in the amount of protein solubilized - which is 
reduced from about 60% to around 35% (Davis and Bloom, 1973; Cotman and 
Taylor, 1972). If CaClg is added at the required concentrations (3-5mM) 
only at the solubilization step the particulate fractions have been 
observed to clump during density gradient centrifugation (Davis and 
Bloom, 1973). This, therefore, gives poor resolution of the fractions. 
This effect was noted at concentrations of CaClg as low aS lOOpM. They 
found, however, that iriclusion of CaClg (50jjM) in all of the solutiens 
used to isolate the parent SPM fraction maintained the junctional 
structure but did not cause clumping of the SJC fractions during their 
isolation. Inclusion of EDTA (lnAl) in the detergent solution was found 
to have no adverse effect oh junctional structure but prevented clumping 
of the particulate fraction. Davis and Bloom (1973), therefore, 
recommended that inclusion of CaCl^ in all isolation media used in the 
preparation of SPM prêtected the juhctional structure but that if it was 
iheluded in the detergenf solutioh the resolution of SJC's from 
cont#iinants was poor.
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Therien and Mushynski (1976) developed an alternative method for 
isolating SJC's in which the SPM fraction was homogenised in a biphasic 
system consisting of Freon 113 and 0.2% (v/v) Triton X-100. The aqueous 
Triton X-100 phase was shown to contain about 25% of the total SPM 
protein. This fraction was subsequently pelleted and resuspended in a 
solution of Triton X-100, dextran sulphate and sucrose (to give final 
concentrations of 0.05, 0.02% (v/v) and 1.2M respectively). The 
resultant suspension was then centrifuged on a discontinuous gradient of 
composition 2.0, 1.5, 1.4 and 1.3M sucrose. The SJC fraction was located 
at the 1.5-2.0M sucrose interface. By adding Triton X-100 and dextran 
sulphate to the gradient Therien and Mushynski found that they could 
minimise the interactions between SJC's and other membranes reported by 
Davis and Bloom (1973).
Isolated SJC fractions are composed predominantly of postsynaptic 
structures plus fragments of associated presynaptic membranes. The 
number of intact synaptic junctions, i.e. where both pre- and 
postsynaptic structures are present, are relatively few. (See section
1.2.1) Therien and Mushynski's method produces an SJC fraction with a 
relatively high proportion of intact SJC's which retain their presynaptic 
dense projections. These structures are usually lost during the 
isolation of synaptic subfractions. The yield of SJC protein in this 
method is, however, lower than that in fractions produced by other 
methods. The yields of SJC protein reported in the literature are given 
in Table 1.2.
1.1.3 Postsynaptic Density Fractions
The postsynaptic density can be isolated by application of more rigorous 
solubilization conditions. A range of detergents have been employed for 
this purpose and include N-lauroyl sarcosinate (NLS), sodium deos^cholate, 
high concentrations of Triton X-100 and a combination of polyethylene 
glycol, dextran T500 and 1-0-n-octyl-^-D-glucosidase (Cotman et al.,
1974; Matus and Taff-Jones, 1978; Cohen et al., 1977; Gurd et al.,
1982). The morphological and biochemical characteristics of the 
resultant fraction depend on the isolation conditions employed (Matus 
and Taff-Jones, 1978). PSD fractions isolated using Triton X-100 contain 
a higher percentage of contaminating membranes than fractions produced 
using the other detergents but the PSD itself retains its characteristic
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f i g . 1.4
Isolation of postsynaptic densities
1. Cotman et al., 1974
2. Cohen et al., 1977
1. SPM fraction SPM fraction
Extract with N-lauroyl sarcosinate 
at 0.5 or 3.9% (w/v) for 6-10 min 
at 4°C.
Apply to gradient
sample
1.0 )
1.4 ) M sucrose
2.2 )
64,000g^^, 75 min
Dilute interface 1:3 
with 0.1 mM EDTA 
and pellet at 78,OOOg^^ for 
20 min
Extract with equal volume of 
1% (v/v) Triton X-100 for 15 
min, 0-4°C.
48,000g^y,20 min
Resuspend pellet in 0.32M 
sucrose containing ImM NaHCO, 
Apply to gradient
sample
1.0 ) M sucrose
1.5 ) +lmM NaHCO^
2.0 )
275,000g^^, 2 h or 
overnight
Dilute interface with 
distilled water and pellet at 
275,000g^^ for 1 h
- ' - i ü L  -
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structure as seen In situ (Matus and Walters, 1975). Sodium deoxycholate 
and NLS solubilize a greater proportion of the PSD protein and yield a 
fraction in which the PSD's have an open lattice-like structure (Matus 
and Taff-Jones, 1978). The procedures used for the isolation of PSD 
fractions are similar to those used for SJC's (Fig. 1.4). The SPM 
fraction is incubated with the detergent solution for 10 minutes at 0-4*C 
or 37°C followed either by direct centrifugation to give the detergent- 
insoluble fraction (designated by some workers as the PSD fraction)
(Cohen et al, 1977; Matus and Taff-Jones, 1978) or by discontinuous 
sucrose density gradient centrifugation (Cohen et al., 1977, 'long 
procedure'). Curd et al. (1982) developed a novel system in which a PSD 
fraction of high purity could be rapidly isolated from SPM. In this 
system the SPM fraction is homogenised in polyethylene glycol, dextran 
T500 and l-O-^-octyl-^-D-glucoside which is then centrifuged at 2250^^^ 
for 7.5 minutes. During centrifugation the polyethylene glycol and 
dextran T500 phases separate and the PSD fraction bands at the interface. 
These workers found that by using the mild, neutral detergent 
n-octyl-glucoside the activity of a PSD protein kinase is preserved. 
(Gurd, unpublished observations reported in Gurd, 1982). The reported 
yields of PSD protein are given in Table 1.2
1.1.4 Purity of Synaptic Subfractions
The reported purities of the synaptic subfractions are given in Table
1.3. The methods for assessing the purity of fractions are fully 
discussed in section 1.2. The purity of the fraction depends on the 
isolation method used. The use of the classical procedures of 
differential and density gradient centrifugation for the isolation of 
synaptic subfractions do not, unfortunately, yield fractions of extremely 
high purity. This is an inevitable consequence of the similarity in 
buoyant densities of the synaptic membranes and potential contaminants.
It is possible that with the advent of monoclonal antibody techniques 
methods for the production of highly purified subfractions will be 
developed. A method for isolating synaptic vesicles using monoclonal 
antibodies has been developed by Reichardt and Matthew, (1982).
1.1.5 The Heterogeneity of Synaptic Subfractions
The synaptic plasma membrane fraction comprises portions of the pre- and
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TABLE 1.3
Reported purity of synaptic subfractions
SPM
% purity Basis of estimate Reference
over 85 
85-90 
80 
85-90 
85-90
chemical and enzymatic
enzymatic
morphological
enzymatic
enzymatic
Morgan et al., 1971 
Levitan et al., 1972 
Jones and Matus, 1974 
Gurd et al., 1974 
Smith and Loh, 1977
SJC
% purity 
65
Extraction medium
0.5% Triton X-100
Basis of estimate Reference
morphology Cotman and 
Taylor, 1972
50 0.2% Triton X-100 Davis and 
Bloom, 1973
65 0.2% Triton X-100/ 
Freon 113
Therien and 
Mushynski, 
1976 '
75 2:1 Triton X-100:protein Nieto- 
Sampedro 
et al., 1982a
PSD
>85 3% NLS morphology Cotman et al., 
1974
>90 0.5% Triton X-100 Cohen et al., 
1977
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postsynaptic membranes and the electron dense bodies associated with 
them. Thus, even at the simplest level, SPM is a heterogeneous fraction 
consisting of membranes and proteinaceous structures derived from two 
cells. Synaptic subfractions appear to be derived, at least primarily, 
from Type I (or asymmetric synapses) rather than Type II (or symmetric 
synapses). This classification of synapses was first made by Gray (1959) 
who later correlated Type I synapses with excitatory transmission and 
Type II synapses with inhibitory transmission (Gray, 1969). This 
selectivity may, however, be due to difficulty in identifying Type II 
synapses since the presynaptic dense projections are usually lost during 
the isolation procedure. Matus and Walters (1976) identified both types 
of synapses in synaptosome fractions thus it is feasible that the 
apparent selectivity of the isolation procedures is merely indicative of 
the difficulty in identification of Type II synapses.
In addition to this structural variety of synapses there is also 
functional heterogeneity. Synapses derived from nerve tracts utilising 
different neurotransmitters have been shown to vary in buoyant density.
De Robertis et al. (1962; 1963) isolated two distinct populations of 
synaptosomes of which the ligher fraction was enriched in cholinergic 
terminals whilst the more dense fraction appeared to contain non- 
cholinergic nerve endings.
More recently it has been shown to be possible to select a specific 
population of synaptosomes using antisera against transmitter-related 
enzymes. Docherty et al. (1982) were able to specifically lyse a 
cholinergic subpopulation of synaptosomes by incubation with an antiserum 
against choline acetyltransferase. Subsequently this group has also been 
able to specifically lyse GABAergic synaptosomes using an antiserum 
against glutamate decarboxylase (Docherty et al., 1983). The possibility 
of selecting specific subpopulations of synapses in this way may offer a 
means of limiting the i n n a t e  heterogeneity of synaptic plasma membrane 
fractions.
1.2 Characterisation of Synaptic Subfractions
1.2.1 Morphological Analysis
Synaptic subfractions can be characterised in a vpûniber-of ways rto :
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ascertain both the content and degree of purity of the fractions. By 
examining a fraction morphologically it is possible to determine whether 
the component of interest is present (assuming that it is morphologically 
identifiable) and is structurally preserved and whether the fraction is 
significantly contaminated (again assuming that any contaminants are 
unambiguously^identifiable).
The SPM fraction is typified by the presence of vesicular p^files
0.5-1.2pm in diameter (Jones and Matus, 1974) with their characteristic 
synaptic densities. Some profiles contain residual synaptic vesicles 
adhering to the presynaptic membrane. Some profiles are, inevitably, 
sectioned in a plane which does not include the synaptic densities which 
makes definite identification of these structures difficult since other 
non-junctional membranes (e.g. axonal and dendritic) have a similar 
appearance. Jones and Matus (1974) reported other contaminants to be 
"sparsely distributed amorphous dense bodies" and synaptic mitochondria 
still enclosed within some nerve endings. Cotman and Matthews (1971) 
also found small electron-dense bodies in their SPM fractions and 
suggested that, on the basis of a similarity in morphology, these might 
be lysosomes.
SJC and PSD fractions have been almost exclusively characterised by 
morphological methods since enzymic analysis is unreliable due to the 
effects of the detergents used in the isolation procedures.
SJC fractions have been reported to consist predominantly of synaptic 
complexes with prominent PSD's Which may be enclosed within a small 
vesicle of postsynaptic membrane (Cotman and Taylor, 1972). Several 
groups have applied quantitative electron microscoj^e methods to the 
analysis of SJC and PSD fractions and have found that only a small 
proportion of structures in SJC fractions are intact synaptic complexes,
1.e. with both pre- and postsynaptic elements present. Nieto-Sampedro 
et al. (1982b) estimated that in their SJC fraction bnly 6-31% of 
identifiable structures were intact SJC's although a minimum of 85% were 
PSD's or PSD plus a fragment of postsynaptic membr^^. Most groups have 
found the presynaptic dqnse projections to be severely damaged or missing 
(Cotman and Taylor, 1972; Davis and Bloom, 1973; Matus et al., 1975). 
Therien and Mushynski (1976), however, fopnd that a much greater 
proportion of identifiable structures in their SJC fraction were intact
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complexes and estimated that about 65% of the total occupied area was 
attributable to junctional structures. In addition many of the complexes 
retained their presynaptic dense projections which, in a few cases, 
appeared to be attached to the PSD although no intervening membrane 
remained. Contaminants have usually been reported to be membranes or 
dense bodies of uncertain origin (Therien and MusKynski, 1976; 
Nieto-Sampedro et al., 1982a).
Postsynaptic density fractions are usually of a higher degree of purity 
than SJC fractions (See Table 1.5). The morphology of the PSD fraction 
depends on the isolation method used. In fractions isolated using Triton 
X-100 (0.5% or 3%, v/v) or low concentrations of deoxycholate (1-2%, w/v) 
the appearance of the PSD closely resembles that seen in situ and 
consists of particles 10-20nm in diameter (Matus and Walters, 1975;
Cohen et al., 1977; Matus and Taff-Jones, 1978). PSD fractions prepared 
using N-lauroyl sarcosinate (0.5% or 3.9%, w/v) or higher concentrations 
of deoxycholate (3%, w/v) remove a higher proportion of the adhering 
membrane (Cotman et al., 1974; Matus and Taff-Jones, 1978). At this 
concentration deoxycholate produces PSD-like structures of lower electron 
density than those produced using Triton X-100 and appear to have a more 
'open' structure which prompted Matus and Walters (1975) to name them 
postsynaptic junctional lattices. Matus and Taff-Jones (1978) suggested 
that these arose due to differential removal of intrinsic PSD proteins by 
deoxycholate. This fraction resembles the "loosened" structures produced 
by various chemical treatments of PSD's which have also been reported to 
remove certain PSD proteins (Blomberg et al., 1977).
The appearance of PSD's produced by the less rigorous treatments has 
been reported as being either bars or crescents with an overall diameter 
of 150-350 nm and 30-40nm thick (Cotman et al., 1974; Cohen et al.,
1977; Matus and Taff-Jones, 1978; Gurd et al., 1982; Nieto-Sampedro 
et al., 1982a). Some PSD's, however, have been found to have a central 
perforation giving them a "doughnut-like" appearance. These PSD's have 
diameters at the higher end of the range (350-370 nm) (Cohen et al.,
1977; Cohen and Siekevitz, 1978; Nieto-Sampedro et al., 1982b).
The PSD appears to consist of dense-staining aggregates 20-30 nm in 
diameter which are connected, in some preparations, by filaments of l 
diameter 6-9 nm (Carlin et al., 1980). Cohen et al. (1977) observed
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diffuse material extending up to 100 nm from the cytoplasmic face of the 
PSD with occasional subsynaptic bodies being connected to the PSD via 
filaments.
Regional differences in PSD morphology have been reported in dog brain 
where cerebellar PSD's appeared to have no central perforations and were 
thinner than cerebral cortex PSD's (Carlin et al., 1980). These workers 
suggested that these PSD's may arise from Type II synapses since this 
type predominates in the cerebellum.
Contaminants of PSD fractions have been reported to be membranes, 
microtubules or amorphous material of uncertain origin (Cotman et al., 
1974; Cohen et al., 1977; Gurd et al., 1982; Nieto-Sampedro et al., 
1982a). On the basis of quantitative electron microscopic studies these 
workers have estimated that PSD fractions are contaminated 10-15% by 
these components.
Thus, the morphology (and degree of contamination) of the SJC and PSD 
fractions depends on the solubilization conditions employed and the 
brain region used as the source of tissue.
1.2.2 Enzymic Analysis
In order to obtain an estimate of the degree of contamination of the 
various synaptic subfractions it is necessary to complement the 
morphological data with marker enzyme distribution analysis.
Determination of the degree of purity of synaptic subfractions on the 
basis of enzymic analysis has been hampered by the lack of specific 
marker enzymes for the junctional region of the neuronal membrane. Thus 
negative marker enzymes, i.e. those specific to putative contaminants and 
positive marker enzymes, i.e. those at least substantially located in 
the synaptic plasma membrane, have been used in characterisation studies.
The enzymes commonly used as positive markers for SPM are (Na^,K^)ATPase, 
5'-nucleotidase and acetylcholinesterase (AChE). Enrichment of these 
enzymes in the SPM fraction over the homogenate is generally considered 
to be a good indication of SPM being the predominant component in that 
fraction.
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Neuronal (Na^jK^)ATPase is usually measured by its sensitivity to ouabain 
which distinguishes it from other ATPase activities which may be present. 
Cotman and Matthews (1971) found that the activity of (Na"*",K^)ATPase was 
enriched 5-fold in their SPM fraction over the homogenate. Morgan 
et al. (1971) and Gurd et al. (1974), however, obtained a 10-15 fold 
enrichment of this enzyme in their SPM fractions. Mahadik et al. (1978) 
suggested that this might be due to the removal of an inhibitor of the 
enzyme by the repeated washings of the fractions in these procedures. 
Schaffer et al. (1974), however, demonstrated the presence of a soluble, 
dialyzable inhibitor of (Na"^,K^)ATPase which may be co-extracted with 
SPM. The inhibiting effect was able to be negated by the use of 
chelators such as EDTA and EGTA.
(Na^,K^)ATPase, however, is also thought to be present in glial 
membranes. Jones and Matus (1974) found that 48% of the total 
(Na ,K )ATPase activity recovered from their sucrose density gradient 
was present in the myelin fraction and 44% in the SPM fraction. If the 
crude mitochondrial fraction was subjected to sonication in addition to 
hypotonic shock 91% of the total activity was found in the SPM fraction. 
Thus excessively high levels of (Na^,K )ATPase activity may indicate 
glial contamination which, in turn, depends on the isolation conditions 
used.
5 *-nucleotidase is also frequently used as a marker for SPM although 
this has been more extensively characterised as a plasma membrane marker 
in liver fractions (Evans and Gurd, 1973). Cotman and Matthews (1971) 
found that 35% of the total activity of this enzyme was associated with 
the myelin fraction and 42% with the SPM fraction which they suggested 
was an indication that this enzyme Was not primarily associated with 
SPM. Henn and Hamberger (1976) have reported finding high activity of 
5'-nucleotidase associated with glial membranes, whilst Kreutzberg 
et al. (1978) suggested that this enzyme is almost exclusively associated 
with glial membranes.
Cotman et al., (1971a) demonstrated that a subfraction of cultured glial 
cells sediment at the same isopycnic density as synaptosomes. Using a 
mixed fraction containing (Î’^ C)leucine labelled cultured glial cells 
and a whole rabbit brain homogenate Henn et al. (1976) found that in 
the synaptosome fraction isolAted from this mixture at least 40% of the 
material was of glial otigih.
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Thus high levels of activity of either (Na^,K^)ATPase or 5'-nucleotidase 
in synaptic subfractions may indicate significant contamination by glial 
membranes which have no morphologically characteristic features. 
Acetylcholinesterase also appears to be associated with low buoyant 
density membrane fragments (Cotman and Matthews, 1971). Shute and Lewis 
(1966) found this enzyme to be associated with axonal, dendritic and 
microsomal membranes. Cotman and Matthews (1971) estimated that about 
44% of the total activity of this enzyme recovered from the gradient was 
present in the SPM fraction. Jones and Matus (1974), however, found 
about 78% of the total activity in the SPM fractions. Since AChE is 
found in a range of membranes which transport water or ions including 
erythrocyte and platelet membranes (for extensive discussion see Silver,
1974) this enzyme is a poor marker for SPM.
In addition to assaying for positive markers of synaptic membranes it is 
possibly more fruitful to assess markers known to be specific to putative 
contaminants.
Mitochondrial contamination is usually estimated by assaying for 
cytochrome c oxidase or succinate dehydrogenase both of which are 
exclusively located on the inner mitochondrial membrane. Only low levels 
of activity of these enzymes are usually found in the SPM fraction e.g.
6% (Cotman and Matthews, 1971), 9% (Jones and Matus, 1974) and less than 
3% (Morgan et al., 1971) using cytochrome c oxidase. Morgan et al. 
(1971), however, suggested that the outer mitochondrial membrane may be 
damaged during the lysis step of the isolation procedure. They based 
this suggestion on the observation of high levels of monoamine oxidase 
(MAO) activity present in their SPML fraction. These workers also 
suggested that MAO in brain tissue might not be confined to the outer 
mitochondrial membrane since estimation of the levels of NADH:cytochrome 
c reductase, which is also present in the outer mitochondrial membrane, 
did not correspond well with the MAO data. NADH: cytochrome c reductase 
is also found in microsomal membranes although microsomal contamination 
is usually monitored by assaying rot enone - ins ens it ive NADPH: cytochrome c 
reductase. Using the latter enzyme the levels ot contamination of SPM by 
microsomal membranes has been estimated to be less than 10% (Morgan 
et_al.ÿ 1971), 3% (Levitan et al., 19721 and 10-15% (Gurd et al., 1974).
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Myelin is another major contaminant of SPM fractions. This can be 
detected by assaying for 2*,3'-cyclic nucleotide 3'-phosphohydrolase 
(Kurihara and Tsukada, 1967). Using this enzyme Jones and Matus (1974) 
estimated that 5% of the total activity recovered from the gradient was 
present in the SPM fraction. Tamir et al. (1976) reported a very low 
activity of this enzyme in their SPM preparation and estimated the myelin 
contamination to be less than 0.5%. They attributed this to careful 
trimming of the cortex prior to homogenisation to remove as much white 
matter as possible and also to the use of sodium diatrizoate gradients 
instead of sucrose. Levitan et al., (1972) estimated myelin 
contamination of their SPM fraction by adding radiolabelled myelin to 
the preparation prior to homogenisation. Subsequently they determined 
the specific activity of the membrane fraction and estimated that myelin 
protein accounted for 1-2% of the total protein in the SPM fraction. In 
a similar way glial and axonal membrane contamination was estimated to 
be 2-3% each and microsomal and mitochondrial contamination to be 3-5% 
each.
Cotman and Matthews (1971) estimated contaminât ion of SPM fractions by 
lysosomes by assaying for acid phosphatase and
^-N-acetylglucosaminidase. They found that about 44% of the total 
recovered activity of these enzymes was present in the SPM fraction.
These workers suggested that lysosomal contamination of the SPM fraction 
probably accounted for only a very small proportion of the protein since 
purified lysosomes have been shown to have a specific activity 100 times 
that of the homogenate (Sawant et al., 1969). They also suggested that 
these enzymes may be loosely associated with SPM since some lysosomal 
enzymes have been found in plasma membranes. (Fleischer and Fleischer, 
1969). Gurd et al., (1974) estimated that lysosomal contamination of 
their SPM fraction was less than 10% on the basis of the distribution of 
these enzymes.
1.2.3 Additional Methods for Assessing Purity
To assess the purity of any fraction accurately the ideal marker should 
be specific to that fraction. Protein species which satisfy this 
criterion for synaptic fractions are the neurdtransmitter receptors- 
These are most easily assayed by radioligand bindii% studies. (See 
review by Mahler, 1977). Salvaterra and Matthews (1980) determined the
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relative enrichment of muscarinic and nicotinic cholinergic receptors by
3 125measuring the specific binding of ( H) quinuclidinyl benzilate and ( I)
bungarotoxin in their SPM fraction. They found a 2-4 fold enrichment of
these receptors in their SPM fraction.
It is also possible to compare the electrophoretic protein profiles of 
the isolated SPM fraction with those of known contaminants. By critical 
comparison of the relative mobilities and abundance of polypeptides on 
SDS polyacrylamide gels it is possible to detect the presence of 
contaminating material.
Myelin, for example, has a very characteristic profile with highly 
enriched polypeptide bands corresponding to the basic proteins of 
apparent molecular weights 14, 17, 18 and 2IK, the DM-20 protein, 20.5K, 
the proteolipid protein, 24K and the WoIfgram proteins, 51, 54 and 62K 
(molecular weights taken from Waehneldt, 1978). Thus contamination of 
the SPM fraction by myelin is readily identifiable especially in the 
lower molecular weight regions of the gel.
The mitochondrial fraction also has a distinctive electrophoretic protein 
profile and shows enrichment of polypeptides of 50 and 5IK over SPM 
fractions (Mena et al., 1980). Other major mitochondrial proteins have 
molecular weights 46.5, 45.5, 42.5, 34, 32.5, 31 and 29.5K. (Mena 
et al., 1980). These low molecular weight polypeptides are particularly 
distinctive and are useful indicators of mitochondrial contamination of 
SPM fractions.
SPM fractions contain four major polypeptides of molecular weights 99,
55, 52 and 43K (Matus, 1978). The identities of these are thought to be 
a subunit of (Na"*",K^ ) ATPase, tubulin, a unique tubulin-like PSD protein 
and actin respectively (Mahler, 1977).
Microsomes show a very similar electrophoretic protein profile to SPM 
(Gurd et al., 1974: Mena et al., 1980). The latter found, however,
that SPM fractions appeared to be enriched in a polypeptide of 32K.
Wang and Mahler (1976) compared the electrophoretic profiles of SPM 
fractions isolated by the methods of Gurd et al. (1974) and Jones and
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Matus (1974). They found that although the overall patterns were similar 
and showed the four major and twelve minor polypeptide bands there 
appeared to be more polypeptides present in the Jones and Matus 
preparation. Since these were in the low molecular weight region of the 
gel they suggested that these may be mitochondrial or myelin proteins.
Interpretation of electrophoretic profiles may be difficult where samples 
have similar profiles. For example, in all of the fractions described 
above, the 50-60K region is extremely complex and contains a number of 
major polypeptides of similar molecular weights. This can be overcome, 
to some extent, by judicious use of gels of different acrylamide 
concentrations which improve the resolution in the chosen area of the 
gel.
Polypeptides are usually located by staining with Coomassie Brilliant 
Blue. Many workers have estimated the relative amounts of polypeptides 
present on the basis of their staining intensities. Coomassie Brilliant 
Blue staining is, however, only semi-quantitative. Phillips and Slater 
(1975) showed that actin binds less dye than does serum albumin. Bray 
and Thomas (1975) estimated that actin showed only 67% of the staining 
intensity of the same amount of serum albumin. It has also been 
demonstrated that Coomassie Brilliant Blue staining of proteins deviates 
from Beer's law at high protein concentrations (Chfambrach et al., 1967).
Matus et al. (198(^ ) used antisera against glial and neuronal filaments 
to detect filament antigens in SDS polyacrylamide gels of synaptic 
subfractions. Other workers have used 2—dimensional electrophoresis to 
identify proteins in synaptic subfractions following trypsin digestion 
(Kelly and Cotman, 1978). Thus, electrophoresis is a powerful tool for 
the analysis and characterisation of synaptic subfractions.
1.3 The Composition of Synaptic Plasma Membranes
1.3.1 Prdtein Composition
Most work on the composition of SPM has centred on the protein components 
in order to define the significance of these constituents With regard to 
the Structure and functioh of the synapiSS. /
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The SPM fraction consists of 50-70 polypeptides when separated by SDS 
polyacrylamide gel electrophoresis (Banker et al., 1972; Mahadik et al., 
1976; Wang and Mahler, 1976; Mahler, 1977) of which about 20 are major. 
Wang and Mahler (1976) estimated that eleven polypeptides of molecular
weights, 250, 225, 175, 137, 97, 68, 54, 44, 37 and 33K accounted for 93%
of the total SPM protein with the 97, 54, 44 and 37K polypeptides 
constituting more than 60%. All SPM fractions appear to be particularly 
enriched in polypeptides of 54 and 45K (Kelly and Cotman, 1977).
Synaptic junctional complex fractions have similar electrophoretic 
profiles to SPM but the relative intensities of some polypeptide bands 
differ from equivalent bands in the SPM fraction (Kelly and Cotman,
1977). These workers found that, although no single SJC polypeptide 
accounted for more than 10-15% of the total, eight polypeptides accounted 
for more than 5% each. SJC polypeptides which were markedly enriched
over SPM fractions had molecular weights of 280, 275, 150, 63, 55, 52, 45
and 32K (Kelly and Cotman, 1977). Therien and Mushynski (1976) reported 
that the 97K polypeptide was enriched in SJC fractions.
The PSD fraction, by comparison, has a simpler elec^pphoretic protein 
profile although the number of polypeptides present varies depending on 
the extraction procedure. The major polypeptide has a molecular weight 
of 52K and has been estimated to account for 45% of the total protein in 
this fraction (Banker et al., 1974; using NLS extraction). Üiese 
workers also found significant quantities of polypepties of 180, 86, 55, 
45, 28 and 26K while Gurd et al. (1982) found polypeptides of 180, 130, 
110, 94, 65 and 60K to be enriched in their PSD fraction. Kelly and 
Cotman (1977) estimated that the 55K polypeptide accounted for 14% of 
the total protein while Banker et al. (1974) estimated that the 97K 
polypeptide constituted 17% of the total protein.
The identities of the synaptic proteins have been sought in order to 
gain some insight into the working of the synapse at the molecular level. 
A number of SPM proteins have now been identified.
* The exact value for the molecular weight varies siightly according to 
the gel system used. Thus the same protelu may be reported to haye 
different molecular Weights by different workers.
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The presence of intermediate filaments and microtubules in electron 
micrographs of the synaptic region (Westrum and Gray, 1976; Yen et al.,
1977) prompted workers to examine synaptic subfractions for the presence 
of fibrous proteins characteristic of the cytoskeleton. In all synaptic 
subfractions there are major polypeptides (molecular weights 56, 54 and 
45K*) with similar electrophoretic mobilities to those reported for 
certain fibrous proteins, namely X  and ^  tubulin and actin (Kelly and 
Cotman, 1977). The polypeptides of 56 and 54K have been shown to 
comigrate, in SDS polyacrylamide gels, with purified and OCtubulin 
respectively. (Feit et al., 1977; Kelly and Cotman, 1977). SJC and PSD 
fractions have been reported to contain both and ^  tubulin which are 
identical to their cytoplasmic form as demonstrated by 2-dimensional 
electrophoresis and tryptic peptide analysis (Kelly and Cotman, 1978). 
These workers estimated that these proteins constitute about 9% of SJC 
and 14% of PSD total protein. Blomberg et al. (1977), however, found 
that tubulin was only a minor component of PSD's isolated from dog 
cortex. This prompted them to suggest that tubulin might be loosely 
linked to the PSD structure. This seems unlikely since tubulin was not 
removed from the PSD under the more severe extraction conditions employed 
by Kelly and Cotman (1977). Babitch (1981) reported that tubulin could 
only be removed from SPM fractions under conditions where the membrane 
was completely destroyed and interpreted this as indicating that tubulin 
was an integral SPM protein. Carlin et al. (1982) demonstrated that 
detergent treatment of the PSD did not reduce the amount of tubulin in 
this fraction. This group, however, observed that the PSD became 
increasingly enriched in tubulin in the postmortem period. Thus the 
variable amounts of tubulin reported by different groups may be a 
consequence of the isolation conditions. It is now thought that tubulin 
is not a major component of synaptic subfractions.
The major PSD polypeptide (mPSDp) has a molecular weight of 52K and 
migrates ahead of purified tubulin (Kelly and Cotman, 1977). Tryptic 
peptide analysis demonstrated that this protein was similar to tubulin 
(Feit et al., 1977) but unrelated to glial fibrillary acidic protein 
which has a similar molecular weight (Mena et al., 1981).
Extensive characterisation of the inPSDp how sefans to suggest that this 
protein is unique to the synapse (Kelly a^d Cotman, 1978). Tryptic 
pep t ide , maps o f pr o teing o£; sitd.lar molecuTar weight s f r om r at brain
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cytosol, rat liver plasma membranes and chick lens gap junctions proved 
to be dissimilar to that of the mPSDp (Kelly and Montgomery, 1982).
These workers, however, did find a 52K polypeptide in a microsomal 
subfraction (P^B^) which resembled the mPSDp in all respects. De Bias 
and Mahler (1978) reported that this fraction was enriched in 
neurotransmitter receptors and concluded that this fraction contained 
postsynaptic membranes minus the PSD. Mena et al. (1981) also observed 
a mPSDp-like protein in a similar microsomal subfraction but, unlike 
Kelly and Montgomery (1982), could find no electron micrographie evidence 
of the presence of junctional structures in this fraction.
Carlin et al. (1980) found that cerebellar PSD's contained relatively 
low amounts of the mPSDp but possessed an apparently unique protein of 
74K. Kelly and Montgomery (1982) also observed a reduction of about 
20-fold in the amount of mPSDp in cerebellar PSD's while SJC fractions 
prepared from rat forebrain minus the cerebral cortices contained about 
half the amount of mPSDp compared with SJC's from the cortex alone.
Both groups suggested that these deficits might reflect the higher 
proportion of Type II synapses in the cerebellum and the cerebral 
structures underlying the cortex. This is difficult to reconcile with 
the suggestion of Kelly and Montgomery (1982) that the microsomal 
SJC-like fraction possibly represented Type II synapses since this 
fraction contained significant amounts of the rnPSDp. Thus more work is 
necessary to define the role of the mPSDp within different types of 
synapses.
The mPDSp appears to be linked to the PSD via ihtermolecular disulphide 
bonds since electrophoretic profiles of unreduced PDS's lack both this 
and a 55K polypeptide (Kelly and Cotman, 1976). These workers suggested 
that, on this basis, disulphide bonds may play an important role in the 
regulation of synaptic function at the level of junctional structure.
The 45K polypeptide present in all synaptic sub Fractions has been found 
to comigrate with actin (Kelly su^ d Cotman,, 1977). Two dimensional 
electrophoresis has shown that/$ and ]f -actin arc prasent in these 
fractions in approximately equal amounts bnt not the o( -actin 
characteristic of muscle calls (Kelly and Cotman, 1978)^ i Matus at al., 
(1982) used antl-actin antibodies to damonstrata“that in Intact tissua 
actin is concantratad in the PSD althou^ thera Is significant
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immunohistochemical staining of the surrounding cytoplasm particularly 
within dendritic spines. Blomberg et al. (1977) found that actin could 
be selectively removed from the PSD by deoxycholate/KCl, deoxycholate/ 
dithiothreitol and deoxycholate/parachloromercuribenzoate. All of these 
treatments caused an 'opening up' of the structure leaving a lattice-like 
entity similar to that derived using high concentrations of deoxycholate 
(Matus and Taff-Jones, 1978). Blomberg et al. (1977) suggested that the 
PSD was composed of aggregates (10-20 nm in diameter) of the mPSDp since 
this was resistant to all of these chemical treatments and that these 
aggregates might be bundles of filaments seen in cross-section. Electron 
micrographs appeared to show that these aggregates were connected by 
narrow filaments composed primarily of actin since these were removed on 
treatment with the above reagents.
Beach et al. (1981) produced a monospecific antibody against chicken
gizzard myosin to which SPM and SJC fractions reacted positively although
PSD and myelin fractions showed no reaction. These workers showed that
the tryptic peptide fingerprints of the putative SJC myosin was
indistinguishable from purified brain myosin but distinct from purified
smooth and skeletal muscle myosins. It was also demonstrated that the
presence of myosin in these fractions was not due to adherence of the
molecule to the junctional apparatus during isolation since addition of 
125
( I) labelled myosin during fractionation was not subsequently found in 
the subfractions.
The presence of these proteins may indicate the existence of an 
actomyosin complex with functional activity at the synapse. Indeed,
Berl et al. (1973) demonstrated that actomyosin-like proteins were 
concentrated in synaptosomal fractions. These workers postulated that 
these contractile proteins might be involved in transmitter release from 
the presynaptic terminal (Berl and Nicklas, 1975). It is possible that 
Other myofibrillar proteins are present at the nerve ending. Bldmberg 
et al. (1977) examined the electrophoretic profiles of mixtures of PSD's 
and myofibrillar proteins. Eight proteins were found to have equivalent 
electrophoretic mobilitlès (molecular weights 110, IQO, 59, 45, 31, 26,
18 and I7K although the 110, 59 and 17K polypeptides were thought to be 
contaminants). No myofibtillar proteiU, however ; %as been definitively 
identified in synaptic sUbfredtions. The 18K polypeptide was sug&estëd
\ - : ' - ^  j ! L_-V, !i. L I ■
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by Blomberg et al. (1977) to be similar to one of the troponin subunits 
- the calcium binding protein troponin C. This was subsequently 
demonstrated to be calmodulin (Grab et al., 1979). Its presence in the 
PSD was confirmed by immunohistochemistry and radioimmunoassay (Lin 
et al., 1980; Wood et al., 1980) (for further discussion of calmodulin 
see section 1.3.3.)
Recent evidence suggested that a high molecular weight doublet observed 
in SDS polyacrylamide gels is fodrin - a spectrin-like protein which 
forms a 'lining' on the cytoplasmic face of plasma membranes (Carlin 
et al., 1983; Kakiuchi et al., 1982; Sobue et al., 1982). Fodrin 
comprises two polypeptides of 250 and 240K which are prominent in SPM,
SJC and PSD fractions. Fodrin has been reported to interact with actin 
in vitro (Levine and Willard, 1981). These workers suggested that fodrin 
might have a role in linking submembranous structures to the membrane 
(Levine et al., 1981). Thus fibrous proteins appear to have an important 
role in synaptic structure and function.
1.3.2 Glycoprotein Composition
Synaptic subfractions have been found to contain a number of 
glycoproteins (Kelly and Cotman, 1977; Restas et al., 1977). This fact 
has generated considerable interest since glycoproteins have been 
implicated in cell-cell recognition and adhesion (see review by Barondes,
1975). Although there is no firm evidence to support the supposition 
several workers have tentatively suggested that the junctional 
glycoproteins might play an important part in the formation 
and maintenance of synaptic contacts (Barondes, 1976). Matus (1980) 
suggested that this could be achieved by either trans-synaptic linkage 
of oligosaccharides from the opposing membranes or by a 
lectin-glycoprotein type bonding. The former possibility would need to 
be supported by demonstration of the existence of glycosyltransferases 
in the region of synaptic junction. While Goodrum et al. (1979) have 
found receptors for glycosyItransferase activity at the synaptic 
junction other workers have been unable to demonstrate the presence of 
these enzymes in this area (Raghupathy et al., 1972; Reith et al.,
1972). The alternative suggestion of a lectin-like interaction is 
possible since lectins have been reported to be present in brain tissue 
(see review by Simpson et al., 1978). Matus, however, was unable to
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find any lectin activity in either soluble or particulate fractions from 
rat brain (Banner and Matus - unpublished observations reported in 
Matus, 1980).
While several groups have examined the sugar composition of synaptic 
subfractions there is little agreement as to the relative proportions of 
the sugars present (Margolis et al., 1975; Churchill et al., 1976).
The most abundant sugars are N-acetylglucosamine, N-acetylgalactosamine, 
mannose, galactose, fucose and sialic acid.
SJC's and PSD's contain relatively low amounts of sialic acid although 
PSD’s show high levels of mannose (Churchill et al., 1976; Gurd, 
unpublished observations reported in Gurd, 1982). Both SJC's and PSD's 
have been found to contain high levels of glucose (Churchill et al.,
1976) which is an unusual component of glycoproteins. These workers 
suggested that-(his may be due to the presence of residual sucrose from 
the isolation media.
Histochemical examination of the synapse has demonstrated the presence 
of high concentrations of lectin receptors in the junctional region 
(Cotman and Taylor, 1974; Kelly et al., 1976). Receptors for Con A and 
Ricinus communis lectin (see Table 1.4) have been identified on the 
postsynaptic membrane where those overlying the PSD show restricted 
lateral mobility and are unable to aggregate in the presence of lectin 
(Cotman and Taylor, 1974; Kelly et al., 1976; Matus and Walters, 1976).
Subsequent studies in which the binding of radiolabelled lectins to 
synaptic subfractions was examined following electrophoresis showed that 
while SPM fractions contained 10-12 Con A binding proteins (Zanetta 
et al., 1975; Gurd, 1977b) SJC fractions contained only 3 major classes 
(molecular weights 180, 130 and IlOK) (Gurd, 1977a, b). Kelly and 
Cotman (1977) identified an additional junctional glycoprotein of 95K 
and designated these glycoprotein components I-IV respectively. These 
workers estimated that these 4 components accounted for 53% of the total 
Con A binding activity of SJC fractions. No binding components were 
found in the 45-55K region in SJC fractions although considerable Con A 
binding was found in this region in SPM fractions. Kelly and Cotman 
(1977) attributed this to the presence of extrajunetional glycoproteins 
in SPM fractions. In addition, they found no Con A binding activity in
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TABLE 1.4
Specificities of plant lectins
Lectin Sugar specificity
Concanavalin A (Con A) D-mannose, D-glucose
Wheat germ agglutinin (WGA) N '-acetyl-D-glucosamine, 
sialic acid
Lens culinaris phytohaemagglutinin (LCH) D-mannose, D-glucose
Ricinus communis agglutinin (RCA) D-galactose, N-acetyl-D* 
galactosamine
Lotus tetragonolobus lectin (fucose 
binding protein)
Fucose
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the PSD fraction and concluded that all of the binding sites must, 
therefore, reside in the junctional membranes. This is supported by 
earlier histochemical studies which indicated that synaptic glycoproteins 
are located on the external surface of synaptic membranes in Type I 
synapses (Wang and Mahler, 1976; Chiu and Babitch, 1978) although Con A 
binding sites have been observed on the cytoplasmic face of postsysnaptic 
junctional membranes in Type II synapses (Matus and Walters, 1976). Gurd 
(1977a, 1982), however, has reported the presence of the three major 
classes of Con A binding proteins in PSD fractions prepared under a 
variety of isolation conditions. The major jifctional Con A binding 
proteins appear to be highly conserved since their presence has been 
demonstrated in different brain areas (Rostas et al., 1979) and a range 
of species including mammals (Blomberg, et al., 1977; Gurd, 1977a; Kelly 
and Cotman, 1977; Rostas et al., 1979; Freedman et al., 1980) and 
amphibia, fish and reptiles (Nieto-Sampedro et al., 1982a). In addition, 
the tryptic peptide maps of the three higher weight Con A receptors are 
very similar (Mena and Cotman, 1982). These glycoproteins appear to be 
unique to the synaptic junction and have not been detected in 
extrajunetional membranes, synaptic vesicles, axolemma, microsomes or 
myelin (Gurd, 1980).
The binding of Con A to these junctional glycoproteins is sensitive to 
K-mannosidase and endoglycosidase H indicating the the lectin binds 
primarily to mannose-rich oligosaccharides (Gurd, 1980; Gurd and Fu, 
1982). These workers have demonstrated that the major proportion of Con 
A binding activity is attributable to two classes of mannose-rich 
oligosaccharides containing 5 and 9 mannose residues (Gurd and Fu, 1982).
In addition to Con A receptors synaptic junctional fractions (both SJC's 
and PSD's) are capable of binding wheat germ agglutinin,
Ricinus communis agglutinin. Lens culinaris phytohaemagglutinin and the 
fucose specific lectin isolated from Lotus tetragonolobus. This 
indicates that a wide range of oligosaccharide structures are present at 
the synaptic junction (Gurd, 1977a, 1979, 1980) and has led Gurd and his 
co-workers to suggest that glycoproteins may play an important role in 
synaptic function.
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1.3.3 Phosphoproteins
Protein phosphorylation is thought to be involved in a number of 
regulatory systems including those at the synapse (Rubin and Rosen,
1975; Greengard, 1978a). There is a considerable body of literature on 
this topic much of which is outside the scope of this review. Only 
synaptic phosphoproteins, therefore, will be discussed.
1.3.3.1 Protein Phosphorylation Mediated by Cyclic AMP
On the basis of the substantial bo^y of evidence built up during the 
1970's (see review by Greengard, 1979) Greengard and his co-workers have 
suggested that cyclic AMP (cAMP) - mediated protein phosphorylation may 
have a key role in neurotransmission. These workers suggested that cAMP 
may play a 'second messenger' role in an analogous way to its role in 
the physiological response of target cells to hormonal action. Greengard 
has demonstrated that binding of certain neurotransmitters to their 
receptors results in activation of adenyl cyclase and thence to increased 
levels of cAMP (Greengard, 1978b). This led Greengard to suggest that 
cAMP-sensitive protein kinases present at the synaptic junction catalyse 
the phosphorylation of certain membrane proteins following 
neurotra^mitter-receptor binding, which in turn regulates some essential 
property of the junctional membranes e.g. permeability. This hypothesis 
has been widely reviewed in recent years (Bloom, 1975; Daly, 1977; 
Nathanson, 1977; Greengard, 1978a; Berridge, 1979) and is represented 
diagrammatically in Fig. 1.5.
The presence of cAMP-sensitive protein kinases in SJC and PSD fractions 
has been demonstrated by several workers (De Bias et al., 1979; Kelly 
et al., 1979; Ng and Matus, 1979a; Carlin et al., 1980). These 
enzymes catalyse the phospjprylation of endogenous substrates in the 
presence of ATP. Termination of the effects of cAMP and protein kinase 
activity requires the conversion of cAMP to AMP by a cyclic nucleotide 
phosphodiesterase (CNP) and the dephosphorylation of the substrate by a 
protein phosphatase. Both enzymes have been detected in synaptic 
subfractions. CNP activity has been detected in Isolated PSD's (Cotman 
et al., 1974) and SJC's (Therien and Mushynski, 1979b). Protein 
phosphatase activity has been detected in PSD fractions (Ng and Matus, 
1979a) but not SJC's (Therien and Mushynski, 1979a).
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f i g. 1.5
Protein phosphorylation at the synapse
Binding of transmitter 
to receptor
inactive Adenyl active 
cyclase
Cyclic
nucleotide
pho sphodies teras e '
ATP
PROTEIN-OH
cAMP ATP
rPi
inactive Protein active Protein
kinase phosphatase
AMP
ADP
PROTEIN-O-Pi
1. Cyclic nucleotide phosphodieterase has been located in SJC and
PSD fractions (Cotman et al., 1974; Therien and Mushynski,
2+1979b) and has been shown to be activated by Ca /calmodulin 
(Grab et al., 1980).
2. A protein kinase activity has been reported in SJC and PSD
fractions (Kelly et al., 1979; Carlin et al., 1980).
Activation of this enzyme is thought to occur by binding of cAMP
to the regulatory subunit thereby enabling the phosphorylation
reaction to be carried out by the catalytic subunit (Walter
2+et al, 1978). Protein kinase activation by Ca /calmodulin has 
also been reported (Grab et al., 1980).
3. Protein phosphatase activity has been reported in PSD fractions 
where it has been estimated to be enriched 2-3 times over SPM 
fractions (Ng and Matus, 1979). Therien and Mushynski (1979), 
however, could detect no activity in their SJC fraction.
-45-
A number of junctional proteins have been found to undergo 
phosphorylation in vitro of which a number are phosphorylated in a 
cAMP-dependent manner (De Bias et al., 1979; Kelly et al., 1979; Ng 
and Matus, 1979a; Berman et al., 1980) (see Table 1.3). All of these 
groups reported cAMP-dep end ent phosphorylation of proteins in the 
molecular weight regions 85-75K and 56-54K which correspond to 
Greengard*s proteins 1 and 11 respectively. Protein 1 appears to be 
unique to nervous tissue and is concentrated in SPM and synaptic vesicle 
fractions (Greengard, 1978b).
Berman et al. (1980), however, found that these two major classes of 
phosphoproteins did not appear to undergo phosphorylation in vivo where 
the predominant phosphorylated proteins were of molecular weight 70, 51 
and 44K. .Other work seems to indicate that the pattern of 
phosphorylation seen in in vitro experiments may be greatly influenced by 
the experimental conditions employed (Ng and Matus, 1979b; Weller, 1979; 
Matus et al.» 1980a). For example, if low ratios of ATP to membrane 
protein are used substrate depletion may influence the results due to 
hydrolysis of ATP by intrinsic ATPases (Matus et al., 1980a). In 
addition, Ng and Matus (1979b) were unable to obtain complete 
déphosphorylation of the endogenous substrates under the standard 
conditions used in in vitro experiments.
Thus, at present, the results of in vitro phosphorylation experiments 
are difficult to interpret in the context of synaptic physiology. The 
results of In vivo experiments are also problematic in view of the long 
duration of phosphorylation of the innate substrates.
1.3.3.2 Protein Phosphorylation Mediated by Calcium Ions
2+The depolarisation-induced influx of Ca ions into the neurone has been 
found to regulate various neurotransmitter-associated processes e.g. the 
rate of neurotransmitter synthesis (Patrick and Barchas, 1974;
Morgenroth, et al., 1975) and phosphorylation of specific endogenous 
substrates (Krueger et al., 1977).
2+A number of SPM proteins have been found to undergo Ca -stimulated 
phosphorylation in the presence of calmodulin (see Table 1.5) (Schulman 
and Greengard, 1978; De Bias et al,, 1979; DeLorenzo, 1982).
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table 1.5
Molecular weights of synaptic phosphoproteins
Enzyme dependence: cAMP 2+Ca /Calmodulin
Fraction: SPM SJC PSD PSL SPM SJC PSD
300^ 300^
220^ 22q3 22o3 23o3
210^ 180^
180^ 18o3 18o3 I55I I55I I55I
160^'3 16o3 16o3 150^
140^ 14o3 14o3 105^
100^ 10o3 10o3 100^ 100^
85^ 85^ 70^
82^ 82^ 62^
80^’^ 801 80^ 58^
75^ 78^ 75' 5i3
74^ 75^ 743 48^ 481 48^
68^ 683 6s3 453
66^ 66^ 66^
59^ 593 593
563 56,3 563
5 5 2 , 4 553
54' 54' 54I
5i3 5i3 5i3
50^ 50^
473
Values are expressed as molecular weight xlO ^
1. De Bias et al., 1979
2. 'Kelly and Cotman, 1979
3. Ng and Matus, 1979
4. Berman et al., 1980
5. Grab et al., 1980
PSL = postsynaptic junctional lattice (Ng and Matus, 1979)
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Calmodulin has been identified in association with the postsynaptic
membrane (Wood et al, 1980) and the PSD (Grab et al., 1979; Grab
et al., 1980) where a calmodulin-activated protein kinase activity (Grab
et al., 1981b) and a number of calmodulin-binding proteins (Carlin
et al., 1981) have been located. The major calmodulin-binding protein
has been reported to have a molecular weight of 51K and appears to be
identical to the major phosphorylated protein. Another
calmodulin-binding protein present in PSD's and which undergoes
2+Ca -dependent phosphorylation has been identified recently as fodrin, a 
spectrin-like molecule of molecular weight 230-240K (Kakiuchi et al., 
1982; Sobue et al., 1982; Carlin et al., 1983).
2+The function of this Ca -dependent phosphorylation system at the 
synapse is uncertain. DeLorenzo has suggested that this may be involved 
in neurotransmitter release (DeLorenzo, 1982). A postsynaptic role may 
also exist in view of the presence of the necessary components in PSD
fractions (see review by Grab et al., 1980).
1.3.4 Antigenic Components of SPM
Immunochemical techniques have been applied to the study of SPM in an 
attempt to further characterise this fraction at a more quantitative 
level than that allowed by SDS gel electrophoresis.
The most extensively characterised SPM antigens are those designated 
synaptin, D^, D^ and D^ by Bock and collaborators (see review by Bock,
1978). D^, D^ and D^ appear to be specific to and enriched in SPM
fractions while synaptin is present in both SPM and synaptic vesicle 
fractions (Bock and Jg(rgensen, 1975) but is also found in chromaffin 
granule membranes of the adrenal medulla (Bock and Hèlle, 1977).
Topographically Dj^  and D^ have been found to be localized on the 
exterior of synaptic membranes while D^ and synaptin have been located 
on the cytoplasmic face of the membrane and, in the case of synaptin, on 
the outside of synaptic vesicles (Jorgensen, 1976) suad chromaffin 
granules (Bock and Helle, 1977).
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All of these antigens are proteins with molecular weights D^, 50 and 
116K (two polypeptides); 139K and D^, 141, 34.4 and 23.5K (three
polypeptides) (Jorgensen, 1977). Synaptin is a glycoprotein of 45K.
Mahadik and co-workers found six SPM components reacted with their 
antisera (Mahadik et al., 1981) although all six antigens were also 
present in rough and smooth microsomal fractions and synaptic vesicles. 
These antigens have molecular weights of 66, 64, 63, 62, 58 and 56K.
Three protein components of PSD's have been shown to have antigenic 
activities (molecular weights 95, 82 and 72K). (Nieto-Sampedro et al., 
1981). The 95K antigen appeared to be specific to the PSD and was found 
to be present in PSD fractions isolated from lower vertebrates 
(Nieto-Sampedro et al, 1982a). These workers suggested that this 
antigen may be useful as a marker for PSD's in subcellular fractionation 
and developmental studies.
The production of monoclonal antibodies against nervous tissue antigens 
promises to be an extremely powerful tool in the investigation of 
synaptic composition. Several workers have reported the production of 
monoclonal antibodies against synaptic structures (MacPherson and 
Kleine, 1978; De Bias et al., 1981; Hawkes et al.; 1982; Reichardt 
and Matthew, 1982; Stoughton et al., 1983), although the specificity 
of these antibodies has not been definitely established. Clearly 
monoclonal antibodies will prove to be useful in both analysis and 
isolation of synaptic plasma membranes.
1.4 Metabolism of Synaptic Proteins
1.4.1 The metabolism of nervous system proteins is of particular
interest in view of its probable involvement in neuronal function and 
pathology and in specific nervous system functions such as information 
processing. It is possible that alterations in the metabolism of 
synaptic proteins may affect synaptic function. Very little information 
is available, however, on the synthesis and turnover of synaptosomal and 
SPM proteins.
The majority, if not all, braih proteins are in a dynamic state and 
subject to continuous tumoyer. In experiments in which rats were fed
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radioactive amino acids during development Lajtha and Toth (1966) showed 
that, at most, 3% of total proteins in adult brain were metabolically 
stable, the remainder being replaced at an average rate of 0.7% per hour 
(Lajtha and Dunlop, 1981). The average rate is thought to comprise two 
elements of which the first is a small rapidly turned over fraction with 
a half-life of 10 hours and represents about 3.5% of the total protein. 
The larger element (about 96% of the total protein) is more stable with 
a half-life of 10 days (Lajtha et al., 1979).
The SPM fraction also contains two classes of protein distinguishable by 
their difference in turnover rate. In vivo studies have shown that one 
group of proteins undergoes rapid turnover which is typified by a rapid 
decline in radiolabel between 4 and 16 hours after injection and a more 
slowly degraded component (Gurd, 1978). Using tritiated fucose Langley 
and Kennedy (1977) found a similar pattern to be true of synaptic 
glycoproteins. On SDS polyacrylamide gel electrophoresis of these 
fucosylated SPM proteins these workers observed that the decline in 
labelling of 123 and 85R components was particularly rapid although a 3IK 
component appeared to be stable. It is possible, however, that these 
results reflect the metabolism of the carbohydrate moieties rather than 
of the whole protein.
Using intraventricular injection of tritiated leucine Von Hungen et al. 
(1968) found that the half-lives of total brain protein, SPM, synaptic 
vesicle and mitochondrial proteins were about 20-21 days. This tended 
to indicate that brain proteins were more stable than liver proteins 
whose average half-lives have been reported to be 5-6 days.
Ramirez et al. (1972) reported that their SPM fraction incorporated 
radiolabelled amino acids and that this incorporation was inhibited by 
chloramphenicol but not by cycloheximide. Other in vitro studies using • 
intact synaptosonies have indicated that there may indeed be a protein 
synthetic system in the nerve terminal (Morgan and Austin, 1968;
Gambetti et al., 1972; Jones, et al., 1975; Wedege et al., 1977; Boyar 
et al., 1981). Most workers have reported inhibition of this protein 
synthesis by cycloheximide indicating that an extramitochondrial 
protein synthetic system exists in the nerve terminal. Wedege et al. 
(1977) observed that the cycloheximide-sensitive system was stimulated 
under depolarising conditions.
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The existence of a synaptosomal protein synthesizing system is 
controversial since ribosomes have not been observed in electron 
micrographs of the nerve ending (Palay et al., 1968). Autoradiographic 
studies, however, have shown that tritiated amino acids are incorporated 
into synaptosomes as well as ribosome containing particles (Cotman and 
Taylor, 1971). Several workers have been unable to demonstrate 
extramitochondrial protein sysnthesis in synaptosomal fractions (Gordon 
and Deanin, 1968; Deanin and Gordon, 1973; Hernandez, 1974).
It is thought, therefore, that most, if not all, SPM proteins are 
produced in the cell body and delivered to the nerve terminal by fast 
axoplasmic transport. The presynaptic membrane proteins and 
membrane-associated enzymes such as adenyl cyclase and 
acetylcholinesterase appear to be transported by the most rapid 
component of axoplasmic transport (see review by Schwartz, 1979).
Similar rapid transport of membrane proteins produced in the cell body 
has been found in dendrites (Kreutzberg et al., 1973). All proteins 
appear to pass through the Golgi apparatus prior to transport since 
studies using monensin (a sodium ionophore which has been reported to 
specifically damage this organelle) showed that transport of proteins 
was decreased although protein synthesis-was not impaired (Hammerschlag 
et al., 1982). Tsukita and Ishikawa (1980) suggested that a membrane 
system might be involved in axonal transport of SPM proteins so that 
these proteins are continuously located in a membrane environment. They 
proposed that membrane proteins are transferred in a series of vesicles 
down the axon. This process appears to be calcium-dependent 
(Hammerschlag, 1980).
These studies concur with the findings of investigations using other 
tissues (see reviews by Rothman, 1980 and Sabatini et al., 1982).
There is now considerable evidence which indicates that membrane 
proteins are synthesized on membrane bound polysomes and simultaneously 
inserted into the adjacent membrane (Sabatini et al., 1982). Wickner 
(1979), however, has suggested that membrane proteins may be released 
into the cytoplasm in a conformation compatihle with the aqueous 
environment but that on reaching their target membrane, refold to expose 
their hydrophobic regions, thus enabling them to penetrate the 
membrane. There is evidence that most mitochondrial and chloroplast 
proteins are coded for by nuclear DNA and are synthesized on cytoplasmic
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ribosomes (Schatz and Mason, 1974; Chua and Schmidt, 1979). Matsuura 
et al. (1981) demonstrated that newly synthesized cytochrome c 
(apoprotein) contains an internal sequence of amino acids which 
specifically recognises the mitochondrial membrane as its target. The 
holocytochrome c does not recognise mitochondrial membranes since the 
recognition sequence is sequestered by the folding of the molecule 
following addition of the haem moiety.
Much work still remains to be done before the mechanisms of SPM 
synthesis are fully elucidated. In addition, nothing is known of the 
synthesis and construction of the insoluble protein dense bodies 
associated with the synaptic membrane.
Very little is known of the degradation of plas% membranes and their 
proteins. In general membrane proteins have been found to undergo 
extensive turnover at heterogeneous rates with degradation being largely 
intracellular (see review by Schimke, 1973). In the case Of SPM local 
breakdown of synaptic proteins is thought to play an important role in 
degradation (see review by Droz, 1973) although the means by which SPM 
proteins are removed from the membrane is unknown.
1.4.2 Factors Affecting Brain Protein Synthesis
There is a considerable body of literature pertaining to factors which 
affect brain protein metabolism of which only a small proportion refers 
specifically to SPM proteins. A number of these factors are listed in 
Table 1.6. It is possible to suppose that many of the factors which 
affect brain protein synthesis generally will also affect the synthesis 
and turnover of S ^  proteins. In a few instances factors which have a _ 
specific effect on synaptic proteins has been studied and these are now 
discussed.
1.4.2.1 Development
The rat is b o m  in a relatively immature state and in the perinatal 
period there are substantial changes in the brain. The period of 
maximal synaptogenesis occurs between the second and fourth weeks after 
birth at which time the majority of nerve endings are formed. A number 
of synapses are present at birth and control essential functions but
-52-
table 1.6
Factors which affect brain protein metabolism 
Factor Effect on protein synthesis Reference
Physical: Hypothermia Inhibition Schain and 
Watanabe, 1971
Hyperthermia Inhibition Millan et al., 
1979
Chemical : LSD )
L-DOPA )
D-amphetamine )
Barbiturates
Inhibition which parallels the 
increase in body temperature 
Effect due to polysome 
disaggregation 
Inhibition
Alcohol (chronic) Decline in synthesis rate
Heikkila 
et al., 1979 
Moskowitz 
et al., 1977 
Satake et al., 
1974 
Wasterlain 
et al., 1977
Biochemical:
Hypothyroidism Inhibition in vivo
Hyperthyroidism Possible stimulation
Gonzales and 
Geel, 1978 
Cook and 
Kieman, 1976
Pathological:
Ischaemia
Electroshock
seizures
Intracerebral
puncture
Malnutrition
Inhibition
Inhibition
Transient inhibition
Inhibition
Cooper et al., 
1977 
Dunn and 
Berget, 1977 
Dunn, 1975
Banay-S chwartz 
et al., 1979
-53-
probably oii:constitute about 10% of those present in the adult brain 
(Bloom, 1972). During synaptogenesis it is probable that there are 
alterations in composition of the growth cone membrane to that of the 
mature synaptic membrane (for reviews see Bloom, 1972; Pfenninger and 
Rees, 1976).
The yield of protein in SPM fractions increases from about 0.5 mg/g 
brain (wet weight) at birth to about 4 mg/g at 90 days old with a 
roughly linear increase occurring over the first 20 days after birth 
(Kelly and Cotman, 1981). During the period of postnatal brain 
development the protein composition of the SPM fraction also changes 
(Jones and Matus, 1975). A number of these development-related 
changes are given in Table 1,7. Of particular interest are the changes 
in glycoprotein composition during this period since these are 
implicated in cell-cell recognition (see section 1.3.2). De Silva et al. 
(1979) demonstrated that the binding of the lectins Con A and W6A 
increased significantly between 5 and 17 days postpartum. The major Con 
A receptors in the SJC fraction were also shown to increase substantially 
over this period.
The synapse-specific antigens synaptin, D^ and D^ rise during postnatal 
development to reach a constant level at about 40 days after birth while 
the level of D^ initially increases but decreases after the brain growth 
spurt (Jaque et al., 1976). These workers suggested that this pattern 
paralleled the rate of synapse formation. More recently it has been 
found that D^ cross-reacts with antibodies to the cell adhesion molecule 
isolated from chick embryo neural tissue which implies that D^ might be 
involved in cell-cell recognition during synaptogensis (Jorgensen 
et al., 1980).
The major development-related increase has been reported to be in the 
amount of the major PSD protein (Fu et al., 1981; Kelly and Cotman,
1981) which increases 20 fold during the 3rd and 4th weeks of life.
Both groups also reported a small decrease in the amounts of tubulin and 
actin in SPM fractions during development.
The rates of synthesis of individual proteins have not been measured.
Fu et al. (1981), however, showed that the absolute incorporation of
3
( H)fucose into synaptic proteins decreased during postnatal
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table 1.7
SPM and SJC polypeptides which show development-related changes
Polypeptides which show increases Polypeptides which show decreases
SPM SJC SPM SJC
220
180*
160*
150-140*
110*
95
88-70
65*
52*(mPSDp)
43
39
250
220
190
180*.(ConAR)
150-140*
130*(Con AR) 
125
110*(Con AR) 
95
65*
62
53
52*(mPSDp)
270
73
59 
56 )
55*) Tubulin 
54 )
45 (Actin)
12
10
9
270
130
120
87
85
60
43
Values are given as molecular weight x 10-3
* Fu et al., 1981; remainder Kelly and Cotman, 1981.
Tentative identifications are given in parenthesis.
Con AR = Con A receptor protein.
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development. The specific activity of the homogenate decreased about 4 
fold between 5 and 28 days postpartum although incorporation into SPM 
decreased by only 2-2.5 fold. This may, however, reflect alterations in 
glycosylation rather than protein synthesis.
Thus there are substantial changes in SPM protein metabolism during 
development with major changes occurring at the time of synaptogenesis,
1.4.2.2. Other Factors
The immature brain is capable of various plastic changes in response to 
external influences. This is apparent in the corresponding alterations 
in the synthesis of the synaptic junctional proteins.
When the rats reared in the dark are first exposed to light the
3 3incorporation of L-( H) fucose and L-( H) lysine into SPM proteins
increases during the first hour. After three hours, however, the
3
incorporation of L-( H)lysine is depressed by 79% (Burgoyne and Rose, 
1980). Burgoyne et al. (1981) demonstrated that the increased synthesis 
of SPM proteins was associated with polypeptides of molecular weights 
100, 71, 44 and 38K with the 44K species being tentatively identified as 
actin.
Prenatal hypoxia has been reported to result in decreased incorporation 
of (^^C) valine into SPM proteins (Gross et al., 1981).
LSD-induced hyperthermia has been shown to cause a 35-45% inhibition in 
both total brain and SPM protein synthesis (Freedman et al., 1981). The 
SPM fraction, however, showed a specific increase in a polypeptide of 
75K. This increase appeared to be dependent on the hyperthermic effect 
of the drug. Hyperthermia induced by raising the ambient temperature 
resulted in increased levels of 75 and 95K polypeptides which were 
thought to be *heat shock' proteins.
Repeated seizures have also been found to cause reduction in cell size 
and number during development (Wasterlain and Plum, 1973).
Electrically-induced seizures have been reported to result in decreased 
cerebral protein synthesis (Wasterlain, 1974). Jorgensen and Bolwig, 
(1979) found that in rats subjected to regular electroconvulsive shocks
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the levels of the synaptic membrane-specific antigens, synaptin and D^, 
were increased in both the forebrain and occipital cortex.
During the period of postnatal development the brain is extremely 
susceptible to insult which may, in turn, result in long term impairment 
of brain function. Some pathological conditions are known to result in 
reduced numbers of synapses although it is not known whether the overall 
process of synapse formation is retarded. For example, administration 
of testosterone to female rats early in development results in reduced 
numbers of synapses in the pre-optic area (Raisman and Field, 1973).
Thyroid hormone deficiency during brain development causes gross effects 
typified by reduced brain weight and water content, reduced cell 
numbers and cell size, decreased lynching of dendrites and decreased 
density of axons and dendrites (see reviews by Sokoloff, 1971;
Balazs ct qI.^ IT77) • Synapse formation has been found to be impaired as 
indicated by morphological studies and developmental profiles of 
transmission-related enzymes such as choline acetyltransferase (Nicolson 
and Altman, 1972; Kalaria et al., 1981). In view of the asynchronous 
development of the brain those areas, such as the cerebellum, which are 
relatively immature at birth are more susceptible to thyroid hormone 
deficiency than areas, such as the cerebral cortex, which are more 
mature at birth.
It has been reported that cerebral protein synthesis in vivo is depressed 
in neonatal hypothyroid rats (Geel et al., 1967; Balazs and Gaitonde, 
1968), although this has not been substantiated in vitro using brain 
slices (Valcana and Eberhardt, 1977) or cell-free systems (Andrews and 
Tata, 1971). Lindholm (1982) has recently reported that protein 
synthesis in perikarya isolated from the brains of two week old 
hypothyroid rates was inhibited. Jarlstedt and Norstrom (1972) found 
that thyroid hormone deficiency in the developing rat results in 
inhibition of total synaptosomal and mitochondrial  ^protein synthesis 
in vivo. The effect of hypothyroidism on total and individual SPM 
proteins is not known, however.
Summary
The considerable amount of work carried out on synaptic fractions in
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recent years is now yielding much information about the nature of the 
synapse. Many of the major synaptic structural proteins have now been 
identified and the interactions between them have been elucidated to 
some degree. Very little is known, however, of the metabolism of 
synaptic proteins and specifically of those proteins present in the 
synaptic plasma membrane. Clearly when the metabolism of the 
constituents is elucidated the importance of the synaptic membrane 
proteins to the functioning of the nervous system will become apparent.
The aim of this project has been, therefore, to determine the rates of 
synthesis of SPM proteins and to investigate certain conditions (using 
drugs and chemically-induced hormone deficiency) in which the synthesis 
of synaptic proteins would be expected to be grossly affected.
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2. MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals
Radiochemicals were obtained from Amersham International, Bucks. The
high molecular weight standards kit for SDS polyacrylamide gel 
electrophoresis was obtained from Bio-Rad Laboratories Ltd., Watford, 
Herts. Acrylamide and N,N*-methylenebisacrylamide (specially purified 
for electrophoresis) were obtained from BDH Ltd., Eastleigh, Hants.
Halothane (Fluothane) was obtained from Arnold Veterinary Products, 
Reading, Berks, pentobarbitone (Sagatal) from May and Baker Ltd., • 
Dagenham, Essex and L-DOPA and 6-n-propyl-2-thiouracil from Sigma 
Chemical Co. Ltd., Poole, Dorset. Spurr's embedding resin was obtained 
from Taab Laboratories, Reading, Berks and X-Omat S X-ray film from Kodak 
Ltd., Hemel Hempstead, Herts. All other chemicals were routinely of 
MALAR grade.
2.1.2 Surgical Materials
The materials used in surgery and implantation of cannulae were as
follows: number 3 round burr drill bits (Busch and Co. Ltd., Germany);
5 "brass screws /32 , lOBA, cheese head (Walter Spencer Components Ltd. , 
Birmingham) ; 9 mm Clay Adams wound clips (Horwell Ltd., London) ;
Howmedica Simplex Rapide dental cement (Gi H. Bloore, Havant, Hants) and 
cannulae with perspex bodies 6 mm long, 3 mm in diameter with hypodermic 
tubes (19 SWG) 5 mm long protruding from the base from Harvard 
Bioscience, Edenbridge, Kent. The general construction of these 
cannulae was as described by Hayden et al. (1966) as modified by Goff 
et al. (1975).
2.1.3 Animals
All rats used were of the Wistar strain and were bred in the 
departmental animal house. The rats were fed ad libitum on PRD pellets 
(Labsure, Poole, Dorset) except those used in the thyroid deficiency 
studies which were fed on the powdered rat diet 4IB (Labsure, Poole, 
Dorset) mixed with 0.3% (w/w) 6-n-propyl-2-thihuracil. The light regime
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in the animal house was 12 h dark/12 h light. The age and sex of the 
rats used is indicated, where appropriate, in the text.
2.2 Isolation of Synaptic Plasma Membrane Fractions
2.2.1 The Jones and Matus (1974) isolation procedure (Fig. 1.2)
Rats were killed by cervical dislocation, their brains removed and 
quickly rinsed twice in ice-cold 0.9% NaCl. The forebrain was then 
homogenised in 10% (w/w) sucrose buffered to pH7.4 with 5 mM HEPES and 
containing 50jjM CaClg (all subsequent sucrose solutions were similarly 
buffered) to give a 10% (w/v) homogenate. Where appropriate cerebella 
were similarly homogenised. Homogenisation was effected by 8 passes at 
400 rpm in a glass-teflon homogeniser of clearance 0.25 mm. All 
subsequent manipulations were carried out at ice temperature, unless 
otherwise stated.
The homogenate was centrifuged at lOOOg^^ for 10 min to remove cell 
debris and nuclei. The resultant supernatant was then centrifuged at 
10,000ggy for 20 min to produce the crude mitochondrial pellet. This 
was washed once and then resuspended in 5mM Tris, pH 8.1 (2.5 ml/brain) 
using a tight-fitting hand-held homogeniser (clearance 0.15 mm). Lysis 
was carried out at 4°C for 60 min. After lysis had been allowed to 
occur two volumes of 48% (w/w) sucrose, buffered as before, were added 
to the lysate. This was successively overlayered with an equal volume 
of 28.5% (w/w) and 5 ml 10% (w/w) buffered sucrose. The gradients were 
centrifuged at 60,000g^^ for 2h in a 6x38 ml MSE swing-out rotor.
After centrifugation the interfaces were removed With a Pasteur pipette, 
diluted with 5 volumes of 10% (w/w) buffered sucrose and pelleted at 
80,000ggy for 20 min. The pellets were resuspended in 10% (w/w) 
buffered sucrose and stored at 4®C until the enzyme assays were 
completed and then stored frozen at -70°C.
2.2.2 The Cotman and Matthews (1971) isolation procedure (Fig. 1.1)
A 20% (w/v) forebrain homogenate was prepared in 0.32 H sucrose buffered 
with 5 mM Tris to pH7.4 and contaihing 50pM XZaCl^ (as were all 
subsequent sucrose solutions) under the same cdnditions as for the
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previous procedure. The resulting homogenate was diluted to 10% (w/v) 
and centrifuged at lOOOg^^ for 5 min. The supernatant was centrifuged 
at 17,000gg^ for 10 min to yield the crude mitochondrial pellet. This 
pellet was resuspended in 0.32M buffered sucrose (1.5 ml/brain) and 
applied (5 ml resuspension/gradient) to a Ficoll-sucrose gradient of 
composition 13% and 7.5% Ficoll in 0.32M buffered sucrose (15 ml of 
each). The gradients were centrifuged at 64,000g^^ for 90 min. The 
synaptosome fraction was removed from the interface between the 13% and 
7.5% Ficoll steps, diluted with 4 vol. of 0.32M buffered sucrose and 
pelleted at 50,000g^^ for 30 min. The pellet was resuspended in 0.32M 
buffered sucrose (0.5 ml/brain) to which 5 vol. of 6 mM Tris, pH8.1 were 
added and was allowed to lyse at 4®C for 90 min. The lysate was 
centrifuged at 25,000g^^ for 20 min after which the pellet was 
resuspended in 0.32M buffered sucrose (0.6 ml/brain) and 0.2 ml of this 
was applied to discontinuous sucrose gradients comprising the following 
steps: 38%, 35%, 32.5% and 25% (w/w) buffered sucrose (7.5 ml each).
The gradients were centrifuged at 60,000g^^ for 90 min in a 6x38 ml MSE 
swing-out rotor. The interfaces were collected, diluted with 3.5 vol. of 
0.1 mM EDTÂ and centrifuged a 
resuspended in 0.32M sucrose.
A t 50,000g^^ for 30 min. The pellets were
Ficoll used for this procedure was purified by dissolving it in a small 
amount of redistilled water and precipitating it with 95% ethanol. The 
precipitated Ficoll was then freeze-dried and stored at -20*C until 
used. This procedure reduces the salt concentration in commercial 
Ficoll and enables full use to be made of its negligible osmotic 
pressure.
2.2.3 The Salvaterra and Matthews (1980) isolation .procedure
This is a modification of the Jones and Matus method designed so that a 
fixed angle rotor instead of a swing-out rotor can be used for the 
gradient step.
Two vol. of 48% (w/w) sucrose (buffered as in section 2.2.1) were added 
to the lysed crude mitochondrial fraction (12.5 ml/brain). This was 
overlaid with 8 ml of 28.5% (w/w) buffered sucrose and 4 ml of 10% (w/w) 
buffered sucrose. The gradiéhts were centrifuged in a Beckman Type 30
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rotor at 30,000 rpm, (j^ t = 1.8x10^^ rad^/sec (approximately 85,000g 
for 30 min) and allowed to decelerate without application of the brake. 
The interfaces were removed and diluted with 5 vol. of 0.1 mM EDTA and 
pelleted at 80,000g^^ for 20 min. The pellets were resuspended in 10% 
(w/w) buffered sucrose.
The advantage of this method is that up to 12 brains can be processed 
separately compared with only 6 when a swing-out rotor is used.
2.2.4 The Gray and Whittaker (1962) procedure for isolating 
synaptosomes
A 10% (w/v) forebrain homogenate was prepared as in section 2.2.2. The 
homogenate was centrifuged at lOOOg^^ for 10 min. The pellet was washed 
once (lOOOggy, 10 min.) and the supernatant added to the initial 
supernatant which was then centrifuged at 17000g^^ for 55 min. to yield 
the crude mitochondrial pellet. This pellet was washed once (17000g^^, 
55 min.) and then resuspended in 0.32M sucrose (2 ml/g tissue) and 5 ml 
was layered on top of a two step discontinuous sucrose gradient of 
composition 0.8M and 1.2M sucrose (15 ml each). The gradients were 
centrifuged at 53000g^^ for 2h in a 6 x 38 ml MSE swing-out rotor. The 
synaptosome fraction was removed from the 0.8M/1.2M sucrose interface, 
diluted with an equal volume of dist illed, deionised water and 
centrifuged at 80000g^^ for 60 min. The pellets were resuspended in 
0.32M sucrose.
All of the solutions used in these three procedures were prepared not 
more than 24 h before use and were stored at 0-4°C.
2.3 Characterisation of SPM Fractions
2.3.1 Marker Enzyme Assays
2.3.1.1 (Na^,K’^ )activated,ouabain-sensitive ATPase ((Na^,K^)ATPase)
This enzyme was assayed by the method of Mahler and Cotman (1970). The 
samples were preincubated in assay buffer (50 mM Tris, 100 mM NaCl, 30 
mM KCl, 3 mM MgCl^, 0.75 mM EGTA, pH7.5) in the presence or absence of
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0.2 mM ouabain for 5 min at 37°C. The reaction was started by addition 
of 50pl of 60 mM disodium ATP (vanadium-free) . The reaction was
allowed to proceed for 10 min and was then stopped by placing the
reaction mixtures on ice and adding 5 ml of 0.2% (w/v) ammonium 
molybdate in 0.2 M H^SO^ to them. The colour was developed by adding 
0.2 ml of Fiske-SubbaRow reducing agent (see below). After 10 min the 
absorbance at 680 nm was measured and the amount of phosphate released 
calculated from a phosphate standard curve (range 0-80 pg phosphate). 
Fiske-SubbaRow reducing agent 
0.5 g l-amino-2-naphthol-4-sulphonic acid
30.0 g sodium bisulphite
6.0 g sodium sulphite
Made up to 250 ml with distilled, deionised water, filtered and stored 
at 0-4°C in a dark glass bottle.
2.3.1.2 Acetylcholinesterase
This enzyme was assayed by the method of Ellman et al. (1961).
Assay mixture: 2.6 ml 0.1 M sodium phosphate buffer, pH8.0
0.1 ml 0.01 M dithiobisnitrobenzoic acid* (DTNB)
0.4 ml enzyme solution
*The substrate is more stable when prepared in the following way: 39.6
mg DTNB was dissolved in 10 ml sodium phosphate buffer, pH7.0 (0.1 M) to 
which was added 15 mg sodium bicarbonate.
Reaction: acetylthiocholine---^ h E  > thiocholine + acetate
thiocholine + DTNB---------- > 5-thio-2-nitrobenzoic acid
(yellow)
The absorbance at 412 nm was recorded to establish the background rate. 
The reaction was started by addition of 20j j1 of 0.075 M. 
acetylthiocholine iodide.
The extinction coefficient of the yellow anion is 1.36 x 10^.
2.3.1.3 Succinate PMS, reductase
This enzyme was assayed by the method of Duncan and Mackler (1966).
Assay mixture: 0.01 ml 10% (w/v) phenazine methosulphate (PMS)
0.10 ml 0.01% (w/v) dichloropheno1 indophenol
0.01 ml 1.0 M sodium succinate
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0.10 ml 10 mM potassium cyanide
0.20 ml 0.2 M potassium phosphate buffer, pH7.5
0.55 ml distilled, deionised water 
The reaction was started by the addition of lOpl of the sample. The 
rate of reaction was measured by following the decrease in absorbance at 
600 nm at a temperature of 38°C.
The extinction coefficient of dichlorophenol indophenol is 1.61x10^.
2.3.2 Protein Determination
Protein concentrations were measured by the method of Lowry et al.
(1951) using crystalline bovine serum albumin as the standard. Since 
brain protein is difficult to redissolve after precipitation with 
trichloroacetic acid (TCA) the following procedure was adopted. 0.1 ml 
of sample, diluted, if necessary, with distilled, deionised water, was 
precipitated by addition of 0.25 ml of 10% (w/v) TCA.
The precipitate was pelleted in a Mechanika Precyzyjna microcentrifuge 
(6 min). The supernatant was removed by syringe and 0.5 ml of 0.2 M 
NaOH was added to thé pellet which was dispersed by vortex mixing and 
allowed to stand overnight at 4®C. 0.5 ml of distilled, deionised water
were added and the solution was thoroughly mixed. Aliquots were assayed 
for protein content.
Stock solutions:
A 1% (w/v) CuSO^. 5H2O
B 2.12% (w/v) potassium, sodium tartrate. THgO
C 4 g NéOH + 20g NagCOg in 1 1 distilled, deionised water
D A + B 1:1 (v/v) )
E C + D  50:1 (v/v) ) Directly before use
5 ml of solution E were added to 1 ml of protein solution. This was
mixed thoroughly and allowed to stand for 10 min. 0.5 ml 
Folin-Ciocalteau reagent (diluted 1:1 with distilled, deionised water) 
was added to the mixture which was then allowed to stand for 30 min.
The absorbance at 750 nm was measured and the protein concentration 
calculated from a bovine serum albumin standard curve (range 0-200 pg).
—64—
2.3.3 Electron Microscopy
2.3.3.1 Procedure for osmium tetroxide/uranyl acetate staining of 
membrane fractions
Membrane fractions were centrifuged at 80,000g^^ for 20 min. The 
pellets were fixed by addition of 4% (v/v) glutaraldehyde in Millonig's 
phosphate buffer (see below) for 30 min at 0-4°C. The fixed samples 
were washed 3 x 30 min in Millonig's buffer and then stained with 1%
(w/v) osmium tetroxide dissolved in Millonig's buffer for 2 h at 4*C.
This was followed by 3 washes (10 min each) in Millonig's buffer and 1 
wash (10 min) in Kellenberger's buffer (see below). The samples were 
then stained with 2% (v/v) uranyl acetate dissolved in Kellenberger's 
buffer overnight at 4°C. The stained samples were washed 3 x 10 min in 
Kellenberger's buffer and dehydrated though graded alcohols as follows: 
30%, 50%, 70%, 90% (15 min each), followed by 2 x 30 min washes in 95% 
ethanol.
The samples were then transferred to ethanol:propylene oxide (1:1, 
v/v) for 30 min. This was decanted and replaced with fresh propylene 
oxide for a further 30 min. The samples were left overnight in a 
mixture of propylene oxide:Spurr's resin (1:1, v/v), passed through 2 
X 2 h changes of fresh resin and then transferred to fresh resin and 
cured in a vacuum oven for 24 h at 60*C.
2.3.3.2 Procedure for ethanolic-phosphotungstate staining of 
membrane fractions
Pelleted fractions were fixed with 5% (v/v) glutaraldehyde as before and 
then washed 3 x 10 min in Millonig's buffer. The samples were dehydrated 
by passing through graded alcohols as before and then stained with 1% 
(w/v) phosphotungstic acid dissolved in absolute ethanol containing 5 
drops of 95% ethanol per 10 ml solution. Staining was allowed to 
proceed for 4 h after which the fractions were quickly rinsed with 
propylene oxide: ethanol (1:1, v/v) followed by a brief rinse with 
propylene oxide. These rinseô were necessary since mixing of ethanolic 
phospho tungs tate and propylene oxide for longer than 3 min may result in 
a explosive exothermic reaction (Bloom and Aghajanian, 1968). The
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samples were subsequently washed 2 x 15 min in propylene oxide then 
immersed in propylene oxide:Spurr's resin (1:1, v/v) overnight and 
embedded in resin as before.
Samples processed in both ways were cut on an LKB ultramicrotome into 
thin sections (500-700 A, pale gold/silver). All sections were stained 
on their grids with lead citrate for 3 min to enhance the contrast. The 
grids were then examined on a Zeiss EM 9a microscope.
Millonig's Phosphate Buffer
Stock solutions:
Buffer:-
A. 2.26% (w/v) sodium dihydrogen phosphate
B. 2.52% (w/v) sodium hydroxide
C. 5.40% (w/v) glucose
D. 41.5 ml A + 8.5 ml B.
45 ml D + 5 ml C .
Kellenberger's Buffer
Veronal-acetate buffer;- 2.94 g sodium barbitone
1.94 g sodium acetate
3.40 g sodium chloride
Made up to 100 ml with distilled,
deionised water.
Kellenberger's buffer;- 5.0 ml veronal-acetate buffer
13.0 ml distilled, deionised water
7.0 ml O.IM HCl
0.25 ml IM calcium chloride 
Adjust to pH6.0 with dilute HCl.
Lead Citrate Solution
0.2115g of lead citrate was shaken with 30 ml of carbon dioxide-free, 
millipore-filtered water to form a milky suspension. 0.8 ml of IM NaOH 
(freshly made up in carbon dioxide-free water) was added to the 
suspension which was then made up to a final volume of 50 ml. When the 
suspension had cleared the solution was stored in a polythene bottle in 
an airtight container containing potassium hydroxide pellets.
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Spurr's Embedding Resin
ERL 4206 10.0 g
DER 736 8.0 g
NSA 26.0 g
S-1 0.4 g
2.3.4 SDS Polyacrylamide Gel Electrophoresis
The SDS polyacrylamide gel electrophoresis system used was basically 
that developed by Laemmli (1970).
The separating gel consisted of 9.8% (w/v) acrylamide, 0.3% (w/v) 
bisacrylamide, 4.54% (w/v) Tris, 0.074% (w/v) EDTA (disodium salt), 0.1% 
(w/v) SDS, 0.03% (w/v) ammonium persulphate and 0.05% (v/v) TEMED. The 
gel mixture was degassed using a water pump. Slab gels of dimensions
120mm X 160mm x 1mm were cast, overlaid with n-butanol and allowed to
polymerize overnight. The following day the butanol was removed by 
blotting the gel surface with filter paper. The stacking gel of 
composition 4.8% (w/v) acrylamide, 0.15% (w/v) bisacrylamide, 1.5% (w/v) 
Tris, 0.074% (w/v) EDTA (disodium salt), 0.1% (w/v) SDS, 0.1% (w/v) 
ammonium persulphate and 0.05% (v/v) TEMH) was applied and allowed to 
polymerise for at least 1 h. Samples were prepared by heating protein 
solutions with a buffer of composition 0.76% (w/v) Tris, 12.5% (v/v) 
glycerol, 1.25% (w/v) SDS, 1.25% (v/v) 2-mercaptoethanol and 0.0025%
(w/v) bromophenol blue for 4 min at 100®C. Solubilized samples were 
applied to the gels (100 pg/track) by syringe through the electrode 
buffer (composition: 0.05 M Tris, 0.384 M glycine, 2 mM EDTA (disodium
salt), 10% (w/v) SDS, pH 8.3). Electrophoresis was carried out at 20 mA
per gel for 1 h to allow entry of proteins into the stacking gel. The
current was then increased to 40 mA per gel until electrophoresis was 
complete as judged by the migration of bromophenol blue marker dye. Gels 
were stained in 50% (w/v) TGA containing 0.2% (w/v) Coomassie Brilliant 
Blue R for 30 min at 60 °C and then destained in propan-2-ol: glacial
acetic acid:water, (12.5:7.5:80, by volime).
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The protein standards used were myosin (200 K),yS-galactosidase (116.5 
K), phosphorylase B (94 K), bovine serum albumin (68 K) , ovalbumin (43 
K) » pepsin (34.7 K) and trypsinogen (24 K), molecular weights are given 
in parenthesis.
Stock solutions: 30% acrylamide )
0.9% bisacrylamide )
1.5 M Tris-HCl, pH8.8 
0.5 M Tris-HCl, pH6.8 
10% (w/v) SDS
0.2 M EDTA (disodium salt)
10% (w/v) ammonium persulphate 
0.1% (w/v) bromophenol blue
w/v in distilled, deionised 
water
Composition of Gels
Composition
Volume (ml)
10% separating gel 5% stacking gel
Distilled, deionised water 18.0 5.6
Acrylamide solution 14.7 1.6
1.5 M Tris-HCl,pH8.8 11.25 -
0.5 M Tris-HCl,pH6.8 - 2.5
0.2 M EDTA 0.45 0.1
10% SDS 0.45 0.1
10% ammonium persulphate 0.15 o.i
TEMED 22.5/jl 5pl
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Compositlon of Sample Buffer
Component Volume (ml)
Distilled, deionised water 7.05
0.5 M Tris-HCl,pH6.8 1.5
Glycerol 1.5
10% SDS 1.5
2-mercaptoethanol 0.15
0.1% bromophenol blue 0.3
2.3.5 Fluorographic Analysis of Brain Fractions
35The incorporation of L-( S)methionine into cerebral polypeptides was 
determined by fluorography following the electrophoresis of brain 
fractions on SDS polyacrylamide gels. Fluorography was carried out as 
described by Bonner and Laskey (1974) and later modified by Laskey and 
Mills (1975). The procedure was as follows:-
The gel was initially soaked in 20 times its volume of dimethyl 
sulphoxide (DMSG) for 30 min then transferred to fresh DMSO for a 
further 30 min. After dehydration the gel was soaked in 4 volumes of 
DMSO containing 22.2% (w/v) PPG for 3 h. Following impregnation with PPG 
the gel was placed in 20 volumes of water for at least 1 h.
The gel was then dried under vacuum on to Whatman No. 3 filter paper 
using a Bio-Rad gel drier. The dried gel was placed in contact with 
Kodak X-Gmat S film which had previously been preflashed according to the 
recommendations of Laskey and Mills (1975) • The film and gel were then 
wrapped in black paper and placed between two glass plates which were 
covered with aluminium foil. The exposure was carried out for 4—6 weeks 
at -70®C. Following exposure (4—6 weeks depending on radioactivity 
loading which was usually about 10,000 dpm per track). The X-ray film 
was developed using Kodak DX80 developer and FX40 fixer.
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2.4 Techniques Used for the Measurement of in vivo Brain Protein
Synthesis
2.4.1 Stereotaxic techniques
Rats were initially anaesthetised in a plastic box, maintained at 37®C 
by partial immersion in a heated water bath, using 4-6% halo thane at a 
flow rate of 1 1/min. The unconscious animal was transferred to a Kopf 
small animal stereotaxic frame. The anaesthetic was administered 
through a face mask at a concentration of 2% and a flow rate of 0.6 
1/min.
The skull was exposed, the bregma located and the co-ordinates noted.
In rats weighing 250-350 g the lateral ventricle is located 0.9 mm 
posterior and 2.5 mm lateral to the bregma. A hole was drilled at this 
position using a number 3 round burr dental drill bit. A second hole 
was drilled 4-5 mm distant from the first and a brass screw was secured 
to the skull with a nut. The cannula was then placed in the first hole 
and fixed to the skull and screw with dental cement. The wound was 
sutured using steel clips. The animal was then injected intramuscularly 
with benzyl penicillin (20,000 units) and locally around the wound with 
xylocaine.
All surgical instruments were sterilised in 0.5% hibitane for 30 min and 
rinsed in sterile 0,9% NaCl before use.
Rats were allowed to recover for 5 days during which time they were 
injected once with 50pl sterile saline to accustom the animals to the 
injection procedure and, therefore, reduce handling stress.
35
2.4.2 Measurement of the Incorporation of L-( S)methionine into 
Brain Proteins
2.4.2.1 Adult animals (gross injection)
35
Rats were injected intraventricularly with 2.5 mg L-.( S)methionine (20 
or 30 jjCi, injection volume 50 pi) via pre-implanted cannulae.
Following the Injection the rAts were marked and retumed to their cage 
where they had free access to food and water. After the incorporation
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period the animals were killed by cervical dislocation. Synaptic 
subfractions were isolated from the forebrain by the Jones and Matus 
(1974) or Salvaterra and Matthews (1980) method.
2.4.2.2 Young animals (trace injection)
In the thyroid deficiency studies the hypothyroid rats were too small to 
implant with cannulae with routine success. It was, therefore, 
necessary to inject the tracer amino acid directly through the skull 
ioto the lateral ventricles. A needle with a stop was used so that the 
correct depth could be gauged. The accuracy of placement using this 
technique was tested using the dye Pontamine sky blue. It was found 
that small rats could be successfully injected in this way. The younger 
animals (1 and 2 weeks old) were injected while conscious. Older 
animals were lightly anaesthetised with halothane before injection. The 
body temperatures of all hypothyroid and 1 and 2 week old control
animals were maintained by housing them in a warm box. The rats were
35
injected with either 50pl L-( S)methionine (1-3 weeks old) or 100 pCi 
35
L-( S)methionine (specific activity 143 mCi/mmol) (4 weeks old). The 
injection volume in all cases was 20 pi and the incorporation period was 
2 h. The rats were killed cervical dislocation and synaptic 
subfractions were isolated by the method of Salvaterra and Matthews 
(1980).
2.4.3 Measurement of the Incorporation of L-(U^^C)valine into 
Brain Proteins
Hypothyroid and control rats were injècted intraperitoneally with 
L-valine at 15 pmol/g body weight as a solution containing 0.5 
mmol/ml and 9.5 pGi L-(U^^G) valine/ml. This quantity has been shown 
to be sufficient to flood the valine pool for 2 h incorporation periods 
(Dunlop et al., 1975). Animals were killed and fractions isolated as 
above.
352.4.4 Determination of the Distribution of L-( S)methionine 
in the Brain
The brain was divided into left (injected), and right (non-injected)
hemispheres and cerebelltML,}. These were homogenised separately and the
35incorporation of L-( S)methionine into each area was determined.
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2.4.5 Measurement of TCA—insoluble Radioactivity
The TCA-insoluble radioactivity in the homogenates and subcellular 
fractions was measured by the filter paper disc method of Mans and 
Novelli (1961).
Brain fractions were sonicated for 5 sec at maximum amplitude in 10% 
(w/v) sucrose (buffered with 5 mM HEPES, pH7.4) and then kept on ice. 
Aliquots were applied to Whatman cellulose filter paper discs (3 mm 
thick, 2.4 cm diameter) and dried at 60°C. In "flooding" experiments 
100 pi aliquots were used while in non-flooding experiments aliquots of 
20 pi and 40 pi of homogenates and subcellular fractions respectively 
were used.
The discs were immersed in ice-cold 10% (w/v) TCA for 5 min and then 
transferred to 5% (w/v) TCA at 90°C for 30 min. The discs were rinsed 
in ice-cold 5% (w/v) TCA (5 min) and then placed in ethanol:ether (3:1, 
v/v) at 37®C for 30 min. This was followed by a 5 min rinse in the 
ethanol:ether mixture at room temperature. The discs were dried and 
placed in sc in filiation vials to each of which were added 100 pi of 
distilled, deionised water and 500 pi of tissue solubiliser (NCS). 
Digestion was carried out at 37®C overnight or for 2 h at 50®C. After 
cooling the vials 20 pi of glacial acetic acid were added to each 
followed by 10 ml of toluene/PPO (5 g/1).
In early experiments the samples were counted on a Packard Tri-Carb 
liquid scintillation counter (Model 3390). Counting efficiences were 
determined using the external standards channels ratio method. A quench 
correction curve was produced by adding increasing concentrations of
chloroform to 10 ml aliquots of toluene/PPO scintillation cocktail
3 14which contained n-(l,2(n)- H)hexadecane or n-(l- C)hexadecane as
internal standards.
In the majority of experiments, however, samples were counted on a 
Beckman LS 7500 liquid scintillation counter using the automatic 
H-factor correction to yield dvp.m. values.
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35
2.4.6 t.I.e. Analysis of S Labelled Amino Acids in Brain Extracts
35
In order to determine the distribution of S in sulphur-containing
amino acids soluble brain extracts were subjected to t.l.c. in the same
system as that used by Amersham International for analysis of 
35L-( S)methionine.
Samples were prepared by adding lOOpl of 0.3M perchloric acid to 100 pi 
of brain homogenate. The precipitate was pelleted in a microcentrifuge 
(6 min). The supernatant was decanted and its pH raised above 1 by 
dropwise addition of 0.5 M potassium carbonate. 25 pi of the resultant 
solution was then applied to cellulose t.l.c. plates (thickness 0.1 mm) 
as a 5 cm band. This was necessary to obtain sufficient radioactivity 
for scintillation counting but without overloading the plate. Solutions 
of standard amino acids (L-methionine, L-cysteine and L-cystine) were 
prepared by dissolving them at a concentration of 5 mg/100 ml in 10%
(v/v) aqueous propan-2-ol. 5 pi of each of these standards was applied 
over 0.5 cm. The plates were run in the following solvent system: 
butan-l-ol: glacial acetic acid: water (120:30:50, by volume).
Following chromatography the sections of the plates containing the amino 
acid standards were cut off and stained with ninhydrin. The area in 
which the sample had run was not stained but 0.5 cm bands were scraped 
off from the origin to the solvent front into separate scintillation 
vials to which were added 0.5 ml NCS and 0.1 ml water. Digestion and 
scintillation counting were carried out as in section 2.4.5.
2.5 In vivo Drug and Thyroid Hormone-Deficiency Studies
2.5.1 ' The Effect of Anaesthetics on Brain Protein Synthesis
2.5.1.1 Halothane
Experimental rats were anaesthetised with halo thane (3%) for 20 min
prior to intraventricular injection, via pre-implanted cannulae, of
35 35
flooding concentrations of L-( S)methionine (2.5 mg L-( S)methionine, 20
or 30 pCi in an injection volume of 50 pi). These rats remained under
anaesthesia during the incorporation period (30 min). Control rats were
intraventricularly injected with a solution of the same composition as
given above.
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The anaesthetised rats were kept in a warm box to maintain their body 
temperatures during the course of the experiment. The rectal 
temperature of the anaesthetised rats was recorded at death.
2.5.1.2 Pentobarbitone
Rats were injected intraperitoneally with pentobarbitone (60 or 75 mg/Kg 
body weight). The tail-flick and eye-blink reflex activities were 
checked to determine whether the animals were unconscious. The rats 
were intraventricularly injected as above 15 min after administration of 
the anaesthetic. Control animals were treated as described in section 
2.5.1.1.
2.5.2 The Effect of L-DOPA on Brain Protein Synthesis
Rats were housed at 30-32®C for 45-60 min before the start of the 
experiment. The experimental rats were injected intraperitoneally with 
L-DOPA (500 mg/Kg body weight). The drug was injected as a suspension 
50 mg/ml in 0.05 M HCl + 0.2 (v/v) Tween 80. Control rats were injected 
with the appropriate volume of vehicle.
After 45 min all rats were injected, via pre-implanted cannulae, with
35
2.5 mg L-( S)methionine (20 pCi, injection volume 50 pi). Following 
a 30 min incorporation period the animals were killed by cervical 
dislocation. Synaptic fractions were isolated by the method of Jones 
and Matus (1974) or Salvaterra and Matthews (1980). Synaptosomes were 
isolated by the method of Gray and Whittaker (1962).
2.5.3 The Effect of Thyroid Hormone Deficiency on Brain Protein
Synthesis
Hypothyroidism was induced by addition of 6-n-propyl-2-thiouraCil to the 
maternal diet four days after the birth of the litter. This antithyroid 
agent was added to powdered rat food (see section 2.1.3) at 3% (w.w).
100 g of this diet was fed per day. The yoting rats were killed at 1, 2, 
3 or 4 weeks old and Synaptic subfractions were isolated by the method 
of Salvaterra and Matthews (1980).
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3. RESULTS AND DISCUSSION
3.1 Characterization of Brain Subcellular Fractions
Since the principal aim of the present study was to examine the in vivo
synthesis and turnover of proteins present in the synaptic membrane it 
was necessary to select an isolation method which produced SPM fractions 
of an adequate purity for this purpose. Thus, SPM fractions isolated by 
the rapid method of Jones and Matus (1974) and by the longer procedure of 
Cotman and Matthews (1971) were characterised and compared by electron 
microscopy, marker enzyme analysis and SDS polyacrylamide gel 
electrophoresis.
3.1.1 Morphological Analysis of Brain Subcellular Fractions
The myelin fraction prepared using the Jones and Matus procedure 
contained large membranous profiles typical of the myelin lamellae (Fig.
3.1.1) and was similar in morphology to the fraction obtained by these 
workers. Some of the profiles contained residual material possibly of 
axonal or dendritic origin. The myelin-enriched fraction obtained using 
the Cotman and Matthews procedure contained a variety of membranous 
profiles of which only a small proportion were characteristic of myelin. 
Many profiles were bounded by only a single membrane and contained 
residual material. The identity of these profiles is uncertain (Fig.
3.1.2).
The SPM fractions.obtained using both procedures contained mainly empty 
membranous profiles (Figs. 3.1.3 and 3.1.4). These were consistent in 
size and shape with the SPM profiles obtained by Jones and Matus (1974). 
Detailed interpretation of these fractions was hindered by the presençe 
of numerous small,, crystalline structures apparently adhering to the 
membranes. This artefact was observed in all SPM fractions examined. 
Ideally the reason for this artefact would have been sought but in view 
of the limited electron microscopic facilities available and the 
comparative nature of these studies this was not possible. Since the 
other subcellular fractions had morphological compositions consistent 
with those reported in the literature it was felt that it was feasible to 
assume that the SPM fractions were also consistent.
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The diameters of the profiles in Figs. 3.1.3 and 3.1.4 were 0.738+0.047 
and 0.793±0.079 pm±S.E.M. (N=18 and N=16) respectively. These values 
compared well with those (0.5-1.2 pm) reported by Jones and Matus (1974).
It has been reported that an ethanolic solution of phosphotungstic acid 
preferentially stains the synaptic junctional apparatus (Bloom and 
Aghajanian, 1968). An SPM fraction isolated using the Jones and Matus 
procedure prepared in this way revealed numerous electron dense 
bar-shaped structures against a grey background (Fig. 3.1.5). The 
appearance of these structures was similar to that reported by Bloom and 
Aghajanian (1968) and was consistent with them being the prdtein 
densities associated with the nerve terminal membrane.
The fractions obtained from the 32,5-35% and 35-38% interfaces of the 
Cotman and Matthews-type sucrose gradient contained mixtures of 
membranous profiles and mitochondria with the latter predominating in the 
fraction of higher buoyant density (Figs. 3.1.6 and 3.1.7).
The mitochondrial fraction obtained using the Jones and Matus procedure 
contained readily identifiable mitochondria with the majority showing a 
high level of structural preservation (Fig. 3.1.8). The corresponding 
Cotman and Matthews-type fraction was poorly embedded and could not, 
therefore, be examined.
3.1.2 Distribution of Marker Enzymes in Brain Subcellular Fractions
3.1.2.1 In Fractions Isolated Using the Jones and Matus Procedure
The distribution of the plasma marker enzymes (Na"*",K*”)ATPase and 
acetylcholinesterase and the mitochondrial marker succinate PMS reductase 
in SPM, myelin and mitochondrial-enriched fractions was determined. The 
plasma membrane markers were concentrated in the SPM fraction while 
succinate PMS reductase was found principally in the mitochondrial 
fraction (Table 3.1.1). (Na'*’,K'^)ATPase and acetylcholinesterase, while 
following a similar pattern to that reported by Jones and Matus (1974), 
did, however, differ slightly in some fractions (Table 3.1.1). It was 
found that the percentage of the total ^ overed (Na ,K )ATPase and 
acetylcholinesterase activities present in the inyelin fraction were lower 
(80% and 67% of the Jones and Matus * values respectively) than those
“7 6—
table 3.1.1
Obtained Using the Jones and Matus Method
Marker Enzyme
Fraction
Protein
(N=4)
(Na‘*’,K‘^)ATPase
(N=4)
AChE
(N=4)
Succinate 
PMS rèductase* 
(N%)
Myelin 16.6±6.4 9.7±3.6
(48.8)
6.1+2.5 
(18.7)
5.0
(8.3)
SPM 23.1±4.2 68.4±4.0 
(44.0)
72.2±7.1
(78.2)
10.4
(8.9)
Mitochondria 60.3+2.9 24.4+7.5
(7.2)
23.3±8.9
(3.5)
84.8
(83.8)
The values are expressed as the percentage of the total activity recovered 
from all three fractions ± S.E.M. The values in parentheses are those of 
Jones and Matus (1974).
N - number of isolations.
* Jones and Matus used cytochrome c oxidase as the mitochondrial marker <
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Pig. 3.1.1. Morphology of the Jones and Matus-type myelin fraction, 
The profiles are typical of myelin lamellae (ML).
Some profiles contain residual material (R). 
Magnification x 7000.
Pig. 3.1.2. Morphology of the myelin-enriched fraction isolated 
using the Cotman and Matthews procedure. A variety 
of membranous profiles are present of which only a 
few show the morphology characteristic of myelin (ML). 
Some profiles contain vesicular material (V), possibly 
of synaptic origin. Magnification x 7000.
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Fig, 3.1.3. Morphology of the SPM fraction prepared by the Jones 
and Matus method. A number of membranous profiles 
are present some of which contain residual vesicular 
material (V). Magnification z 7000
m i
j
Fig. 3.1.4. Morphology of the SPM fraction prepared T?y the Cotman 
and Matthews method. This fraction consists mainly 
of empty membranous profiles although some appear to 
contain residual vesicular material (V). Magnification 
X 7000.
Ijpt
t
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Pig, 3.1.^iiMo;i^ology of the SPM fraction prepa2;i#W""(|^e Jones 
ahdi Matus method and stained with B-P^S^Thlpsy'naptic 
densities (SD) are seen as electron dense bars. 
Magnification x 7000.
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Pig. 3.1.6. Morphology of the intermediate Cotman and Matthews 
fraction located at the 32.5-35^  (w/w) sucrose 
interface. This fraction contains a variety of 
membranous profiles including some mitochondria (Mt) 
Magnification x 4000.
m m #
Pig. 3.1.7. Morphology of the intermediate Cotman and Matthews 
fraction located at the 35-38^  (w/w) sucrose 
interface. This fracti n contains a mixture of 
empty membranous profiles and mitochondria (Mt) 
some of which appear to be damaged (Mf). 
Magnification x 7OOO.
s) ' 3
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Pig. 3.1.8,. Morphqlogy of the Jones and Matus-typejnitochondrial
J I'" ''- y,
. fraction. This fraction consists almost entirely of 
mitochondria (Mt) most of which are^undainaged. 
Magnification x 7OOO.
m m
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reported by Jones and Matus (1974). The percentage of these enzymes 
in the mitochondrial fraction was higher than reported by these authors. 
While the percentage of acetylcholinesterase in the SPM fraction was 
found to correspond well with the literature value the percentage of 
(Na jK )ATPase was 55% higher. It is Impossible to determine whether 
these differences are statistically significant since no standard errors 
or deviations were given by these workers.
The distribution of the mitochondrial marker enzyme corresponded very 
closely to that obtained by Jones and Matus using cytochrome c oxidase. 
The yield of protein in the SPM fraction was 1.36+0.20 mg protein/g 
tissue (wet weight)±S .E.M. which compared well with the value of 1.0 mg 
protein/g tissue reported by Jones and Matus (1974).
3.1.2.2 In Fractions Isolated Using the Cotman and Matthews Procedure
The plasma membrane marker enzymes were located primarily in the SPM 
fraction (located at the 25-32.5% (w/w) sucrose interface), while the 
mitochondrial marker was found to be concentrated in those fractions 
which, on the basis of electron microscopic examination contained the 
highest proportions of mitochondria (i.e. the fraction located at the 
35-38% (w/w) sucrose interface and the pellet) (Table 3.1.2).
(Na^,K^)ATPase was enriched 3.32±1«2 times (±S.E.M.,N=3) and 
acetylcholinesterase 3.05 times (N=2) in the SPM fraction over the 
homogenate.
The distribution of protein in the fractions obtained from the sucrose 
gradient was similar to Cotman and Matthews* data. The largest 
difference, although not statistically significant, was in the slightly 
lower percentage of protein present in the myelin-enriched fraction 
(10.5±4.7 compared with 18.5±1.4 obtained by Cotman and Matthews).
The overall pattern of enzytie distribution was similar to that reported 
by Cotman and Matthews. A lower percentage of (Na ,K )ATPase and 
acetylcholinesterase, however, was found in the my el in- enriched fraction 
(56.8 and 57.2% of the Cotman and Matthews values respectively). 
Conversely, the mitochondrial fraction contained higher levels of these 
enzymes (397% and 844% respectively) although the acetylcholinesterase 
value did show a large standard error of the mean. None of these
-84-
TABLE 3.1.2
Percentage Distribution of Marker Enzymes and Protein in Brain Subfractions 
Obtained Using the Cotman and Matthews Method
Marker Enzyme
Fraction
Protein
(N=5)
(Na]*',K"'") ATPase 
(N=5)
AChE
(N=4)
Succinate 
PMS reductase* 
(N=3)
1 10.5±4.7
(18.5±1.4f*
10.313.3
(18.014.5)
19.717.4
(39.616.7)
3.010.4
(0.610.1)
2 31.7±2.0
(31.8+1.7)
51.315.3
(53.013.9)
48.914.7
(43.716.9)
11.816.6
(6.212.4)
3 20.8±3.9
(18.0+2.3)
17.514.4
(13.014.9)
11.112.6
(10.511.1)
12.212.2
(19.315.5)
4 22.0±4.7
(20.3+2.7)
8.911.6
(13.113.0)
9.014.8
(4.411.1)
27.9110.7
(43.113.5)
5 15.0±3.0
(11.5±4.9)
11.914.9
(3.011.1)
15.2112.8
(1.810.1)
31.9110.2
(30.417.6)
The composition of the fractions was as follows :-
1.predominantly myelin; 2. SPM; 3, membrane fragments + mitochondria;
4.mitochondria + membrane fragments; 5. mitochondria.
The values are expressed as in Table 3.1.1.
* Cotman and Matthews used cytochrome c oxidase as the mitochondrial marker. 
CobvxoA OAol Atajkiews' vtiiuAS
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differences were found to be statistically significant using Student's t 
test. The distribution of the mitochondrial marker, succinate PMS 
reductase, was similar to that obtained by Cotman and Matthews using 
cytochrome c oxidase. The percentage of the former enzyme located in the 
SPM fraction was higher than reported (11.8+6.6% compared with 6.2+2.4%) 
by Cotman and Matthews but similar to that obtained using the Jones 
and Matus procedure (10.4%). The differences in distribution of the 
mitochondrial marker compared with the data of Cotman and Matthews were 
not statistically significant.
The yield of protein in the SPM fraction was 2.38±0.38 mg protein/g 
tissue (wet weight) which compared well with that of 1.5-2.0 mg/g tissue 
reported by Cotman and Matthews (1971).
3.1.3 SDS Polyacrylamide Gel Electrophoretic Analysis of Brain 
Subcellular Fractions: Comparison of Fractions Obtained 
by the Jones and Matus (1974) and Cotman and Matthews 
(1971) Procedures
A comparison of the electrophoretic protein profiles of fractions 
obtained using both procedures is shown in Figs. 3.1.9.a and 3.1.9.b.
The myelin fraction isolated by the Jones and Matus procedure contained 
relatively few polypeptide bands (track 5). By comparison, the 
myelin—enriched fraction isolated by the longer procedure contained more 
polypeptides of which ten were present in substantial am-ounts (track 4). 
This more complex polypeptide composition of this fraction is in 
agreement with the morphological finding that the Cotman and 
Matthews'-type myelin—enriched fraction contains a high proportion of 
membranous material of non—myelin origin. The most prominent polypeptide 
band in this fraction corresponded to the 46K species observed in the 
Jones and Matus-type myelin fraction. Only a faint band, however, 
corresponded to the major 25K species in the latter fraction. The 
mitochondrial profiles of fractions obtained by the two methods were 
found to be very similar (tracks 10 and 11), The two most prominent 
mitochondrial proteins had molecular weights of 49 and 29.5K. Additional 
major polypeptides had molecular weights of 123, 83, 43, 40, 31.5, 30,
27, 25.5, 24.5 and 23.5K. The four lowest molecular weight species 
formed a distinctive pattern in the low molecular weight region of the
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Fig. 3.1.9.b
Track No.
Myelin
25K
66K
2B0K
49K
29-5K43K
Mitochondria
27K
—87"*
10 11 12
200K
I6-5K 
94 K
68K
!43K
Pig. 3.1.9* a) Coomassie blue stained 10^ SDS polyacrylamide gel
comparing subcellular fractions isolated using both 
procedures.
Tracks contain;
I. protein standards 
2,3. brain homogenates
4. Cotman and Matthews myelin-enriched fraction 
5* Jones and Matus myelin fraction
6. Cotman and Matthews SPM fraction
7. Jones and Matus SPM fraction
8. Cotman and Matthews 32.5-35^ (w/w) sucrose fraction
9. Cotman and Matthews 35-38^ (w/w) sucrose fraction
10. Cotman and Matthews mitochondrial fraction
II. Jones and Matis mitochondrial fraction 
12. protein standards
Each track contained 100/ig protein 
Pig. 3.1.9. b) Densitometric scans of electrophoretic protein profiles 
of myelin, SPM and mitochondrial-enriched fractions 
isolated using both procedures.
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gel. Another characteristic feature of the mitochondrial profiles was 
the lack of polypeptides of molecular weights in excess of 123K. The 
Cotman and Matthews-type fractions which were intermediate between the 
SPM fraction and the mitochondrial pellet (tracks 8 and 9) showed 
increasing amounts of the major mitochondrial polypeptides with 
increasing buoyant density. The SPM fractions prepared by both methods 
were very similar with all polypeptide species being present in both 
profiles. Both fractions showed a characteristic pattern of four bands 
of molecular weights 53, 50, 47 and 46K. Other major SPM polypeptides 
had molecular weights of 230, 94, 66, 43, 38, 34.5 and 30K. The most 
notable difference between the SPM electrophoretic profiles was in the 
amount of protein present in the 94K band.
This was a prominent species in the Jones and Matus-type preparation but 
only a minor component in the Cotman and Matthews SPM fraction. The 53 
and 50K species were present in lower proportions in the Jones and 
Matus-type fraction compared with the Cotman and Matthews-type fraction.
No band was present in either SPM fraction which corresponded to the 
major 25K myelin polypeptide. The presence of a band corresponding to 
the 46K myelin polypeptide could not be positively ascertained since this 
would have been located in the most complex region of the SPM profiles. 
The major mitochondrial polypeptides did not appear to be represented in 
either SPM fraction and no bands corresponded to the characteristic low 
molecular weight mitochondrial species.
Both myelin fractions, by comparison, appeared to contain bands which 
corresponded in molecular weight to principal components of the SPM 
fraction, particularly the 53, 50, 47, 46, 38 and 34.5K species. Traces 
of the 230 and 94K polypeptides were also observed in both myelin 
fractions. Relatively more of all of these species was present, however, 
in the Cotman and Matthews-type myelin-enriched fraction.
The intermediate Cotman and Matthews-type fractions (tracks 8 and 9) also 
contained small amounts of polypeptides which corresponded to major SPM 
species, particularly the 230, 47 and 38K polypeptides.
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3.1.4 DISCUSSION
3.1.4.1 Comparison of the Purity of Synaptic Fractions with Literature
On the basis of these characterisation studies it would appear that the 
SPM fractions isolated by both methods are comparable in purity and 
composition to those reported in the literature. While the overall 
pattern of marker enzyme distribution compared well with that reported by 
Jones and Matus (1974) and Cotman and Matthews (1971) some differences 
were observed. Comparison of the distribution of enzymes in Jones and 
Matus-type fractions with the literature was difficult, however, since 
these authors did not quote any standard deviations or standard errors of 
the mean in their results. By comparison with the figures quoted by 
Cotman and Matthews (1971), however, the S.E.M. values in the present 
study were similar to those reported by these authors. Although some 
differences were observed in the presentage distribution of marker 
enzymes were observed between the present study and that of Cotman and 
Matthews none were found to be statistically significant using Student's 
t test. This suggests that although individual S.E.M. values were 
relatively small there is, nevertheless, a substantial degree of 
variability in the isolation procedures. While every effort was made to 
standardise the routine procedures involved in the isolation of these SPM 
fractions it is inevitable that various steps in the preparative 
procedures are susceptible to substantial systematic errors inherent in 
the methods used, for example, in the removal of fractions from the 
sucrose gradients. This, in itself, may account for the differences in 
percentage distribution that were observed..
In the brain subfractions obtained by the two procedures it was found 
that smaller percentages of the plasma membrane markers were observed in 
the myelin fractions and higher percentages in the mitochondrial 
fractions than were reported in the literature. It is unlikely that this 
was due to malfunctioning of the sucrose gradients since the morphology, 
as judged by electron microscopy, and the electrophoretic protein 
profiles of the isolated fractions compared well with the literature 
(Cotman and Matthews, 1971; Jones and Matus , 1974; Blomberg et al., 
1977; Mena et al., 1980). In addition, the enrichment of the plasma 
membranes marker enzymes in the SPM fractions ovot the homogenates were 
similar to those reported by othet workers (Cotm^ ^ d  Matthews, 1971;
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Morgan et al., 1971; Gurd et al.. 1974). Furthermore the distribution of 
protein and the mitochondrial marker enzyme succinate PMS reductase on 
the sucrose gradients was consistent with that reported by the respective 
authors.
It is possible that the low percentage of plasma membrane markers in the 
myelin fractions is a consequence of the lower yield of protein in this 
fraction. In the present study a lower yield of protein (57% of the 
Cotman and Matthews' value) was routinely obtained in this fraction 
although this was not statistically significant. This deficit may, 
therefore, have distorted the percentage distribution of the plasma 
membrane markers in the remaining fractions.
The higher levels of plasma membrane markers in the mitochondrial, 
fractions, it may be argued, might be due to the presence of unlysed or 
partially lysed synaptosomes or to non-specific association of membranes 
containing these enzymes with mitochondria due to the effect of sucrose 
as described by Day et al., (1971). While neither of these possibilities 
can be entirely ruled out both are unlikely since the electron 
microscopic evidence suggests that neither synaptosomes or significant 
amounts of non-mitochondrial membranes were present in the mitochondrial 
fraction.
It was observed that the Jones and Matus-type SPM fraction contained a 
higher percentage of (Na"^,K^)ATPase than was reported by these workers. . 
Jones and Matus (1974) suggested that high levels of this enzyme might 
indicate glial contamination of SPM since sonication of the lysate 
resulted in a 46% increase of this marker in the SPM fraction. These 
workers suggested that this was due to the release of glial membranes, 
which contain (Na"^,K^)ATPase (see section 1.2.2), from myelin by this 
procedure. While the possibility that the present SPM fraction was 
contaminated by glial membranes cannot be ruled out it is unlikely that 
this contamination is substantial since brain tissue was homogenised 
under the same conditions as those used for the Cotman and Matthews 
procedure. The SPM fraction isolated using the latter procedure showed a 
percentage distribution of plasma membrane markers very close to that 
reported by Cotman and Matthews. In addition, morphological examination 
of the Jones and Matus-type myelin fraction showed that this was not 
significantly more damaged than the corresponding fraction obtained by 
these workers.
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In order to determine the percentage purity of SPM fractions a number of 
workers have isolated highly purified fractions of putative contaminants 
e.g. microsomes, mitochondria, etc. and compared the specific activity of 
marker enzymes in these fractions with the specific activity of these 
enzymes in SPM fractions (Levitan et al., 1972; Gurd et al., 1974). This 
was not done in the present study since the aim was to compare the 
distribution of marker enzymes with those reported in the literature. It 
is feasible to assume that if the percentage distribution of marker 
enzymes is similar to literature values that the percentage contamination 
is similarly comparable. In early papers the levels of contamination of 
SPM were generally agreed to be between 10 and 15% (see section 1.1.4). 
These percentages were based, however, only on measured contaminants and 
failed to take into account axonal and dendritic etc. membranes which 
could not be distinguished from SPM using the available techniques. It 
is now thought that the 'purity' of SPM fractions may be much lower than 
original estimates. Based on quantitative electron microscopic evidence 
the purity of SPM fractions may be as low as 55-65% (Gurd, 1982). Thus 
these fractions should be referred to as SPM-enriched fractions.
Thus the distribution of marker enzymes in SPM, myelin and 
mitochondrial-enriched fractions isolated by these two procedures is 
comparable to those obtained by these authors except for minor, 
non-significant differences.
3.1.4.2 Comparison of SPM Fractions Isolated by Both Procedures
The SPM fractions isolated by both methods were similar in their marker 
enzyme constitution, morphology and electrophoretic protein profiles.
The latter were used to compare the protein composition of both SPM 
fractions. The electrophoretic profiles of the SPM fractions were 
virtually indistinguishable and closely resembled published profiles 
(Blomberg et al., 1977; Matus et al., 1980b; Mena et al., 1980; 
Nieto-Sampedro et al., 1981a). The prominent SPM polypeptides reported 
by Jones (1976) and Walters (1976) were present in both fractions. The 
principal SPM polypeptides were shown to have apparent molecular weights 
of 53, 50, 47, 45, 43, 38, 34.5 and 30K. Although there was a slight 
discrepancy in the measured molecular weights (Carlin et al., 1982, 
have suggested that this may be due to variations in batches of SDS) it 
is thought that the 53 and 50K polypeptides may be ^ andtubulin, the
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47K band may be the major PSD protein and the 43K band actin (see section 
1,3.1). The identity of the 45K band is not known but has been observed 
in all published profiles of SPM fractions. Some of the major myelin 
proteins, the Wolfgram proteins, have molecular weights in this region 
but it is unlikely that the 47 or 45K bands are due to myelin 
contamination since the other major myelin proteins, the proteolipid and 
basic proteins, were not detected in either SPM fraction.
The Jones and Matus-type SPM fraction contained a prominent polypeptide 
of 94K which has been reported to be a major component of SPM 
electrophoretic profiles (Blomberg et al., 1977; Matus et al., 1980b; 
Burgoyne et al., 1981). It has been suggested that this SPM band may 
correspond to the major subunit of (Na ,K )ATPase (Morgan et al., 1973).
Of the remaining SPM polypeptides a 230K species has been reported to be 
fodrin (Kakiuchi et al., 1982; Sobue et al., 1982; Carlin et al., 1983). 
Jones (1976) tentatively suggested that, on the basis of a similarity in 
molecular weights, a 28K polypeptide (which corresponds to the 30K band 
in the present study) might be glucose-6-phosphatase.
Neither SPM fraction appears to be significantly contaminated by either 
myelin or mitochondrial polypeptides which suggests that contamination 
from these sources is minimal and is unlikely to be in excess of the 
values quoted by other workers.
Thus the SPM fraction produced by the rapid method of Jones and Matus 
does not seem to be substantially different in composition from that 
produced by the longer procedure. There does not appear, therefore, to 
be any merit in using the Cotman and Matthews method in preference to the 
more rapid method. The Jones and Matus method has now been adopted by a 
number of workers (De Bias and Mahler, 1976; Burgoyne and Rose, 1980; 
Sorensen and Mahler, 1981; 1983) and is now, therefore, considered to be 
of use in the study of functional components of the synaptic membrane.
3.2 Measurement of Total Cerebral Protein Synthesis and Precursor
Incorporation into Brain Subcellular Fractions In Vivo
While a considerable amount of work has been carried out in recent years 
to determine the rate of synthesis of brain proteins very little is known
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about the synthesis of SPM proteins and their incorporation into the 
synaptic plasma membrane. The aim of the present study has been, 
firstly, to establish a method for measuring the in vivo incorporation of 
radiolabelled precursor into SPM proteins and other subfractions of the 
brain and, secondly, to examine the effects of selected drugs and thyroid 
hormone deficiency on this incorporation in vivo.
3.2.1 Principles Governing the Choice of Method for the Measurement 
of Cerebral Protein Synthesis Rates In Vivo
Overall rates of protein synthesis are usually determined by measuring 
the accumulation of radioactivity in protein at a measured interval after 
administration of radiolabelled precursor. The rate of accumulation is 
an index of the rate of protein synthesis but only approximates closely 
to the absolute rate of synthesis if certain conditions are fulfilled.
To determine the absolute rate of synthesis it is necessary that the 
precursor specific activity in the pool used for protein synthesis is 
known during the incorporation period or can be calculated.
Frequently trace amounts of precursor have been used in the estimation of 
cerebral protein synthesis rates. This method, however, is subject to 
many problems stemming from the difficulty in determination of the 
precursor specific activity in the tissue and uncertainty as to the 
precursor pool used for protein synthesis. These problems have been 
discussed extensively elsewhere and, therefore, will not be examined in 
detail here (for reviews see: 0 j a , 1973; Lajtha and Dunlop, 1976; Dunlop
et al., 1977; Dunn, 1977 ; Waterlow et al., 1978; Rannels et al., 1982). 
Since the precursor specific activity varies during the incorporation 
period when trace amounts are used it is necessary to measure the 
time-integrated specific activity in order to obtain an estimate of the 
rate of protein synthesis (Heath and Barton, 1973) . This procedure is 
lengthy and requires large numbers of animals and substantial amounts of 
labelled precursor and is, therefore, rarely attempted.
In order to overcome the problems associated with using trace quantities 
of labelled precursor a number of methods have been developed in which 
the precursor specific activity is maintained at a constant level during 
the incorporation period. This can be achieved by repeated injections 
(Austin et al., 1972) implantation of pellets (Lajtha and Dunlop, 1976)
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and continuous infusion of precursor (Garlick and Marshall, 1972; Seta 
et al., 1973). These methods are still subject to uncertainty as to 
whether the precursor specific activity in the protein synthetic pool is 
close to the mean specific activity of the free precursor in the tissue. 
In addition, the incorporation periods used in these methods tend to be 
long (several hours) which may, therefore, lead to errors in calculating 
the rate of protein synthesis due to réutilisation of labelled amino 
acid •
An alternative method is available, however, in which high concentrations 
of precursor are administered in a single injection in order to ewamp the 
in vivo pools (Dunlop et al., 1975). In using this method it is assumed 
that over short incorporation periods (less than 1 h) all pools are 
labelled to the same specific activity which is close to that of the 
injected precursor. This method is the simplest of those designed to 
maintain the precursor specific activity and, since all precursor pools 
are of approximately the same specific activity, overcomes the problem of 
definition of the protein synthetic pool. All methods for measuring 
rates of protein synthesis assume, however, that the specific activity of 
the precursor in the tissue is close to the specific activity of the 
relevant amino acyl tRNA which is the ultimate precursor in the protein 
synthetic pool.
Single amino acid precursors are most commonly used in studies of protein 
synthesis. Ideally the precursor should be an essential amino acid with 
a small cerebral free pool and subject to only minimal metabolism in the 
brain. If the precursor is to be administered peripherally it should 
have a high uptake index into the brain. The route of administration may 
be either peripheral (sub-cutaneous, intraperitoneal or intravenous) or 
intracranial. The choices of route of administration and precursor are 
interdependent and are governed by the aim of the experiment.
In order to measure rates of incorporation of radiolabelled precursor 
into SPM proteins it is necessary to be able to achieve a sufficiently 
high precursor specific activity in the brain for measurable amounts of 
radioactivity to be attained in SPM protein. This can best be achieved
by intracranial injection of flooding levels of labelled precursor.
35
Gaitonde and Richter (1956) used gross injections of L-( S)methionine to 
measure cerebral protein synthesis rates. These workers administered the
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precursor by either intracistemal or subarachnoid injection under ether
anaesthesia. It has been reported, however, that ether anaesthesia
inhibits cerebral protein synthesis (Schotman et al., 1977). The effect
at
of anaesthesia can be avoid^^by injecting animals while conscious via a
previously implanted cannula. . Hence a method where flooding levels of 
35
L-( S)methionine were injected via pre-implanted intraventricular 
cannulae was developed to measure total cerebral protein synthesis rates 
and precursor incorporation into brain subcellular fractions in vivo.
353.2.2 Measurement of the Rate of Incorporation of L-( S)methionine 
into Brain Protein Using Gross Intraventricular Injection
Rats were injected intraventricularly initially with 1 mg 
35L-( S)methionine since this was reported by Gaitonde and Richter (1956)
to be sufficient to flood the brain methionine pools. It was found,
however, that the incorporation of precursor into brain protein over 1 h,
using this concentration, was not linear. In addition, the calculated
rates of incorporation at 20, 40 and 60 min after injection steadily
35decreased from 0.75 to 0.46)jmol L-( S)methionine incorporated/g 
protein/h (Fig. 3.2.1). This indicated that the precursor specific 
activity during the incorporation period was decreasing and, therefore, 
that the methionine pools were not flooded.
A trial study was made, therefore, to compare the incorporation rates
35
measured in animals injected with either 1 mg or 5 mg L-( S)methionine 
(Table 3.2.1).
The higher value represented the maximum amount of L-methionine able to
be dissolved in 100 pi. There was found to be a large difference in the
35measured rates of incorporation of L-( S)methionine into brain protein 
at 40 min after administration with the rate at 5 mg being considerably 
higher than at 1 mg.
The larger injection volumes used in this study, however, resulted in 
adverse reactions in the rats. Animals appeared to lose their balance 
and become disorientated for 2—3 min after injection although they 
recovered quite quickly. This effect was probably a consequence of the 
increased intracranial pressure following the injection of such a large 
volume of liquid. The maximum feasible injection volume, based on the
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Ptg. 3.2.1. Time Course of lacorporation of Img and 2.5mg of
L-[35smethionine into Total Forebrain Protein In Vivo
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0-0 1mg L-P^sl.methionine, male rats, 120 days old, body weights 378-11 g
2.$mg methionine, female rats, Tidays old, body weights .
225-6g
Conscious rats were intraventricularly injected via preimplanted cannulae 
with 1 or 2,5mg L - m e t h i o n i n e  (3Q;*Ci, injection volume, $(^l). Each • 
time point is the mean of values obtained from 4 rats (2.$mg time course) 
or 3 rats (l.Omg time course) with the exception of the 60min point where 
Na2. The animals were killed hy cervical dislocation after the appropriate 
incorporation period. The rates of incorporation at each time point were 
as follows ; 20 min, 0.75^0.08; 40 min, 0.55-0.02; 60 min, 0.46; for the 
Img time coursel 15 min, 0.65-0.03; 30 min, 0.57-0*03; 45 min, 0.62-0.02 
/imol methionine incorporated/ g protein/h-S.B.M. -Hw- 2-5/»^  ooorse.
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tabLE 3.2.1
Trial Comparison of the Rate of Incorporation of L-(^^S)methionine Using 
noses of 1 mg or 5 mg
Dose of methionine Rate of incorporation
(jjmol methionine incorporated/
g protein/h ± S.E.M.)
1 mg (N = 3) 0.47 ± 0.04
5 mg (N = 2) 0.96, 0.78
N * number of rats.
Female rats (100 days old, body weights 393 ± 18 g) were
35
intraventricularly injected with either 1 or 5 mg L-( S)methionine 
(lOyCi, injection volume, 50 >il).
The animals were killed by cervical dislocation after a 40 min 
incorporation period.
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absence of any discernible stress in the animals, was found to 50 j j I .  It
was necessary, therefore, to determine whether it was possible to flood
the brain methionine pools with the maximum amount of L-methionine able
to be dissolved in this volume. Trial studies showed this amount to be
2.5 mg L-methionine. Using this concentration of precursor the
35
incorporation of L-( S)methionine into the total forebrain TCA-insoluble 
fraction was examined (a representative graph is given in Fig. 3.2.1) at 
the incorporation periods of up to 45 min. In addition, the rates of 
incorporation at 15, 30 and 45 min were constant which implied that, at 
this concentration, the precursor specific activity was constant during 
the incorporation period.
35
The rate of incorporation of L-( S)methionine into total forebrain
protein under these conditions was found to be 0.64 jjmol methionine
incorporated/g protein/h (this figure is a representative value based on
3 separate time course observations). Using intraperitoneal flooding
14
injections of L-(U C)valine King (1980) obtained a value of 2.23±0.08 
Jjmol valine incorporated/g protein/h for the rate of cerebral protein 
synthesis. To compare the value obtained in the present study with that 
obtained by King the value must be corrected for the different abundances 
of methionine and valine in the brain. Lajtha and Toth (1974) estimated 
that, in rat brain, methionine accounted for 2.5% (jjmoles/lOOpmoles amino 
acid residues) and valine constituted 8.6%. Thus by correcting the rate 
obtained in the present study for comparison with valine a value of 2.2
Jjmol valine incorporated/g protein/h is obtained. Thus the rate of
35incorporation of L-( S)methionine into brain protein obtained using 
intraventricular injection is comparable to values for the rate of 
cerebral protein synthesis reported by other workers.
The incorporation of L-(^^S)methionine into brain subcellular fractions 
was also examined (Fig. 3.2.2). It was found that the rate of 
incorporation of precursor into mitochondrial protein was close to that 
of total forebrain protein (e.g. 0.571±0.03 and 0.51310.006 jjmol 
methionine incorporated/g protein/h IS.E.M. into forebrain and 
mitochondrial proteins respectively at 30 min after administration) and 
followed a similar pattern. Incorporation of labelled methionine into 
the proteins of the SFM and myelin fractions, however, was much lower 
(e.g. 61.3%±2.03 and 38.411.20 of the forebrain values at 30 min after 
administration (IS.E.M.)). In all of the fractions the rates of
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incorporation remained constant over incorporation periods of up to 45 
min.
35
3.2.3 The Distribution of S in Methionine, Cysteine and Cystine 
Following Intracranial Injection
TLC analysis of perchloric acid extracts of forebrain homogenates showed
that the major proportion of the label was found in a band corresponding
in mobility to the methionine standard (Rf 0.57+0.008 (IS.E.M.)) (Fig.
3.2.3). The radioactivity in this band accounted for 70-80% of the total
recovered from the t.l.c. plate. In the presence of oxidising acids
(e.g. performic or perchloric acid) cystine and cysteine are oxidised to
cysteic acid (Lehninger, 1976). This amino acid derivative was found to
migrate close to the origin (Rf 0.08±0.003 (iS.E.M.)). The percentage of 
35S in this band was difficult to quantitate since it was not 
substantially greater than the background activity found between the 
origin and the methionine band. Estimations of the radioactivity due to 
cysteic acid, however, were found to be never in excess of 10% of the 
total radioactivity recovered from the plate. Other labelled metabolites 
of methionine were not measured.
35
3.2.4 Rates of Incorporation of L-( S)Methionine into the 
TCA-Insoluble Fractions of Gross Brain Areas
35The rates of incorporation of L—( S)methionine into the protein of the 
left and right cerebral hemispheres (injected and non-injected sides 
respectively) and the cerebellum were compared to determine whether the 
distribution of labelled precursor was uniform throughout the brain. A 
small deficit (6.4%) was observed in the rate of incorporation of 
precursor into the protein of the right cerebral hemisphere compared with 
the left (injected) hemisphere but this was not found to be statistically 
significant using Student’s t test (Table 3.2.2.a). This finding was 
corroborated by further experiments. The largest deficit observed was of 
10.45% (Table 3.2.2.b) although this, again, was not statistically 
significant.
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table 3.2.2.a
35
Rates of Incorporation of L-( S)methlonine into Gross Brain Areas
Brain Area Rate of incorporation 
(umol methionine 
incorporated/g 
protein/h ± S.E.M.)
Percentage difference
Left hemisphere (N=5) 0.78±0.03 -
Right hemisphere (N=4) 0.73±0.05 —6.4
Cerebellum (N=5) 0.80±0.04 +2.6
TABLE 3.2.2.b
Brain Area Rate of incorporation 
(umol methionine 
incorporated/g 
protein/h ± S.E.M.)
Percentage difference
Left hemisphere (N*6) 0.72±0.03 -
Right hemisphere (N=6) 0.6510.05 -10.45
Cerebellum (N=6) 0.7110.03 —6.4
N ** number of rats.
Conscious rats (78 day old male rats, body weights 205 ± 5 g.
Table 3.2.2.©,; 83 day old rats, body weights, 2r7 t
Table 3.2.2.b) were injected into the left lateral ventricle via 
preimplanted cannulae with 2.5 mg L—(^^S)methionine (20 pCi, injection 
Volume 50 pi) . The animals were, killed by cervical disloation after a 30 
iDinute incorporation period.
None of the differences were statistically significant using Student s t 
test.
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Pig. 3.2.2. Time Course of Incorporation of L-[^^inretfaIonine(2.3mg) 
into Brain Subcellular Fractions In Vivo
^  A
•H
Female rats (71 days old, body wei^ts 225^ 6g) were intraventricularly 
injected with 2.$mg methionine (20^Ci, injection volume 5Qttl).
Animals were killed by cervical dislocation after the appropriate 
incorporation periods and subcellular fractions were isolated by the 
method of Jones and Hatus (1974).
•  Porebrain homogenate, A — A ogrelin, A A 8PM,
0 — 0  mitochondria.
• Rate of incorporation 
(Mmol methionine incorporated/ g protein/ h-S.E.M,)
Incorp. period (min) • 15 30 45
Porebrain homogenate 0.65-0:03 0.57±0.03 0.62±0.02
Myelin 0.2 6—0.07 0.22±0.02 0.22±0.01
8PM 0.38±p.05 0.37-0.02 0.38±0.03
Mitochondria 0 .58^0 .06 O.51I0 .OO6 0 .52±0 .0 3
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Pig. 3.2.3. Distribution of Perchloric acid-soluble labellelled
Amino Acids in Brain Extracts Following t.l.c.
The perchloric acid extracts of brain homogenates were run on 
cellulose t.l.c. plates in the solvent system n-butanol: glacial 
acetic acid* water (l2: 3: 5» by volume). After chromatography 
0,5cm bands were scraped off the plate and the distribution of 
radioactivity determined by scintillation counting.
3a 15min after injection
3b 30min after injection
3c 45min after injection
i
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3.2.5 The Effect of Selected Drugs on the Incorporation of 
35
L-( S)methionine into the Proteins of Total Brain Homogenates 
and Subcellular Fractions In Vivo
A variety of drug treatments have been reported to affect brain protein 
synthesis (see review by Lajtha and Dunlop, 1981). In many instances, 
however, drug effects have been studied using trace amounts of labelled 
precursor and, therefore, it is difficult to assess whether the observed 
effect is real or an artifact of, for example, precursor availability 
(see section 3.2.1) or other factors, e.g. alterations in the transport 
of precursor across the blood-brain barrier. In addition, a substantial 
number of drugs produce their effect on cerebral protein synthesis due to 
alterations in body temperature which, in some studies, has not been 
strictly monitored.
It was decided, therefore, that the effects of selected drugs on brain
protein synthesis would be examined using intraventricular injection of
35flooding concentrations of L-( S)methionine as described in section 
3.2.2.
3.2.5.1 The Effect of Halothane and Pentobarbitone-induced Anaesthesia
Halothane and pentobarbitone are frequently used in the anaesthetisation 
of small animals. It is, therefore, of interest to determine whether 
these drugs have any effect on cerebral protein synthesis since, in many 
studies, this has been examined in anaesthetised animals.
Halothane was found to cause a reduction in the rate of incorporation of 
L-(^^)methionine into brain protein in young rats (35-40 days old). This 
depression was observed in both forebrain and cerebellar homogenates and 
also in brain subcellular fractions (representative results are given in 
Table 3.2.3). In all of the fractions, except the myelin fraction, the 
rate of incorporation was reduced by around 40%. The myelin fraction was 
more severely affected and the rate of incorporation of labelled 
precursor into myelin protein was reduced by almost 70%. All of these 
reductions were found to be statistically significant using Student's t 
test.
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taBLE 3.2.3
,35,The Effect of Halothane and Pentobarbitone on the Rate of Incorporation of L-( S)methionine into 
Total Homogenate and Subcellular Fractions
Fraction
Rate of incorporation 
(umol methionine incorporated/g protein/h ± S.E.M.)
Conscious
(N=3)
+ Pentobarbitone 
(N=4)
+ Halothane 
(N=4)
Percentage
Pentobarbitone
inhibition
Halothane
Homogenates :
•
Left hemisphere 0.82±0.05 0.82±0.05 0.49±0.07 0 40.2*
Right hemisphere 0.86±0.09 0.88±0.08 0.50±0.07 +2.3 41.9*
Cerebellum 0.88±0.02 0.76±0.07 0.45±0.04 13.6 48.9*
Fractions :
Myelin 0.22±0.03 0.22±0.02 0.07±0.02 0 68.2*
SFM 0.49±0.03 0.51±0.05 0.30±0.03 +4.1 38.8**
Mitochondria 0.82±0.06 0,79±0.07 0.47±0.05 3.7 42.7**
N = Number of rats.
Male rats (37 days old, body weights 192.5 ± 13 g) were anaesthetised with either halothane (3%) 
or pentobarbitone (60 mg/kg body weight, i.p.). After 20 min the rats were injected 
Intraventricularly with 2.5 mg L“( S)methionine (20 uCi, injection volume 50 ul) via 
pre-Implanted cannulae. The control rats were injected in the same way \diile conscious. After a 
30 min incorporation period the animals were killed by cervical dislocation and subcellular 
fractions prepared by the method of Jones and Matus (1974). All anaesthetised rats were kept in 
Warm boxes during the experiment.
* p<0.02; ** p<0.01.
The percentage inhibitions due to pentobarbitone anaesthesia were not statistically significant 
'Wing Student's t test.
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table 3.2.4
The Effect of Pentobarbitone on the Rate of Incorporation of
35T.«r S)methlonlne into Total Homogenate and Subcellular Fractions
Fraction
Rate of incorporation 
(jjmol methionine incorporated/g protein/h ± S.E.M.)
Conscious
(N=5)
+ Pentobarbitone 
(H=4)
Percentage
inhibition
Homogenates :
Left hemisphere 0.78±0.03 0.7910.07 +1.3
Right hemisphere 0.7310.05 0.6810.05 6.8
Cerebellum 0.8010.04 0.7110.03 11.3
Fractions :
Myelin 0.4310.10 0.4510.08 +4.7
SPM 0.5810.08 0.5810.03 0
Mitochondria 0.8810.01 0.7510.05 14.8
N = number of rats.
Male rats (78 days old, body weights 205 ± 5 g) were treated as in Table
3.2.3 except that the dose of pentobarbitone was increased to 75 mg/kg 
body weight.
None of the values were statistically significant.
-107-
Pentobarbitone, by comparison, did not appear to significantly alter the 
rate of incorporation of L—( S)methionine into brain protein at doses of 
either 60 or 75 mg/kg body weight (Tables 3.2.3 and 3.2.4) in any of 
the fractions examined.
The reduction in the incorporation of precursor into brain protein in 
halo thane-anaesthetised rats was not due to any alteration in body 
temperature since all rats were housed in warm-boxes during the 
experiments. The rectal temperatures of all rats, both control and 
anaesthetised, were taken at death and were all close to 37®C.
3.2.5.2 The Effect of L-DOPA
A number of workers have observed that large doses of L-DOPA (500 mg/kg 
body weight) cause transient disaggregation of brain polysomes and reduce 
the incorporation of labelled amino acids into brain protein (Weiss 
et al., 1971; Roel et al., 1974). This effect has been found to be 
dependent on treated rats becoming hyperthermic on administration of 
L-DOPA which Moskowitz et al. (1977) have reported to play a permissive 
role in polysome disaggregation. Work carried out in this laboratory
3
(Ring, 1980) using either trace levels of L-(3,4 H)valine or
3
L-(4,5- H)lysine administered subcutaneously or flooding concentrations 
of L-(U-^^C) valine administered intraperitoneally failed to show any 
significant effect of L-DOPA on brain protein SjAthesis. It was decided, 
therefore, that the in vivo flooding method described earlier should be 
applied to the study of the effects of this drug and, therefore, resolve 
this discrepancy.
Moskowitz et al. (1977) observed that the L-DOPA-related hyperthermia, 
which was necessary for polysome disaggregation to occur, was only 
brought about if the treated animals were housed at an ambient 
temperature of 26®C. Under these conditions the rate of incorporation of 
L-( S)methionine into brain protein was not found to be affected by 
L-DOPA treatment (Table 3.2.5). It was observed, however, that the 
body temperatures of the L-DOPA treated rats were not significantly 
elevated and were well below the temperature of 39-40®C reported by 
Moskowitz et al. (1977) to be necessary for polysome disaggregation.
Trial experiments showed that to obtain the requisite degree of 
hyperthermia L-DOPA treated rates must be housed at an ambient temperature 
of 30“C for at least 45 min before administration of the drug and
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table 3.2.5
,35.
Hnmoeenate and Subcellular Fractions (Ambient Temperaturet, 26°C)
Fraction Rate of incorporation
(jjmol methionine incorporated/g protein/hiS.E.M.)
Control
(N=4)
+ L-DOPA 
(N=5)
Forebrain homogenate 0.88±0.07
Myelin 0.46±0.04 
SPM 0.51±0.05 
Mitochondria 1.35±0.29
0.9410.06
0.54+0.06
0.5410.04
1.3310.24
Mean body temperature (*C)
36.05±0.26 36.710.30
N » number of rats.
Male rats (34 days old, body weights 140.0 ± 11.5 g) were maintained at an 
ambient temperature of 26®C for 1 h prior to injection of L-DOPA (500 
mg/kg body weight, i.p., in 0.05 M HGl, 50 mg/ml) or vehicle and 
throughout the rest of the experiment. After a further 45 min both groups 
of rats were injected intraventricularly via pre-implanted cannulae with
2.5 mg L-(^^S)methionine. After a 30 min incorporation period the rats 
were killed by cervical dislocation and stibcellular fractions were 
isolated by the method of Jones and Matus (1974).
None of the differences were statistically signifient using Student s t 
test.
-109-
tabLE 3.2.6
,35.
Hnmogenate and Subcellular Fractions (Ambient Temperature, 30°C) 1.
Fraction Rate of incorporation 
(Jjmol methionine incorporated/g 
protein/hlS.E.M.)
Percentage
Inhibition
Control
(N=3)
+ L-DOPA 
(N=3)
Forebrain homogenate 0.9810.10 0.6810.11 30.6
Myelin
Synaptosomes
Mitochondria
0.7910.10
0.6110.08
0.9210.10
0.6310.18
0.4610.09
0.6210.10
20.2
24.5
32.6
Mean body temperature (*C)
39.910.10 41.510.54
N » number of rats.
Female rats (45 days old, body weights 165.211.4 g) were maintained at an 
ambient temperature of 30*C for 1 h prior to injection of L-DOPA (500 
mg/kg body weight, i.p., in 0.05 M HCl + 0.2% Tween 80, 50 mg/ml) or 
vehicle. The rats were subsequently treated as described in Table 3.2.5. 
Synaptosomes were isolated by the method of Gray and Whittaker (1962). 
None of the differences were statistically significant using Student's t 
test.
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The Effect of L-DOPA on the Incorporation of L-(^^S)methlonine Into Total Homogenate and 
Subcellular Fractions (ambient temperature. 30°C) 2
Fraction
Rate of incorporation 
(gmol methionine incorporated/g protein/h ± S.E.M^ Percentage 
inhibition 
(with regard to 
room temperature 
control)
Control (room temperature) Control (30“C) + L-DOPA 
(N=4) (N=2) (N=4)
Forebrain
homogenate 0.90±0.02 û-«\6 0.65±0.08 27*
Myelin 0.31±0.01 0.32 0.2710.02 13
Synaptosomes 0.48±0.03 0.53 0.4010.04 17
Mitochondria 0.70±0.03 0.83 0.5310.05 24**
Mean body temperature (®C)
37.1±0.12 38.5 39.510.20
N = number of rats.
Male rats (39 days old, body weights 136.6 ± 5.1 g) were housed either at an ambient temperature 
of 30®C or room temperature (iSC) throu^out the experiment. The animals were injected as 
described in Table 3.2.6. Synaptosomes were isolated by the method of Gray and Whittaker 
(1962).
* P < 0.05; ** p < 0.02
—111—
table 3.2.8
,35.
Hnmoeenate and Subcellular Fractions (Ambient Temperature. 30°C) 3.
Fraction Rate of incorporation 
(Jjmol methionine incorporated/g 
protein/hlS.E.M.)
Percentage
Inhibition
Control + L-DOPA 
(N=6) (N=5)
Forebrain homogenate 1.1110.05 0.7910.18
/
29.3*
Myelin
SPM
Mitochondria
0.3910.05 0.4710.19 
0.5110.07 0.5610.17 
0.8410.02 0.5510.11
+20.5 
+ 9.8 
34.0*
Mean body temperature (*C)
39.7510.21 42.410.43
N » number of rats.
Female rats (37 days old, body weights 113.513.3 g) were treated as 
described in Table 3.2.6. SPM fractions were prepared by the method of 
Jones and Matus (1974).
* P < 0.02
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throughout the remainder of the experiment. It is possible that this 
requirement for a higher ambient temperature during the experimental 
period is a consequence of the difference in strains since Moskowitz 
et al. used Sprague-Dawley rats while Wistar rats were used in the 
present study.
Repetition of the experiment using an ambient temperature of 30®C an 
inhibition of precursor incorporation of between 20 and 30% was observed 
in both the homogenates and subcellular fractions (Table 3.2.6). None 
of these inhibitions, however, were statistically significant. Further 
experiments produced similar inhibitions of protein synthesis with the 
deficits in the homogenates and mitochondrial fraction being 
statistically significant (Table 3.2.7). The deficits in incorporation 
of precursor into the myelin and synaptosomal proteins, although 13% and 
17% respectively, were not statistically significant.
In earlier experiments the control rats had been housed at the same 
ambient temperature as the L-DOPA treated rats. This resulted in an 
elevation of body temperature in the control animals although not to as 
high a degree as that observed in the drug-treated rats (e.g. 39.9“C 
compared with 41.5*C respectively). It has been reported that 
hyperthermia results in inhibition of protein synthesis in young rats 
(Millan et al., 1979) although Lajtha and Dunlop (1981) observed that in 
young rats protein synthesis proceeded at its maximal rate at 37-39*0.
It was of great importance, therefore, to check whether the observed 
elevation in the body temperature had any effect on precursor 
incorporation into brain protein. Comparison of control animals housed 
at a high ambient temperature (30*0) with rats housed at room temperature 
(20*0) showed that there was no difference in incorporation between 
these two groups of control rats.
In a further experiment in which SPM fractions were isolated no 
inhibition in incorporation of precursor into SPM and myelin protein was 
observed (Table 3.2.8). The depression in the rate of incorporation 
previously observed in the forebrain homogenate and mitochondrial 
fractions were found and were, again, statistically significant.
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3.2.6 DISCUSSION
3.2.6.1 The Use of Intraventricular Injeetlons of Flooding
35
Concentrations of L-( S)methionine for Measuring Cerebral 
Protein Synthesis In Vivo
The time course studies showed that the incorporation of 
35
L-( S)methionine into total brain protein was linear over 45 min after 
injection and that the rates of incorporation at specified time points 
within this period were constant. This Implies that the precursor 
specific activity in the brain was also constant during the 
incorporation period. Comparison of the overall rate of incorporation of 
precursor into total forebrain protein with the value obtained by King 
(1980) using L-(U-^^C)valine showed that these values were in close 
agreement. This strongly suggests that the rate of incorporation of 
precursor into brain protein measured by this method is close to the 
absolute rate of protein synthesis.
It is unlikely that the rate of protein synthesis obtained in the present 
study is subject to serious error due to the réutilisation of labelled 
precursor since the incorporation periods used were relatively short. 
Equally, since all cerebral free methionine pools are assumed to be 
labelled to the same extent under flooding conditions errors due to the 
heterogeneity of the precursor pools are minimised.
Metabolism of the precursor amino acid which results in the production of 
other labelled amino acids can prove to be a problem. Fqr example, 
leucine has been reported to undergo extensive catabolism to glijamate and 
aspartate (Dunn et al., 1971; Hershkowitz et al., 1975). Both cysteine 
and cystine are produced from dietary methionine, t.l.c. analysis of 
perchloric acid extracts of brain tissue indicated that the radioactivity 
due to both of these amino acids was unlikely to be more than 10% of the 
total radioactivity. This is not surprising since the catabolism of 
methionine occurs in the liver « thus any labelled residues produced from 
methionine are likely to be greatly diluted in the body and are, 
therefore, unlikely to contribute significantly to the observed rate of 
incorporation of ^^S-labelled precursor into brain protein.
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Similarly errors in the rate of protein synthesis measured by this method 
due to poor distribution of labelled precursor throughout the brain are 
probably small since the rates of incorporation measured in different 
gross brain areas were similar. The primary site of CSF production is in 
the choroid plexuses of the lateral ventricles from where it circulates 
via the third and fourth ventricles to the subarachnoid spaces. This 
circulation is aided by arterial pulsations of choroid plexuses which are 
transmitted throughout the CSF (Katzman, 1976). Injection of the 
precursor into the CSF of the lateral ventricles, therefore, maximises 
the opportunity for its even distribution through the brain.
Dunn (1975) reported that intracerebral injections caused inhibition of 
brain protein synthesis. These studies, however, were carried out on 
animals which were anaesthetised with ether and which were operated on on 
the day of the experiment. Later studies using rats which had been 
preimplanted with intraventricular cannulae and injected with precursor 
while conscious showed that protein synthesis was not affected by 
intracerebral injection, in itself (Schotman et al, 1977).
In the present study every precaution was taken to minimise stress to the 
rats due to handling, in general, and the injection procedure, in 
particular. The latter was performed with the aid of an experienced 
animal technician. Stressful stimuli should be reduced to a minimum 
since these have been reported to cause an increase in the rate of 
cerebral protein synthesis. (Jakoubec et al., 1970; Rees et al., 1974; 
Schotman et al., 1977). The latter workers estimated that the stress due 
to intracranial injections via preimplanted cannulae was no greater than 
that due to subcutaneous injections. In the present study the animals 
did not appear to be unduly stressed following intraventricular injection 
and their behaviour during the post-injection period was normal.
It might be argued that the injection of gross quantities of precursor 
may affect the measured rate of protein synthesis. Dunlop et al. (1975), 
however, were unable to show any significant effect on cerebral protein 
synthesis following the injection of flooding concentrations of valine. 
The maj or advantage of the present study is, that by using the local 
flooding method, high specific activities of precursor can be achieved in 
the brain. This, in turn, permits the measurement of the rate of 
incorporation of precursor into brain subcellular fractions.
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The rate of incorporation of L-(^^S)methionine into SPM protein was found 
to be close to 60% of that of total forebrain protein. This is 
consistent with the finding of Gurd (1978) who, using trace levels of
3
L-(4,5- H)leucine reported that the specific activity of synaptosomal
protein was 40-50% of that of the brain homogenate. The rate of
incorporation of precursor into SPM protein cannot be considered to be
equivalent to the rate of synthesis of these proteins since the value
includes a component due to the speed of axoplasmic transport. The fact
that a substantial amount of radioactivity is found in the SPM fraction
at 15 min after injection is, perhaps, not surprising in view of the
relatively short lengths of axons in the brain (Barondes, 1976).
Electron microscopic studies of autoradiograms of mouse brain have
demonstrated that labelled protein is found at the synapse within 15 min
of injection of precursor (Droz and Barondes, 1969). Gurd
(1978) reported that maximal incorporation of L-(4,5- H)leucine into SPM
protein occurred at 2-4 h after administration of the precursor
indicating the arrival of proteins synthesized in the cell body and a
second, smaller peak of incorporation at 16 h due to the arrival of
further protein exported by a slower component of axoplasmic transport.
It is possible that the rapid appearance of labelled protein in the SPM
fraction may be due, in part, to local synthesis of SPM protein (see
section 1.4.1). Due to the complicating factor of axonal transport in the
35rate of incorporation of L-( S)methionine into SPM protein it is 
difficult to determine whether SPM proteins are actually synthesized at a 
faster or slower rate than the overall rate of cerebral protein 
synthesis •
The rate of incorporation of precursor into myelin protein is slower than 
for any of the other fractions. This is consistent with the observation 
that the half-lives of myelin proteins are longer than those of other 
brain proteins although the reported values vary widely (Fischer and 
Morrell, 1974). Hamberger and Blomstrand (1969) estimated that the rate 
of incorporation of (^H)leucine into a purified 'nerve cell' fraction was 
three times greater than into a glial fraction Isolated from rabbit 
brain. The lower molecular weight myelin protestes (the basic and 
proteolipid proteins) are thought to be synthesized more slowly than the 
higher molecular weight Wolf gram proteins (Norton, 1976).
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Conversely, the incorporation of precursor into mitochondrial proteins is
similar to that of total protein. This is consistent with the findings
of Clouet and Richter (1959) that the specific activity of rat brain
mitochondria was slightly less than that of the total homogenate 30 min
35
after intracistemal injection of DL-( S)methionine. Reported values 
for the turnover of brain mitochondrial proteins vary considerably 
according to the method used for their measurement. For example, the 
half-lives of cerebral cortex mitochondrial proteins have been reported 
as 20.5 days (von Hungen et al.. 1968) and 41 days (Rodriguez de Lorez 
Arnaiz et al., 1971) and, in liver, 4-5 days (Swick et al., 1968).
These overall rates of incorporation are, perhaps, of limited value since 
they represent the average rates of synthesis of a highly heterogeneous 
protein population. Thus, it would be of considerable interest to 
examine the incorporation of labelled precursor into individual SPM 
proteins.
3.2.6.2 The Effect of Selected Dmgs on Brain Protein Synthesis In Vivo
The methodology employed in the present study of the effect of selected 
drugs has aimed to overcome any inaccuracies due to experimental 
conditions. Thus rats were preimplanted with cannulae which avoids any 
effect of surgery and related stress on the measured rate of protein 
synthesis. In addition, all drug-treated animals were maintained at a 
strictly controlled temperature. Every effort was made to minimise 
stress due to handing etc. which may also have affected the rate of 
protein synthesis (Schotman et al., 1977).
Under these conditions and using young animals (35-40 days old) who are 
more susceptible to drug treatments the anaesthetic halothane and L-DOPA 
caused a decrease in the rate of synthesis of total brain protein 
although the anaesthetic pentobarbitone did not appear to affect 
protein synthesis.
Halothane reduced the incorporation of precursor into all brain fractions 
examined although myelin was the most severely affected. Halothane has 
been reported to cause a reversible inhibition of protein synthesis in 
lung tissue (Wartell et al* > 1981; Rannels et al., 1983). The 
depression in synthesis was reported by these workers to be equivalent to
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10% per 1% increment in halothane concentration. This is consistent with
the present results in which a 40% inhibition was observed on
administration of 3% halothane. This anaesthetic has been reported to
accumulate in brain particulate fractions (Divakaran and Wiggins, 1982).
These workers proposed that this was a consequence of the lipophilic
nature of halothane. Myelin has been found to accumulate halothane
to a much greater extent than any other brain fraction (Cohen et al.,
1972; Divakaran and Wiggins, 1982). This is consistent with the
observation that the myelin fraction showed that the largest deficit in
35incorporation of L-( S)methionine.
Allison and Nunn (1968) suggested that the induction of general
anaesthesia is dependent upon the depolymerization of neuronal
microtubules. Since most, if not all, SPM proteins are delivered to the
nerve ending by rapid axonal transport it might be expected that a large
35deficit in the incorporation of L-( S)methionine into this fraction 
might be observed if the neuronal microtubules were affected by 
halothane. Since the reduction in incorporation of precursor into the 
SPM fraction was similar to the overall reduction in the homogenate it is 
unlikely that halothane significantly affects the axonal micro tubules. 
This is consistent with the findings of Kennedy et al., (1972) who were 
unable to find any inhibition of axonal transport by halothane in vivo 
although in vitro 4% halothane caused a 40% reduction in the rate of 
axonal transport.
General anaesthesia has been reported to cause a general depression of
brain metabolism (Abood and Hoss, 1976). The mechanism by which this
occurs is not known but may be due to either a reduction in the
respiratory rate, reduced cerebral blood flow or by a more specific
effect on cerebral metabolism. Since it might be ^pected that this
effect would be observed in both pentobarbitone and halothane
anaesthetised rats it is unlikely that the inhibition of protein
synthesis in the latter is due to a general depression in brain
metabolism. Ether anaesthesia has been reported to result in elevated
3
plasma corticosterone levels and reduced incorporation of L—( H)leucine 
into brain protein (Schotman et al» , 1977) é Whether the inhibition of 
protein synthesis observed in halothane anaesthetised rats is also 
mediated by a hormonal mechanism is uncertain but may be ao^  area for 
further investigation* These results indicate, however, that halothane.
—11 fi­
as well as ether, anaesthesia should be avoided if cerebral protein 
synthesis is to be studied.
Pentobarbitone, by comparison, did not appear to have any significant 
effect on brain protein synthesis in any of the fractions examined in 
this study. In studies where trace amounts of precursor have been used 
the reported effects of barbiturate anaesthetics on cerebral protein 
synthesis have varied widely. Satake et al. (1974) found that 
amobarbital and phénobarbital both caused inhibition of the incorporation 
of (^^C)algal protein hydrolysate into isolated perikarya and into the 
cerebral cortex. Conversely, Hitzemann and Loh (1977) reported that the 
incorporation of ( H)lysine into the SPM proteins isolated from 'light' 
synaptosomes i.e. those which band at the interface between 1.0 and 1.1 M 
sucrose, was enhanced by pentobarbital. It is known that 'light' 
synaphosomes are enriched in GABÂergic nerve endings which are thought to 
be involved in the mode of action of barbiturate anaesthesia (Willow and 
Johnston, 1981). The effect reported by Hitzemann and Loh (1977) was 
relatively small, however, and would be unlikely, therefore, to be 
observed in the present study which did not differentiate between SPM 
proteins derived from different synaptosome populations.
The administration of large doses of L-DOPA resulted in reduced 
incorporation of precursor into the forebrain homogenate, myelin, 
synaptosomal and mitochondrial protein under conditions where the 
experimental animals' body temperatures were elevated to at least 39*C. 
These deficits were only statistically significant: in the homogenate and 
mitochondrial fractions. The lack of significance in the other fractions 
is probably a consequence of the variation in the results rather than a 
lack of effect by Lr-DOPA. Natural variation in the response of 
individual animals to the drug is inevitable. In the present study it _ 
was found that some animals showed only small inhibitions in protein 
synthesis following L-DOPA treatment. This effect was also observed 
by King (1980) who suggested that these 'non-responders' might correspond 
to rats who failed to show the necessary elevation in body temperature.
In the present study all animals treated with L-DOPA showed the 
characteristic behavioural responses to the drujg of hyperactivity or 
stereotypy interspersed with periods of catatonia and extreme sensitivity 
to acoustic stimuli. In addition there was no correlation between body 
temperature and poor response to the drug since all rats showed elevated 
temperatures.
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There are, inevitably, several factors contributing to the variability of 
results in experiments of this nature. Firstly, there is the natural 
variation in response to both the drug and possibly also to the high 
ambient temperatures used and, secondly, the variations in subcellular 
fractions due to small variations in the isolation procedure (as 
discussed in section 3.1.4). The latter probably explains the lack of 
significance in the subcellular fractions. Nevertheless in animals which 
showed a large inhibition in incorporation into the homogenate there was 
a correspondingly large inhibition in the subcellular fractions. The 
variation in results can be minimised by using large numbers of rats. In 
the present investigation, however, this was not possible since only a 
limited number of brains were able to be fractionated simultaneously.
The results do suggest, however, that the inhibition of incorporation of 
35
L-( S)methionine into total brain protein and mitochondrial protein is 
real. The value of 20-30% for this inhibition is similar to that 
obtained by Roel et al. (1974) and King (1980). While it is possible 
that there is some effect on incorporation into SFM, synaptosomal and 
myelin proteins further work is needed to clarify this. It should be 
observed, however, that to obtain an effect on protein synthesis requires 
very severe treatment of relatively young animals. It was found that the 
death rate of L-DOPA treated rats during the experimental period was 
quite high and amounted to about 1 in 6 animals.
In the study of these drug effects it was necessary to use young rats
since these are more susceptible to drug treatments. This accounts for
the higher rates of protein synthesis in these studies than were observed
earlier (using 100 day old rats). The rate of cerebral protein synthesis
has been shown to decline with age although this decline is most rapid
between birth and 28 days (Dunlop et al., 1977). In a subsequent section
(3.1.3) the rate of protein synthesis in young rats was measured using
X A
intraperitoneal injection of flooding concentrations of L-(U— C)valine. 
In 31 day old rats it was found that the rate of protein synthesis in 
the forebrain was 2.95+0.21 pmol valine incorporated/g protein/h. By 
correcting the value of 0.82 jjmol methionine incorporated/g protein/h 
obtained in the anaesthesia experiments for comparison with valine (as 
earlier) a figure of 2.82 jjmol valine incorporated/g protein/h in these
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37 day old rats. Thus the higher rates of synthesis in the anaesthesia 
studies were consistent with the age of the rats used.
In the L-DOPA experiments, however, the animals were subject to quite 
severe treatments and it is likely that in addition to the rates of 
synthesis being higher due to the younger ages of the rats there may also be 
an increment due to stress due to the high ambient temperatures and the 
necessity of injecting the drug as a suspension. While these factors can 
be minimised by careful handling of the rats it is not possible to 
totally eliminate stressful stimuli which are inherent in the experimental 
design.
3.3 The Effects of Hypothyroidism on the Development and Synthesis
of Total Brain Protein and SPM and Mitochondrial Polypeptides
Thyroid hormone deficiency in young rats is known to produce profound 
effects on brain structure and function including a reduction in the 
number of synapses (Balazs et al., 1977). Deficiency of these hormones 
during the critical period of brain development prevents the normal 
morphological changes which accompany brain maturation and results in the 
characteristic anatomical and functional anomalies associated with 
cretinism. The severity of the effect of hypothyroidism varies between 
different brain regions and depends on the relative stage of maturity of 
the region at the onset of hypothyroidism. The overall effect, however, 
is large enough to be easily studied in gross brain areas.
Synaptogenesis has been reported to be severely affect<adby neonatal 
thyroid hormone deficiency (Nicholson and Altman, 1972). The aim of 
this study, therefore, was to determine whether any specific alterations 
in SPM composition or synthesis occurred in hypothyroid rats.
3.3.1 General Effects of Hypothyroidism
3.3.1.1 The Effect on Body and Brain Weights
The pups of rats fed on a diet containing PTÜ from 3 days after the birth 
of the litter and throughout the suckling period showed a variety of 
symptoms associated with neonatal hypothyroidism. These pups showed 
retarded development, poor coordination, retention of djifantile body 
shape and features and substantially reduced body weights compared with
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3*3*1* The Effect of Hypothyroidism on the Body Weight of 
Developing Rata
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N=6 for 8 day old rats 
Na4 for the remaining points
Each point represents the mean value for litter mates of the same 
age. The difference "between hypothyroid and euthyroid rats was 
statistically significant at each age at p< 0.001. The S.B.M. 
values for the hypothyroid rats were 0.20, 0.54^^and 0.73 at 
each age respectively.
The number of rats per litter was 9-1$.
control, 0 — 0  hypothyroid.
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Fig. 3.3.2. The Effect of Hypothyroidism on the Weight of 
Porebrain and Cerebellum in Developing Rats.
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Cerebellum;Control, O.OO8, O.OO5, 0.003;
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The p values were as follows 
Porebrain; 0.001, 0.001, 0.01, 0.001.
Cerebellum; HS, NS, 0.001
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control rats (Fig. 3.3.1). The deficit in body weight increased over the 
first four weeks of life, reaching 64% at 34 days postpartum. This 
pattern was observed in all of the hypothyroid litters examined and was 
statistically significant in all age-paired litters.
Deficits in the weights of forebrains and cerebella were observed in 
hypothyroid rats compared with euthyroid controls (Fig. 3.3.2) although 
these were not as large as the deficits in body weight. These deficits 
were observed in at least 4 separate sets of paired litters. The 
reduction in forebrain and cerebellar weights increased with age and in 
both regions was over 20% at 4 weeks postpartum. At all of the ages 
examined the reduction in forebrain weight was statistically significant 
using Student's t test. The reduction in cerebellar weights at 9 and 13 
days postpartum, however, was not statistically significant. This may be 
a consequence of the difficulty in accurately dissecting all of the 
underlying material from the cerebellum in such small rats. This was 
particularly true of the hypothyroid animals whose brains were very soft 
and, therefore, difficult to dissect.
3.3.1.2 The Effect on Protein Yields in Total Homogenates and 
Subcellular Fractions
The yields of protein in the forebrain homogenates were reduced on both a 
mg protein/brain and mg protein/g tissue basis at all four ages (Tables
3.3.1 and 3.3.2). Not all of these deficits were statistically 
significant, however, but it was observed that on both bases the deficit 
in the 13 day old rats was significant. The yields of protein in the 
cerebellar homogenates showed a deficit on a mg protein/brain and mg 
protein/g tissue basis which was statistically significant at 13 and 34 
days postpartum. The deficit in the cerebellar homogenates at 2 weeks 
postpartum was larger than that in the forebrain (37% and 18.2% 
respectively, mg protein/brain).
In the SPM fractions it was observed that there was no significant 
difference in protein yield on either basis. A small deficit of 6-17% was 
observed in the SPM protein yield on a jjg SPM protein/jjg homogenate 
protein basis although this was not statistically significant (Table
3.3.3).
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TABLE 3.3.1
Protein Yields in Homogenates and Subcellular Fractions Isolated from 
Hypothyroid and Euthyroid rats (mg protein/brain)
Age (days)
Protein yield (mg protein/brain ± S.E.M.)
7 13 21 34
Forebrain
homogenate:
Control 27.26+2.04 62.9211.94 73.8314.14 106.4615.32 ,
Hypothyroid 23.38±0.93 51.4611.49 59.3514.59 79.4214.14
(N=9) NS (N=8) 0.001* (N=4) NS (N=4) 0.01
Cerebellar
homogenate:
Control 9.6010.71 9.66l0.68 - 22.2010.33
Hypothyroid 8.8211.36 6.0410.05 - 18.9710.88
(N-6) NS (N=7) 0.01 (N=6) 0.01
Myelin:
Control 0.3110.04 0.3910.03 0.8110.08 0.7210.08
Hypothyroid 0.4510.04 0.4210.04 0.5610.02 0.4510.04
(N=6) 0.05 (N=6) NS (N=5) 0.02 (N=5) 0.05
SPM:
Control 0.5810.05 1.5810.10 ■ 3.2110.06 1.8810.13
Hypothyroid 0.8510.03 0.8710.04 2.2910.05 1.9010.25
(N=6) 0.01 (N=7) NS (N=6) NS (N=5) NS
Mitochondria:
Control 1.7010.07 2.5310.12 3.7110.15 5.3010.07
Hypothyroid 2.4710.13 2.1510.18 2.3710.13 3.0010.24
(N=6) 0.001 (N=6) NS (N=5) 0.01 (N«5) 0.01
N = number of rats.
NS = not statistically significant using Student's t test.
* p values using Student's t test.
All litters contained 9-15 rats.
Subcellular fractions were isolated by the method of Salvaterra and Matthews 
(1980).
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TABLE 3.3.2
Protein Yields In Homogenates and Subcellular Fractions Isolated from 
Hypothyroid and Euthyroid rats (mg protein/g tissue wet weight)
Protein yield (mg protein/g tissue ± S.E.M.)
Age (days) 7 13 21 34
Forebrain
homogenate:
Control 57.26±3.86 74.0010.93 99.5211.68 89.0013.31
Hypothyroid 54.8811.53. 65.6910.93 85.6510.89 82.0613.03
Cerebellar
(N=*9) NS (N=8) 0.001* (N=4) 0.01 (N=4) NS
homogenate:
Control 81.3413.30 78.0013.25 - 95.4510.62
Hypothyroid 78.6117.40 
(N=6) NS
59.4314.13 
(N=7) 0.01
108.0013.33 
(N=4) 0.01
Myelin:
Control 0.5210.05 0.4310.04 0.8210.08 0.6310.07
Hypothyroid 0.6710.06 0.4510.03 0.6010.03 0.5210.05
SPM:
(N=6) NS (N=6) NS (N=5) NS (N=5) NS
Control 1.4310.13 1.5310.11 2.8110.07 1.6510.13
Hypothyroid 1.2510.06 1.3710.09 2.6710.06 2.1910.29
(N=6) NS (N=5) NS (N=5) NS (N=5) NS
Mitochondria:
Control 2.8110.08 2.5710.13 3.2710.03 4.4310.06
Hypothyroid 3.6310.21 2.1810.18 2.5910.02 3.1110.27
(N=6) NS (N=6) NS (N=5) NS (N=5) NS
N = number of rats.
NS = not statistically significant.
* p values using Student's t test.
Subcellular fractions were isolated by the method of Salvaterra and Matthews 
(1980).
-126-
table 3.3.3
Protein Yield In the SPM Fraction Isolated from Hypothyroid and Euthyroid 
Rats (jjg protein/jjg protein in the Forebrain Homogenate)
Protein yield (pg/ in SPM/pg in homogenate 1 S.E.M.)
Age (days) 9 13 20 31
Control
Hypothyroid
1.8010.20 
1.6810.10 
(N=6) NS
2.6010.10 
2.3910.10 
(N«6) NS
3.6010.40 
3.0010.30 
(N=5) NS
1.6510.10 
2.2010.30 
(N=5) NS
N = number of rats.
NS = not statistically significant.
SPM fractions were isolated by the method of Salvaterra and Matthews, (1980)
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On a mg protein/g tissue (wet weight) basis, no significant differences 
were observed in the myelin and mitochondrial fractions isolated from 
hypothyroid rats compared with euthyroid controls. On a mg protein/brain 
basis, however, significant deficits of 30-40% were observed in both 
fractions at 21 and 34 days postpartum.
3.3.2 The Effect of Hypothyroidis.m on the Incorporation of
L-(U-^^C)valine into Total Homogenates and Subcellular 
Fractions In Vivo
14The rates of incorporation of L-(U- C)valine into total brain protein 
and subcellular fractions were measured using the in vivo flooding method 
developed by Dunlop et al. (1975). This involved the intraperitoneal 
injection of flooding concentrations of valine and was adopted since it 
was found that it was not feasible to carry out the intraventricular 
cannulation of young rats and particularly the hypothyroid animals with 
routine success.
In both the control and hypothyroid rats a decline in the rate of 
incorporation was observed between 9 and 31 days postpartum (Table
3.3.4). In both cases the rate of incorporation was approximately 45% 
lower at 31 days than 9 days postpartum in the forebrain. A similar 
decline in the rate of incorporation was observed in all of the fractions 
examined.
Comparison of the rates of incorporation in the forebrain and cerebellar 
homogenates showed that while there were small deficits (8-10%) in all 
but the 31 day old cerebellar homogenates these were only statistically 
significant in the forebrain at 20 days and in the cerebellum at 13 days 
after birth.
A similar pattern was observed in the subcellular fractions where 
deficits were found in hypothyroid animals of up to 20 days old. The SPM 
fraction showed a statistically significant deficit of 25% in 13 day old 
rats and was observed in a further two repetitions of this experiment.
At 9 and 20 days, while deficits of 11.5% were observed in hypothyroid 
rats, these were not found to be significant using Student's t test. The 
rate of incorporation of labelled valine into myelin protein was most
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table 3.3.4
14,The Effect of Hypothyroidism on the Incorporation of L-(U- C)valine into
Rats
Age (days)
Rate of incorporation 
(jjmol valine incorporated/g protein/h ± S.E.M.)
9 13 20 31
Forebrain
homogenate:
Control 6.3510.40 7.1210.25 4.4210.12 2.9510.21
Hypothyroid 5.7810.32 6.5210.31 3.6710.10 2.6210.13
(N»7) NS (N*6) NS (N=5) 0.01* (N=7) NS
Cerebellar
homogenate:
Control 6.6010.35 6.7910.15 - 3.1810.25
Hypothyroid 5.9510.32 5.7810.32 - 3.3610.11
(N*7) NS (N»6) 0.02 (N=7) NS
Myelin:
Control 4.8810.53 3.6710.54 2.9510.11 1.3510.31
Hypothyroid 3.2510.36 1.7710.37 2.3210.19 2.3310.55
(N=6) 0.05 (N=5) 0.02 (N=5) 0.02 (N«5) NS
SPM:
Control 4.3810.29 4.9910.36 3.4910.03 1.6310.26
Hypothyroid 3.8710.33 3.7410.31 3.0910.33 1.8910.15
(N=6) NS (N=6) 0.02 (N=5) NS (N=6) NS
Mitochondria:
Control 4.3510.05 4.8510.22 3.5910.14 2.3510.19
Hypothyroid 4.0210.22 4.3110.25 3.6010.21 2.6010.16
(N»6) NS (N=6) NS (N=5) NS (N=6) NS
N = number of rats.
NS = not statistically significant.
* p values using Student's t test.
14
Animals were injected with L-(U- C)valine (15 jumol/g body weight, i.p.,
0.5 mmol valine/ml, specific activity 20 jjCi/mmol valine for 1-3 week old rats, 
10 pCi/mmol valine for 4 week old rats). The animals were killed by cervical 
dislocation 2 h after injection. Subcellular fractions were isolated by the 
method of Salvaterra and Matthews (1980).
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severely affected by thyroid hormone deficiency. The largest deficit 
(52%) in incorporation was observed at 13 days postpartum. At 9 and 20 
days, however, the rate of incorporation of precursor into myelin protein 
was reduced by 33 and 21% respectively. All of these reductions were 
st^stically significant. The mitochondrial fraction showed small, 
non-significant reductions in the rate of incorporation of valine at 9 
and 13 days postpartum but not at later ages.
3.3.3 The Effect of Hypothyroidism on the Amounts of and the
35
Incorporation of L-( S)Methionine into SPM, Mitochondrial
and Total Brain Polypeptides In Vivo
Homogenates of forebrains and cerebella from both hypothyroid and 
euthyroid rats were analysed by SDS polyacrylamide gel electrophoresis. 
The levels of individual polypeptide bands in age-paired hypothyroid and 
euthyroid samples of the same protein loading were compared by 
monitoring the relative densities of the Coomassie Brilliant Blue 
stained bands both by visual inspection of the gels and by 
densitometry. (It should be observed, however, that on 1-dimensional 
gels each polypeptide band may comprise a number of polypeptide species 
of similar molecular weights.) Since in most pairs of tracks some small 
differences were observed between hypothyroid and euthyroid samples it 
was necessary to define a criterion by which to judge whether these 
differences were due to hypothyroidism.
It was decided, therefore, that for any variation between deficient and 
normal rats to be designated as being due to thyroid hormone deficiency 
the difference should be consistently present and of similar magnitude 
in all of the paired samples available for that particular subcellular 
fraction and age of rat. Routinely this involved a minimum of two 
separate isolations comprising 4 paired samples for the homogenates and 2 
paired samples for the subcellular fractions. Thus variations observed 
in individual pairs of tracks were discounted. For example, the 
densitometrie scans of 1 week old cerebellar homogenates (Fig. 3.3.3.l.b) 
show a series of 4 low molecular weight polypeptide bands which appear to 
be present in lower amounts in the hypothyroid fraction than in the 
control. This was observed in only 2 out of 4 pairs of samples, however, 
and was discounted on the criterion described above. Thus, on this 
basis, no consistent differences induced by thyroid hormone deficiency in
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Pig. 3.3.3.1. Comparison of the Coomassie Brilliant Blue-stained 
electrophoretic profiles of forehrain protein from hypothyroid 
and euthyroid neonatal rats.
a) Protein samples were separated on 10^ SDS polyacrylamide slah 
gels (lOOyUg protein/ track). No consistent differences between 
hypothyroid and euthyroid samples were observed. (The variation 
between pairs of samples is an artifact of the photographic 
processing and is not due to differences between gels which were 
of similar quality),
b) Densitometric scans of Coomassie Brilliant Blue-stained gels. 
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Pig. 3.3.3.2. Comparison of the incorporation of L-(^^s) methionine 
into forebrain protein from neonatal hypothyroid and euthyroid rats 
by fluorographic analysis.
a) Rats were injected as described in section 2.4.2.2. and killed by 
cervical dislocation after a 2h incorporation period. Samples were 
separated on SDS polyacrylamide gels. Constant amounts of radioactivity 
were loaded per track (l6,000, 8,000, 5,000 & 6,000dpm at 8, 16, 22
<fe 34 days respectively). These gels were subsequently processed 
for fluorographic analysis.
b) Densitometric scans of fluorograms.
Consistent differences between hypothyroid and euthyroid samples 
are indicated by ▼ Wiere the incorporation of labelled methionine 
is enhanced in hypothyroid samples and V where incorporation is 
reduced relative to euthyroid samples.
Molecular weights are given as ;^ 0“^
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Fig. 3.3.3.3. Comparison of the Coomassie Brilliant Blue-stained 
electrophoretic profiles of cerebellar protein from neonatal 
hypothyroid and euthyroid rats.
a) Coomassie Brilliant Blue-stained gels loaded with constant 
amounts of cerebellar homogenate protein (1OO^g/ track) from both 
hypothyroid and euthyroid rats.
Densitometric scans of Coomassie Brilliant Blue-stained gels of 
cerebellar fractions.
No consistent differences in the amounts of individual polypeptide 
bands were observed at any of the ages examined which could be 
attributed to thyroid hormone deficiency.
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Fig. 3.3*3.4- Comparison of the incorporation of L-(^^s) methionine 
into cerebellar protein from neonatal hypothyroid and euthyroid rats.
a) SDS polyacrylamide gels loaded with constant amounts of radio­
activity per track (12,000, 6,500, 6,000 Sc 6,000dpm at 8, 16, 22 &
34 days respectively)- were processed for fluorographic analysis.
b) Densitometric scans of fluorograms.
Polypeptide bands showing possible thyroid hormone deficiency-related 
alterations are indicated as before.
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Fïg. 3.3.3.5* Comparison of the Coomassie Brilliant Blue-stained 
electrophoretic profiles of SPM protein from neonatal hypothyroid and 
euthyroid rats.
a) SPM fractions were isolated from neonatal hypothyroid and euthyroid 
rats hy the method of Salvaterra and Matthews (1980) and subjected
to SDS polyacrylamide gel electrophoresis at a constant protein 
loading of 100^/ track and then stained with Coomassie Brilliant 
Blue.
b) Densitometric scans of Coomassie Brilliant Blue-stained gels 
of SPM fractions isolated from hypothyroid and euthyroid neonatal 
rats.
No consistent differences were observed between individual polypeptide 
bands which could be attributed to thyroid hormone deficiency.
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Fig. 3.3.3.6. Comparison of the incorporation of L-(^^S) methionine 
into SPM protein from neonatal hypothyroid and euthyroid rats,
a) Fluorograms of polyacrylamide gels loaded with constant amounts 
of radioactivity per track (20,000, 6,500, 4,000 & 5,000dpm at 
8, l6, 22 & 34 days respectively), 
h) Densitometric scans of fluorograms.
Polypeptide bands showing possible thyroid hormone deficiency-related 
differences are indicated as before.
Fig. 3.3.3.7.b.
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Pig. 3.3.3.7. Comparison of the Coomassie Brilliant Blue-stained 
electrophoretic profiles of mitochondrial protein isolated from 
hypothyroid and euthyroid rats.
a) Mitochondrial fractions were isolated hy the method of Salvaterra 
and Matthews (198O) and subjected to SDS polyacrylamide gel electro­
phoresis at a constant protein loading of lOO^g/ track and then 
stained with Coomassie Brilliant Blue.
b) Densitometric scans of Coomassie Brilliant Blue-stained gels of 
mitochondrial fractions isolated from hypothyroid and euthyroid 
rats.
No consistent differences were observed between individual polypeptide 
bands which could be attributed to hypothyroidism.
-144-
P ig . 3 . 3 . 3 . 8 . b
8 days
days
22 days
34 days
31 .5
-145-
31 5^
H H H H
Age (days) 8 16 22 34
Fig. 3.3.3.8. Comparison of the incorporation of L-(^^S) methionine 
into mitochondrial protein from neonatal hypothyroid and euthyroid 
rats.
a ) Pluorograms of SDS polyacrylamide gels loaded with constant 
amounts of radioactivity (25,000, 13,500, 5,000 & 6,000dpm at 
8, l6, 22 & 34 days respectively), 
h) Densitometric scans of fluorograms.
Polypeptide bands showing possible hypothyroidism-related alterations 
are indicated as before.
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the relative amounts of individual polypeptide bands were observed in 
either the forebrain or cerebellar homogenates of rats aged up to 34 days 
(Figs. 3.3.3.1 & 3.3.3.3).
Corresponding SDS polyacrylamide gels on which age-paired hypothyroid
and euthyroid samples of the same specific radioactivity were loaded
were monitored by fluorography to detect whether there were any
35differences in the incorporation of L-( S)methionine into individual
polypeptide bands. The same criterion as described above for
designating differences as being due to hypothyroidism was adopted. On
35this basis it was observed that the incorporation of L-( S)methionine
into polypeptide bands of molecular weights 52 and 42Klwas relatively
greater in the forebrain and cerebellar homogenates of 2 week old
hypothyroid rats than in the corresponding control animals (Figs.
3.3.3.2 and 3.3.3.4). These differences were consistently found in 2
series of experiments. In addition, a number of other, smaller
differences in incorporation of precursor were observed. In the
35forebrain of hypothyroid rats the incorporation of L-( S)methionine 
into a polypeptide band of 9OKIwas reduced at 1 and 4 weeks postpartum.
It is possible that similar deficits were present in 2 and 3 week old 
animals but these were not consistently observed in all of the samples 
analysed. There were also small deficits in the incorporation of 
labelled precursor into polypeptide bands of molecular weights 72, 68 
and 52K'in the forebrain homogenates of 4 week old hypothyroid rats. In 
addition, there were small relative increases in incorporation into 
polypeptide bands of 62 and 33K in 1 week old hypothyroid animals. In 
the cerebellar homogenates of 4 week old hypothyroid rats increased 
incorporation of label into a polypeptide band of 85K was observed while 
small deficits were found in 69 and 30K polypeptide bands.
Initially it had been intended that subcellular fractions would be 
isolated from both the forebrain and cerebellum of hypothyroid and 
euthyroid rats. It was found, however, that the yield of protein in the 
subcellular fractions isolated from cerebella were very low, even after 
pooling 4-6 of these. SDS polyacrylamide gel electrophoretic analysis 
of cerebella-derived fractions was not, therefore, feasible using these 
procedures. Similarly, the yield of protein in the myelin fractions
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obtained from the brains of these young rats was very low. While 
sufficient myelin could be isolated from each sample to run single gel 
tracks it was difficult to achieve sufficiently high concentrations of 
protein and radioactivity in the sample buffer for electrophoresis to 
allow detailed analysis of this fraction. Since the primary aim of the 
present study was to monitor the effect of thyroid hormone deficiency on 
the SPM fraction it was felt that the refinements of the techniques 
necessary to monitor the myelin fraction also would be prohibitively 
lengthy. In addition, the effects of hypothyroidism on myelinogenesis 
have been extensively studied by other workers (Freundl and Van 
Wynsberghe, 1978; Waiters and Morell, 1981). Thus only the SPM and 
mitochondrial fractions isolated from the forebrain were examined in 
on&er to obtain sufficient amounts of protein for analysis 2 forebrains 
were pooled prior to fractionation.
Assessment of the Coomassie Brilliant Blue staining patterns of 
hypothyroid and euthyroid SPM fractions showed that there were no 
consistent differences which could be attributed to thyroid hormone 
deficiency (Fig. 3.3.3.5). The fluorographic analysis of the SPM 
fractions showed that at 1, 3 and 4 weeks postpartum there were no 
obvious differences between hypothyroid and euthyroid fractions (Fig.
3.3.3.6).
In the SPM fractions isolated from 2 week old rats, however, there was 
an observable increase in the 52 and 42Kipolypeptide bands in 
hypothyroid rats. Since this increase was relatively small and 
partially masked by a flaw in the fluorogram it can only be tenatively 
suggested that this is a real effect of hypothyroidism. However, since 
this effect was observed in all of the other fractions examined it seems 
likely that the parallel enhancement of the labelling of these 
polypeptide bands in the SPM fraction is due to thyroid hormone 
deficiency.
Examination of the electrophoretic protein profiles of mitochondria 
isolated from hypothyroid and euthyroid forebrains showed that there 
were no significant differences int the levels of individual polypeptide 
bands (Fig. 3.3.3.7). Fluorographic analysis of mitochondrial profiles 
(Fig. 3.3.3.8) indicated that the incorporation of labelled methionine
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into polypeptide bands of 52 and 42K'.was, again, enhanced in 2 week old 
hypothyroid rats. In 1 and 3 week old rats there were no significant 
differences between hypothyroid and control animals. At 4 weeks 
postpartum, however, the incorporation of labelled methionine into 
polypeptide species of 31.5 and 28K was higher in hypothyroid rats than 
in the corresponding controls.
3.3.4 DISCUSSION
The present investigation of the effects of PTU-induced neonatal 
hypothyroidism has indicated that this treatment results in reduced body 
and brain weights, lowered protein yields and depressed rates of protein 
synthesis. A reduction in body and brain weight due to hypothyroidism 
has been reported by many workers and the deficits observed in the 
present study are comparable to those reported in the literature (Geel 
and Timiras, 1970; Battie and Verity, 1979). Undernutrition which 
frequently accompanies abnormal hormonal states, has been reported to 
cause severe retardation of body and brain growth (Balazs, 1977). While 
this cannot be entirely ruled out in the present study it is unlikely 
that this contributed significantly to the observed effects since the 
mother rats fed normally and consumed 70-100 g/day of diet containing 
PTU.
ieP
In addition^the overall decrease in the weight of both forebrain and 
cerebellum of hypothyroid rats showed a deficit in protein yield on both a 
mg protein/brain and mg protein/g tissue (wet weight) basis. Although 
the postnatal increase in protein yield due to the development-related 
decrease in brain water content (Davis and Himwich, 1973) was observed 
in both euthyroid and hypothyroid animals this increase was smaller in 
the deficient rats. These deficits were statistically significant at 2,
3, and 4 weeks postpartum in both the forebrain and cerebellar 
homogenates. This is consistent with the findings of Geel and Timiras 
(1970) who reported that the water content of 22 day old hypothyroid 
rats was significantly higher than euthyroid controls (82.8±0.09% in 
hypothyroid rats compared with 81.9±0.06% in controls, p<0.001). The 
protein yields in the subcellular fractions were also reduced in 
hypothyroid animals although these deficits were not always statistically 
significant. In addition, the yield of protein in the SPM fraction
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obtained from hypothyroid rats showed a slight deficit on a jjg protein in 
this fraction/ug protein in the forebrain homogenate basis. Although 
this was not statistically significant it may indicate that, in addition 
to an overall reduction in protein yield there may also be a relative 
reduction in the SPM protein yield. This is consistent with the 
observation reported by Battie and Verity (1979) who found deficits 
in the yield of protein in synaptosome fractions derived from 7, 14 and 
21 day old hypothyroid rats. The deficit at 14 days was statistically 
significant and was estimated to be about 44%. Similarly Smith et al. 
(1980) reported deficits in the yield of total membrane protein (mg 
protein/g tissue, wet weight) in 21 and 34 day old rats which were 
statistically significant although small (12 and 6% respectively).
The lack of statistical significance in many of the results in the 
present study may be due, in part, to variation in the degree of 
hypothyroidism achieved by individual rats. Ruiz-Marcos et al. (1979) 
found that, following surgical thyroidectomy, the majority of rats 
stopped growing and showed a large decrease in pituitary growth hormone.
A number of animals, however, continued to grow, although at a much 
reduced rate compared with controls. This variation is, inevitably, 
compounded by the variation in the isolation procedure (discussed in 
section 3.1.4) and, together with the limited number of brains able to be 
fractionated simultaneously probably accounts for the lack of statistical 
significance in some of the results. Nevertheless the overall trend and 
the statistically significant results are consistent with there being a 
thyroid hormone deficiency-related effect on protein content of the 
brain.
The effect of thyroid hormone deficiency on cerebral protein synthesis 
has been subject to much debate in recent years. In a number of studies 
hypothyroidism has been reported to reduce protein synthesis in the 
brain (Geel and Timiras, 1970; Jarlstedt and Norstrom, 1972; Lindholm, 
1982). It has also been demonstrated that tri-iodothyronine regulates 
the levels of somatotropin mRNA in cultured rat pituitary cells (Martial 
et al., 1977). Other workers, however, have been unable to demonstrate 
any depression of cerebral protein synthesis in hypothyroid animals 
in vivo (Bergner et al., 1981), in cell-free systems (Andrews and Tata, 
1971) or in brain slices (Valcana and Eberhardt, 1977). All of these 
studies, however, measured the rate of incorporation of trace amounts of
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precursor into brain protein. It may be argued that by using the trace 
amounts of precursor, which is subject to methodological difficulties 
anyway (see section 3.2,1), in a morphologically atypical tissue, such 
as that found in hypothyroid rats, it is very difficult to extrapolate 
any effect on the measured rate of incorporation to that on the absolute 
rate of protein synthesis. It is, for example, possible that the 
compartmentation of precursor in hypothyroid tissue might be different 
from that in euthyroid tissue. These difficulties were overcome in the 
present study by using the in vivo flooding method of Dunlop et al.
(1975) to obtain the overall rates of protein synthesis in developing 
hypothyroid and euthyroid rats.
While the development-related decrease in the rate of cerebral protein 
synthesis reported by Dunlop et al. (1977) was observed in both 
hypothyroid and euthyroid rats the rates of protein synthesis were 
reduced in the hypothyroid animals compared with the controls. Although 
not all the deficits were statistically significant this, again, suggests 
that hypothyroidism has an effect on protein synthesis in vivo.
The largest deficit (25%) in the rate of incorporation of precursor into 
SPM protein was observed at 2 weeks postpartum, was statistically 
significant and was found in three separate experiments. This deficit 
in synthesis occurs at a critical period of brain development when 
neuronal differentiation occurs which is characterised by the 
proliferation of axonal and dendritic fibres and the subsequent formation 
of synapses (Bass et al., 1969a; Bloom, 1972). This would indicate, 
therefore, that normal synaptic development is likely to be severely 
affected in hypothyroid rats. The myelin fraction also showed large 
deficits in the rate of incorporation of precursor in hypothyroid rats. 
The myelin fraction also showed large deficits in the rate of 
incorporation of precursor in hypothyroid rats. This was the most 
severely affected subcellular fraction with a 52% statistically 
significant deficit at 2 weeks after birth. Between 10 and 50 days 
postpartum neuroglial cells migrate from the subependymal zone into the 
cerebral cortex where they differentiate. Some cells differentiate to 
form the oligodendrocytes which are responsible for the myelination of 
the newly formed axons and dendrites. (Bass et al., 1969b). 
Hypothyroidism has been reported to impair myelinogenesis in young rats 
resulting in a permanent deficit in the amount of myelin in the brains
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of these animals (Freundl and Van Wynsberghe, 1978; Walters and Morrell, 
1981), The results of the present study suggest that this may be at 
least partly due to a reduction in the synthesis of myelin during the 
period of its most rapid accumulation.
There did not appear to be any significant effect on the rate of 
incorporation of precursor into mitochondrial protein due to 
hypothyroidism although a non-significant deficit (11%) was observed at 
2 weeks postpartum.
It might be expected that larger deficits would be found in fractions 
isolated from cerebellar tissue since this is relatively more immature ^ 
at birth than the forebrain. Patel et al. (1976) estimated that 
postnatal cell acquisition in the forebrain accounted for about 50% of 
the total number of cells in adult forebrain. The major proporation, 
however, of these cells were glial. In the cerebellum, however, these 
workers estimated that 97% of cells are formed after birth and the 
majority of these were neurones.
Examination of the fluorographic profiles of fractions isolated from
35hypothyroid rats indicated that incorporation of L-( S)methionine into 
polypeptides of molecular weights 52 and 42R was higher in 2 week old 
rats than in euthyroid rats. The similarity in apparent molecular 
weights, relative abundance and prominence of these polypeptides compared 
with literature (Feit et al., 1977; Kelly and Cotman, 1978) suggests that 
these might be tubulin and actin. Both of these proteins have been 
reported to undergo a development-related decrease (Burgoyne et al.,
1981; Fu et al., 1981; Kelly and Cotman, 1981). This decrease appears to 
be retarded in the brains of hypothyroid rats since the incorporation of 
precursor into these polypeptides is higher in these rats than in 
euthyroid controls. By 3 weeks postpartum, this large difference is no 
longer clearly observable. Examination of the electrophoretic profiles 
of subcellular fractions of rats of the same age indicate that there is 
no corresponding increase in the amount of these polypeptides in 
hypothyroid rats than in controls. Further studies are needed to confirm 
these findings. For example, alterations in amounts of tubulin could be 
monitored by colchicine-binding studies.
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It was also observed that the incorporation of precursor into a 90K
polypeptide in the forebrain homogenate was reduced in 1 and 4 week old
hypothyroid rats. Whilst some difference may exist at 2 and 3 weeks
this could not be unequivocally demonstrated in the present study. This
polypeptide has a similar molecular weight to the major subunit of 
+ +
(Na ,K )ATPase. The activity of this enzyme has been reported to be 
reduced in hypothyroid rats and its developmental increase retarded 
(Geel and Timiras, 1970; Lo and Edelman, 1976).
The composition of total brain and subcellular fractions isolated from
hypothyroid rats, however, was qualitatively and quantitatively very
similar to that of euthyroid rats, as was the pattern of incorporation 
35
of L-( S)methionine. This implies that although there are a number of 
small differences between hypothyroid and euthyroid rats the overall 
protein composition is not significantly affected but the amount of 
protein in the brain is reduced by thyroid hormone deficiency.
These results which are in agreement with earlier studies, tend to 
indicate that brain development in hypothyroid rats is retarded and 
impaired since those proteins which show development-related alterations 
do so at a slower rate than that observed in normal rats. The results 
tend to indicate that structural proteins such as tubulin and actin and 
plasma membrane markers such as (Na^,K^)ATFase are specifically affected 
5'-nucleotidase, which is also located in the plasma membrane, has 
been reported to show depressed activity in hypothyroid rats (Smith 
et al., 1980). These findings would tend to agree with the observation 
that hypothyroid rats have lower amounts of neuropil material i.e. axons 
and dendrites, and, therefore, have decreased cell surface areas. 
Nicholson and Altman (1972) and Balazs (1972) suggested that the 
"ontogenetic clock" is slower in hypothyroid animals. Whether the 
duration of functional and structural maturation of the brain is 
sufficiently lengthened in the hypothyroid brain to allow it to approach 
the normal state cannot be deduced from these relatively short-term 
experiments but in view of the permanent impairment of mental function 
this seems likely.
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SUMMARY
1. The present study has demonstrated that it is possible to obtain good
approximations of the rate of cerebral protein synthesis by using
intraventricular injections of flooding concentrations of
35radiolabelled precursor. Using L-( S)methionine it was observed 
that the rate of incorporation of this amino acid was linear over 45 
min after injection. In addition, errors due to uneven 
distribution of precursor or metabolism of methionine to other 
labelled amino acids were minimal. Thus it was estimated that the 
rate of synthesis of total brain protein in mature rats (approx.
100 days old) was 0.65 fmol methionine incorporated/g protein/h 
which was close to values reported by other workers.
2. The use of this local flooding method permits the examination of 
the incorporation of precursor into subcellular fractions since it 
is possible to attain relatively high levels of radioactivity in 
the brain. Although the method developed here provides a value for 
the rate of incorporation of precursor into SPM protein rather than 
the rate of SPM protein synthesis it does, however, permit the 
examination of the effect of various factors on this incorporation.
3. Various drug treatments have been demonstrated to alter the
incorporation of precursor into SPM protein. Halothane, a volatile
anaesthetic, was shown to depress brain protein synthesis by about
3540% and the incorporation of L-( S)methionine into SPM protein by 
a similar amount. Conversely pentobarbitone, which is also an 
anaesthetic, did not appear to have any significant effect on 
either total or SPM protein synthesis.
The means by which halothane effects this inhibition of cerebral 
protein synthesis is not known. Ether has been reported to inhibit 
cerebral protein synfhasis via alterations in hormonal levels 
(Schotman et al., 1977) . This may indicate a possible line of 
investigation of the effect of halothane on brain protein synthesis.
L-DOPA was found to inhibit cerebral protein synthesis by close to 
30% under conditions where the animal's body temperature was raised
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to at least 39®C. The precursor incorporation into myelin, 
synaptosomal and SPM proteins appeared to be less affected by 
L-DOPA. Further experiments are required to verify this reduced 
effect on the subcellular fractions since this would suggest that 
the synthesis of synaptic and myelin proteins might be 
preferentially protected under certain conditions.
4. Propyl thiouracil-induced hypothyroidism was shown to result in
reduced body weight, brain weight, protein yields, rate of total
protein synthesis and rate of incorporation of radiolabelled amino
acid into subcellular fractions. Examination of the incorporation
35of trace amounts of L-( S)methionine into individual polypeptides 
suggested that development-related changes in a number of brain 
proteins are retarded in hypothyroid rats. This may indicate that 
the time course of structural and functional maturation of the 
brain is prolonged in hypothyroid animals and, in addition, may be 
defective since there appears to be permanent impairment of brain 
function.
The present results tentatively indicate that the incorporation of 
precursor into polypeptides of apparent molecular weight 52 and 42K‘. 
(tentatively identified as tubulin and actin) was enhanced in 2 
week old hypothyroid rats compared with control animals. No 
corresponding increase, however, was found in the amount of these 
two polypeptides. This, clearly, would be a particularly 
interesting area for further investigation since these results 
suggest that there may be a preferential effect of thyroid hormone 
deficiency on at least some of the major structural proteins of the 
brain. Possible lines for further investigation are:
(a) To use protein-specific assays for quantitation of individual 
structural proteins, e.g. colchicine binding assays for tubulin or 
quantitative immunological techniques to determine whether 
hypothyroidism has any effect on the relative amounts of individual 
proteins.
(b) To examine the effect of thyroid hormone deficiency on the 
amounts and synthesis of structural proteins in discrete brain 
areas. Since different brain areas mature asynchronously it is
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possible that areas such as the cerebellum in which the major 
proportion of neurones develop after birth (in the rat) may show 
larger effects due to hypothyroidism.
(c) The SPM fraction contains a high proportion of structural 
proteins. It would, therefore, be of considerable interest to 
examine the effect of hypothyroidism, in detail, on these 
proteins. In order to obtain meaningful results it would probably 
be more useful to examine SPM fractions from different brain areas 
(see above). This would require a number of refinements to be made 
to the techniques used for the preparation and examination of SPM 
proteins. For example, the SPM isolation procedure would need to 
be adapted for the fractionation of small amounts of tissue.
5. The use of subcellular fractions in experiments of the type carried 
out in this project is subject to a number of problems. An 
important difficulty arises from the limited number of observations 
able to be made, which is dependent upon the number of simultaneous 
individual fractionations which can be carried out. This is 
especially important in the determination of the effects of drugs 
which, ideally, require a large number of observations to be made 
in order to obtain statistically significant results. Another 
serious problem is that of contamination of SPM fractions which are 
now thought to be only 50-70% 'pure'. The combination of these two 
factors tends to make observations obtained using SPM fractions 
isolated by traditional methods tentative. It is possible that 
with the recent rapid development of monoclonal antibody techniques 
that it will soon be feasible to isolate SPM fractions of high 
purity. Reichardt and Matthew (1982) reported that they were able 
to produce a pure synaptic vesicle preparation by incubation of a 
crude lysed synaptosome fraction with vesicle-specific antibody 
which was then precipitated after mixing with protein A coupled 
with acrylamide beads. The development of isolation procedures 
using these techniques, assuming that suitable monoclonal 
antibodies can be raised, would clearly permit the preparation of 
pure fractions and would, possibly, allow more observations to be 
made.
-156-
BIBLIOGRAPHY
A“bood,L.G. & Hoss,W. (1976) in Basic Neurochemistry (Siegel,G.J., Albers,
R.W., Katzman,R. & Agranoff,B,W., eds.), pp. 103-123, Little Brown,
Boston.
Allison,A.C. & Nunn,J. (1968) Lancet 2^  1326-1329 
Andrews,T.M. & Tata,J.R. (1971) Biochem. J. 124. 883-889
Austin,L., Lowry,O.H., Brown,J.G. & Carter,J.G. (l972) Biochem. J. 126. 351-359 
Babitch,J.A. (198I) J. Neurochem. jl* 1394-1400
Balazs,R. (1972) in Human Development and the Thyroid Gland - Relation 
to Endemic Cretinism (Stanbury,J.B. & Kroc,R.L.,eds.) Advances in 
Experimental Medicine and Biology, vol. 30, 385-415, Plenum Press,
New York
Balazs,R. (1977) in Thyroid Hormones and Brain Development (Grave,G.B., ed.) 
pp. 287-300, Raven Press, New York
Balazs,R. & Gaitonde,M.K. (1968) Biochem. J. 106. 1-12
Balazs,R., Patel,A.J. & Lewis,P.D. (l977) in Biochemical Correlates of 
Brain Structure and Function (Davison,A.N., ed.) pp. 43-83, Academic 
Press, London
Banay-Schwartz,M., Guiffrida,A.M., De Guzman,T., 8ershen,H. & Lajtha,A.
(1979) Exp. Neurol. 157-168
Banker,G., Crain,B. & Cotman,C.W. (1972) Brain Res. 4 2, 508-513
Banker,G. Churchill,L. & Cotman,C.W. (1974) J. Cell Biol. 6^, 456-465
Barondes,S.H. (1975) in The Nervous %rstem, vol. 1, The Basic Neurosciences 
(Tower,D.B., ed.), pp. 129-136, Raven Press, New York
Barondes,S.H. (1976) in Basic Neurochemistry (Siegel,G.J., Albers,R.W., 
Katzman,R. & Agranoff,B.W., eds.), pp. 329-341, Little Brown, Boston
Bass,N.H. Netsky,M.G. St Young,E. (1969a) Neurology (Minneap.) 258
Bass,N.H. Netsky,M.G. St Young,E. (1969b) Neurology (Minneap.) 22, 405
Battie,C.A. & Verity,M.A. (l979) Dev. Neurosci. 2. 139-148
-157-
Beach,R.L., Kelly,P.T. Babitch,J.A. & Cotman,C.W, (1981) Brain Res. 225 
75-93
Bergner,H., Simon,0., Munchmeyer,R. & Siedel,C. (1981) Arch. Tierenahrung 
il, 109-118
Berl,S., Pu8zkin,S. & Nicklas,W.J. (1973) Science 179. 441-446
Berl,S. & Nicklas,W.J. (1975) in Metabolic Compartmentation and.Neurotransmission 
Related to Brain Structure and Function (Clarke,C.B. & Schneider,D., 
eds.), pp. 247-271, Plenum Press, New York
Berman,R.P., Hullihan,J.P., Kinnier,W.J. & Wilson,J.E. (198O) J. Neurochem.
34, 431-437
Berridge,M.J. (1979) in The-Neurosciences Fourth Study Programme ( Schmitt,
P.O. & Worden,P.O., eds.), pp. 873-889, M.I.T. Press, Cambridge, Mass.
BlbmWeg,?.,Cohen,R.S. & Siekevitz,Fw (l977) J. Cell Biol. %4 , 204-225
Bloom,F.E. (1972) in Structure and Function of Synapses (Pappas,G.B. &
Purpura',D.P., eds.), pp. 101-120, Raven Press, New York
Bloom,P.E. (1975) Rev. Physiol. Biochem. Pharmacol. ][4> 1-103
Bloom,F.B. & Aghajanian,G.K. (1968) J. Ultrastructure Res# 22, 361-375
Blomstrand,C. & Bamberger,A. (1969) J. Neurochem. 1j6, 14OI-1407
Bock,E. (1978) J. Neurochem. jO, 7-14
Bock,B. & Belle,K.B. (l977) FBB8 Letts. 5 2, 175-178
Bock,E. & Jorgensen,O.S. (1975) FEES Letts. ^2, 37-39
Bonner,M.W. & Laskey,R.A. (1974) Bur. J. Biochem. 4 6, 83-88
Boyar,M.M., Coutinho-Netto,J., Abdul-Ghani,A.S. & Bradford,H.P. (1981)
J. Neurochem. 1371-1376
Bray,D. & Thomas,C. (1975) Biochem. J. 147. 221-228
Burgoyne,R.D. & Rose,S.P.R. (198O) J. Neurochem. i4> 510-517
Burgoyne,S.D., Rudge,J.S. & Murphy,S. (198I) J. Neurochem. ^6, 661-669
Carlin, R.K., Bartelt,D.C. & Siekevitz,?. (1983) J. Cell Biol. 5 6, 443-448
-158-
Carlin,R.K., Grab,D.J,, Cohen,R.S. & Siekevitz,?. (1980) J. Cell Biol.
86, 831-843
Carlin,R.K., Grab,D.J. & Siekevitz,?. (1981) J. Cell Biol. 8^, 449-455 
Carlin,R.K., Grab,d.j. & Siekevitz,?. (1982) J. Neurochem. 38. 94-100 
Chiu,T.-C. & Babitch,J.A. (1978) Biochim. Biophys. Acta 510. 112-123 
ChramT&ch,A., Riesfeld,R.A., %ckoff,M. & Zaccari^J. (19^7) Anal. Biochem.
20, 150-154
Chua,N.-H. & Schmidt,G.W. (l979) J. Cell Biol. 461-483
Churchill,L. Cotman,C.W., Banker,G., Kelly,?.T. & Shannon,L. (1978) 
Biochim. Biophys. Acta 448. 57-72
Clouet,D.H. & Richter,D. (1959) J. Neurochem. i, 219-229
Cohen,B.N., Chow,K.L. & Mathers,L. (1972) Anesthesiology 37. 324-331
Cohen,R.S. , Blomberg,P., Berzins,K. & Siekevitz,?. (1977) J* Cell Biol.
24, 181-203
Cohen,R.S. & Siekevitz,?, (1978) J. Cell Biol. J8, 36-46
Cook,R.A. & Kiernan,J.A. (1976) Exp. Neurol. ^2, 515-524
Cooper,H.K., Zalewska,T., Kawakami,S., Hossman,K.-A. & Kleihues,?. (l977) 
J. Neurochem. 28, 929-934
Cotman,C.W. (1972) in Research Methods in Neurochemistry (Marks,N. & 
Rodnight,R., eds.), vol. 1, pp. 45-93, Plenum Press, New York
Cotman,C.W., Banker,G., Churchill,L. & Taylor,D. (1974) J. Cell Biol, 
ii, 441-455
Cotman^,C.“W,,Hershman,H. & Taylor,D. (l97l) J* Neurobiol. 2, 169-18O
Cotman.C.W., Levy,W., Banker,G. & Taylor,D. (l97l) Biochim. Biophys.
Acta 406-409
Cotman,C.W. ,& Matthew,?.A. (1971 ) Biochim. Biophys. Acta 249. 380-394 
CotmanyC.,W.& Taylor,?.A. (l97l) Brain Res. 2g, 366-372 
Cotman,C.W. & Taylor,?. (1972) J. Cell Biol. 25» 696-7 11 
Cotman,C.W. & Taylor,?. (1974) J. Cell Biol. 236-242
—159—
Daly,J ,W, (1977) Int. Rev. Neurobiol. 20. 105-I68 
Davis,G.A. & Bloom,P.B. (1973) Brain Res. 62, 135-154
Davis,J.M. & Himwich,W.A. (1973) in Biochemistry of thr Developing Brain 
(Himwich,W.A., ed.), vol. 1, pp. 55-110, Marcel Dekker, New York
Day,E.D., McMillan,P.N., Mickey,?,D. & Appel,S.H. (1971) Anal. Biochem.
i2, 29-45
?eanin,G.G. & Gordon,M.W. (1973) J. Neurochem. 20, 55-68
?e Bias,A.L., Busis,N.A. & Nirenberg,M. (1981) in Monoclonal Antibodies 
to Neural Antigens (M°kay,R., Raff,M.C. & Reichardt,L.P., eds.). Cold 
Spr. Harb. Rep. Neurosci., vol. 2
?e Bias,A.L. & Mahler,H.R. (1976) Biochem. Biophys. Res# Commun. 72. 24-32
De Blas,A.L. & Mahler,H.R. (1978) J. Neurochem. 563-577
De Bias,A.L., Wang,Y.-^., Sorensen,R. & Mahler,H.R. (l979) J* Neurochem.
jl, 647-659
De Lorenzo,R.J. (1982) Fed. Proc. 41, 2265-2272
De Robertis,E., Pellegrino De Iraldi,A., Rodrigues De Lores Arnaiz,G. & 
Salganicoff,L. (1962) J. Neurochem. 2, 23-35
De Robertis,E., Rodriges De Lores Arnaiz,G., Salganicoff,L., Pellegrino 
Do Iraldi,A. & Zieher,L.M. (1963) J . Neurochem. 10, 225-235
De Silva,N.S., Gurd,J.W. & Schwartz,C. (l979) Brain Res. l65. 283-293
Divakaran,?. & Wiggins,R.C. (1982) Neurochem. Res. %, 1347-1358
Docherty,M., Bradford,H.P. & Anderton,B. (1982) FBBS Letts. 144 . 47-50
Docherty,M., Bradford,H.P. & Anderton,B. (1983) FBBS Letts. 152. 57-61
Droz,B. (1973) Brain Rea. 62^ 383-394
Droz,B. & Barondes,S.H. (1969) Science 165. 1131-1132
Duncan,M.M. & Mackler,B.J. (1966) J. Biol. Chem. 241. 1694-1697
Dunlop,?.S., Van EIden,W. & Lajtha,A (1975) Neurochem. 24, 337-344
Dunlop,D.^ S..y^ Lajtha,A. & Toth,J. (l977) iu Mechanisms,Regulation, abd Special
—160—
Dunlop,D.s#, Lajtha,A, & Toth,J. (19T7) in Mechanisms, Regulation and 
Special Function of Protein Synthesis in the Brain*.(Roberts,S., 
Lajtha,A. & Gispen,W.H,, eds.),pp. 79-96, Elsevier/North Holland 
Press, Amsterdam
Dunn,A. (1975) Brain Res, 22» 405-409
Dunn,A. (1977) in Mechanisms, Regulation and Special Functions of Protein 
Synthesis in the Brain (Roberts,S., Lajtha,A. & Gispen,W.H. eds.), 
pp. 97-105, Elsevier/North Holland Press, Amsterdam
Dunn,A. & Berget,B.J. (1976) J. Neurochem. 26, 369-375
Dunn,A., Guiditta,A. & Pagliuca,N. (l97l) J* Neurochem. J[8, 2093-2099
Ellman,G.L., Courtney,?., Andres,V. St Featherstone,R.M. (196I) Biochem. 
Pharmacol. %, 88-95
Evans,W.H. St Gurd,J.W. (1973) Biochem. J. 133. 189-192
Feit,H. Kelly,P.T. St Cotman,C.W. (1977) Proc. Natl. Acad. Sci. U.S.A.
24, 1047-1051
Fischer,C.A. St Morell,P. (1974) Brain Res. 74. 51-56
Figzer,S. St De Robertis,E. ( 1967) Brain Res. 31-44
Fleischer,B. St Fleischer,S. (1969) Biochim. Biophys. Acta 183. 265-271
Freedman,M.S., Clarke,B.D., Cruz,T.F., Gurd,J.W. & Brown,I.R. (198I)
Brain Res. 207. 129-145
Freundl,E. St Van 1fynsberghe,D.M. (1978) Biol. Neonate 33. 217-223
F\i,S.C., Cruz,T.F. St Gurd,J.W. (l981) J. Neurochem. 36, 1338-1351
Gaitonde,M.K. St Richter,?. (1956) Proc. Roy. Soc. B, 145. 83-99
Gambetti,P., Autilio-Gambetti,L.A., Gonatas,N.K. St Shafer,B. (1972)
J. Cell Biol. 52, 526-535
Garlick,P.J. St Marshall,!. (1972) J. Neurochem. Tg, 577-583
Geel,S.B., Valcana’,T. & Timiras,P.S. (1967) Brain Res. 4 , 143-150
Geel,S.B. St Timiras,P.S. (l970) in The Role of Hormones in Cerebral
Protein Metabolism (Lajtha,A., ed.), pp. 137-193,Plenum Press, New York
—16l—
Goff,?., Millar,A.A., Smith,E.B., Smith,S.J. & Wheatley,P.L. (1975)
Demonstration for thr British Pharmacological Society, Univ. of
Cambridge.
Gonzales,L.W. & Geel,S.E. (1978) J. Neurochem. 1239-1245 
Goodrum,J.P., Bosmann,H.P. & Tanaka,R. (1979) Neurochem. Res. 4 , 331-337 
Gordon,M.W. & Deanin,G.G. (1969) J. Biol. Chem. 243. 4222-4226 
Grab,D.J., Berzins,K., Cohen,R.S. & Siekevitz,?. (1(^9) J* Biol. Chem.254.
8690-8696
Grab,D.J., Carlin,R.K. & Siekevitz,P. (1980) Annals New York Acad. Sci.
1 5 6, 55-72
Grab,D.J., Carlin,R.K. & Siekevitz,?. (1981) J. Cell Biol. 440-448
Gray,E.G. (1959) J* Anat. (Bond.) 22» 420-433
Gray,E.G. (1969) Prog. Brain Res. 2lf 141-155
Gray,E.G. & Whittaker,V.P. (1962) J. Anat. (Lond.) 2l, 79-87
Greengard,?. (1978a) Science 199. 146-152
Greengard,?. (1978b) in Cyclic Nucleotides, Phosphorylated Proteins and 
Neuronal Functions . New York, ^ci>jca
Greengard,?. (1979) Fed. Proc. j8, 2208-2217
Gross, J.I., Burgoyne,R.D. & Rose,S.P.R. (198I) J. Neurochem. 229-237
Gurd,J.W. (1977a) Brain Res. 126. 154-159
Gurd,J.W. (1977b) Biochemistry 16. 369-374
Gurd,J.W. (1978) Brain Res. 147. 201-204
Gurd,J.W. (1979) Biochim. Biophys. Acta 555. 221-229
Gurd,J.W. (1980) Can. J. Biochem. ^8, 941-1003
Gurd,J.W. (1982) in Molecular Approaches to Neurobiology (Brown,I.H., ed.)
pp. 99- 103, Academic Press, New York
Gurd,J.W. & Fu,S.C. (1982) J. Neurochem. j2» 719-725
Gurd,J.W., Gordon-Weeks,P. & Evans,W.H. (1982) J. Neurochem. 22» 1117-1124
—162—
GurdjJ.W,, Jones,L.R., Mahler,H.R. & Moore,W.J. (1974) J. Neurochem. 22.
281-290
Hammerschlag,R. (1980) Fed. Proc. 22» 2809-2814
Hammerschlag,R., Stone,G.C., Bolen,F.A. Lindsey,J.D. & Ellisman,M.H. (1982) 
J. Cell.Biol. 22» 568-575
Hawkes,R* Niday,E. & Matus,A. I. (1982) Proc. Natl. Acad. Sci. U.S.A. 79.
2410-2414
Hayden,J.P., Johns6n,L.R. & Maikel,R.P, (1966) Life Sci. 2» 1509-1515
Heath,?.P. & Barton,R.N. (l973) Biochem. JT. 136. 503-518
Heikkila,I.J., Holbrook,L. & Brown,I.R. (l979) J* Neurochem. 22.» 1793-1799
Henn,P.A., Andersen,D.J. & Rustad,D.G. (1976) Brain Res. 101. 341-344
Henn,P.A. & Hamberger,?.T. (1976) Neurochem. Res. 4 , 261-268
Hernandez,A. (1974) Biochem. J. 142. 7-17
HershkowitZjM., Wilson,J.E. & Glassman,E. (1975) J* Neurochem. 25. 687-694  
Hitzemann,R.J. & Loh,H.H. (1977) Life Sci. 20, 35-42
Jakoubec,B., Seminovsky,B., Kraus,M. & Erdossova,R. (l970) Life Sci. 2#
1169-1179
Jaque,C.M., Jorgensen,O.S., Baumann,N.A. & Bock,E. (1976) J. Neurochem.
21» 905-909
Jarlstedt,J. & Norstrom,A. (1972) Erptl. Neurol. 24» 51-6.3
Jones,D.H. (1976) Ph. D. Thesis, University of London
Jones,D.H. & Matus,A.I. (1974) Biochim. Biophys. Acta 356. 276-287
Jones,D.H. & Matus,A.I. (1975) Neurosci. Lett. 1_, 153-158
Jones,L.R., Mahler,H.R. & Moore,W.J. (1975) J» Biol. Chem. 250. 973-983
Jorgensen,O.S. (1976) J. Neurochem. 21, 1223-1227
Jorgensen,O.S. (1977) Proc. Int. Soc. Neurochem. 4 » 271
Jorgensen,O.S. & Bolwig,T,G. (1979) Science 205. 705-707
—163—
Jorgensen,O.S., Delouvee,A., Thiery,J.-P. & Edelman,G.M. (198O) FEES Lett.
111. 39-42
Kakiuchi,S., Sobue,K., Morlmoto,K« & Kanda,K. (1982) Biochem. International 
S, 755-762
Kalaria,E.N., Kotas,A.M., Prince,A.K. & Reynolds,^* (1981) Abstracts 8th 
Meeting International Society of Neurochemistry, pp. 134
Katzman,R. (1976) in Basic Neurochemistry (Siegel,G.J., Albers,R.W.,
Katzman,R. & Agranoff,B.W., eds.), pp. 414-428, Little, Brown, New York
Kelly,P.T. & Cotman,C.W. (1976) Biochem. Biophys. Res. Commun. 73. 858-864
Kelly,P.T. & Cotman,C.W. (1977) J. Biol. Chem. 252, 786-793
Kelly,P.T. & Cotman,C.W. (1978) J. Cell Biol. 22, 173-183
Kelly,P.T. & Cotman,C.W. (1981) Brain Res. 206. 251-271
Kelly,P.T. & Montgomery,P.R. (1982) Brain Res. 233. 265-286
Kelly,P.T., Cotman,C.W. & Largen,M. (l979) J* Biol. Chem. 254. 1564-1575
Kelly,P.T. Cotman,C.W., Gentry,C. & Nicolson,G. (1976) J. Cell Biol.
2 1, 487-496
Kennedy,R.S., Pink,B.R. & Byers,M.R. (1972) Anesthesiology 26, 433-443
King,M.D. (1980) Ph. D. Thesis, University of London
Kreutzberg,G.W., Schubert,P., Toth,L. & Rieske,B. (1973) Brain Res.
62, 399-404
Kreutzberg,G.W., Barron,K.D. & Schubert,P. (1978) Brain Res. 158. 247-257 
Krueger,B.K., Porn,J. & Greengard,P. (1977) J* Biol. Chem. 252. 2764-2273 
Kurihara,T. & Tsukada,Y. (1967) J. Neurochem. H ,  1167-1174 
Laemlli,U.K. (1970) Nature 68O-685
Lajtha,.A. & Dunlop,?. (1976) in Subcellular Mechanisms in Reproductive 
Neuroendocrinelogy (Naftolin,?., I^an,K.J. & Davies,J., eds.), 
pp. 63-80, Elsevier/North Holland Press, Amsterdam
Lajtha,A. & Dunlop,?.S. (1981) Life Sci. 22, 755-767
—164—
Lajtha,A. & Toth,J. (1966) Biochem. Biophys. Res. Commun. 22, 294-298 
Lajtha,A. & Toth,J. (1974) Brain Res. % 6, 546-551
Lajtha,A., Dunlop,D.S., Patrick,C. & Toth,J. (l979) Biochim. Biophys. Acta
461, 491-501
Langley,O.K. & Kennedy,P. (1977) Brain Res. 130. 109-120 
Laskey,R.A. & Mills,A.D. (l975) Eur. J. Biochem. 4 6, 335-341 
Lehninger,A. (1976) in Biochemistry, pp. 95-123, Worth, New York 
Levine,J., Skene,P. & Willard,M. (1981) Trends Neurosci. 4, 273-277 
Levine,J. & Willard,M. (1981) J. Cell Biol. 22, 631-643
Levitan,I.B. Mushynski,W.E. & Ramirez,G. (1972) J. Biol. Chem. 247. 5376-5381
Lin,C.-H., Dedman,K.R., Brindley,B.R. & Means,A.R. (1980) J. Cell Biol.
82, 473-484
Lindholm,D.B. (1982) Biochem. Biophys. Res. Commun. 109. 805-812
Lo,C.S. & Edelman,I.S. (1976) J. Biol. Chem. 251. 7834-7840
Lowry,O.H*> Rosehorough,N.J., Parr, A.L. & Randall,R.J. (1951) J. Biol. Chem. 
122» 268-275
Macpherson,C.P.C. & Kleine,L. (1978) Immunochemistry 1 4, 149-156
Mahadik,S.P., Korenovsky,A. & Rapport,M.M. (1976) Anal. Biochem. %6, 615-633
Mahadik,S.P., Tamir,H. & Rapport,M.M. (1978) Advances in Neurochemistry 
(Agranoff,B.W. & Aprison,M.H., eds.), vol. 3, pp. 99-163, Plenum 
Press, New York
Mahadik,S.P., Korenovsky,A., Ciccarone,V. & Rapport,M.M. (1981) J. Neurochem.
2 6, 1675-1682 
Mahler,H.R. (1977) Neurochem. Res. 2, II9-147
Mahler,H.R. & Cotman,C.W. (1970) in Protein Metabolism of the Nervous System 
(Lajtha,A., ed.), pp. 151-I84, Plenum Press, New York
Mans,R.J. & Novelli,G.D. (1961) Arch. Biochem. Biophys. 94. 48-53
Margolis,R.K., Margolis,R.U., Preti,C. & LaijD. (l975) Biochemistry 14. 
4797-4804
-165-
Matsuura,M.M., Arpin,C., Hannum,E., Margoliash,D.D., Sabatini,D.D. & 
Morimoto,T. (1981) Proc. Natl. Acad. Sci. U.S.A. jS, 4368-4372
Matus,A.I. (1978) in Intercellular Junctions and Synapses (Feldman,J., 
Gilula,N.B. & Pitts,J.D., eds.), pp. 99-139, Chapman & Hall, London
Matus,A.I. (1980) Proc. 3rd Meeting Eur.. Soc. Neurochem. (Brzin,B., Sket,
K. & Bachelard,H., eds.), pp. 193-209, Pergamon, New York
Matus,A.I. & Taff-Jones,D.H. (1978) Proc. R. Soc. Lond. B. 203. 135-151
Matus,A.I. Walters,B.B. (1975) J » Neurocytol. 4 , 369-375
Matus,A.I. & Walters,B.B. (1976) Brain Res. IO8, 249-256
Matus,A.I., Ng,M.L. & Mazat,J.-P. (1980a) in Protein Phosphorylation and 
Bio-Regulation,FMI-BMBO workshop, Basel,1979» pp. 25-35» Karger, Basel
Matus,A.I., Walters,B.B. & Jones,D.H. (1975) J . Neurocytol. 4 » 357-367
Matus,A.I., Ackermann,M., Pehling,G., Byers,R.H. & Fujiwara,K. (1982)
Proc. Natl. Acad. Sci. U.S.A. 12» 7590-7594
Matus,A.I., Pehling,G., Ackermann,M. & Maeder,J. (l980h) J. Cell Biol.
8%, 346-359
Martial,J.A., Baxter,J.D., Goodman,H.M. & Seeburg,P.H. (1977) Proc. Natl. 
Acad. Sci U.S.A. 1 4 , 1816-I82O
Mena,E.E. & Cotman,C.W. (1982) Science 2l6. 422-424
Mena,B.E., Hoeser,C.A. & Moore,B.W. (198O) Brain Res. 188. 207-231
Mena,B.B., Foster,A.C., Fagg,G.B. & Cotman,C.W. (1981) J. Neurochem. 37
1557-1566
Millan,N., Murdock,L.L., Bleier,H. & Siegel,F.L. (1979) J. Neurochem.
22, 311-317
Morgan,I.G. & Austln,L. (1968) J, Neurochem. 15. 41-51
Morgan,I.G., Wolfe,L.S., Mandel,P. & Gombos,G. (1971) Biochim. Biophys. Acta
241» 725-736
Morgan,I.G., Reith,M., Marinari,U., Breckenridge,W.C. & Gombos,G. (1972) 
in Glycolipids, Glycoproteins and Mucopolysaccharides of the Nervous 
System (Zambotti,V., Tettamanti,G. & Arrigoni,M. eds.), pp. 209-228 
Plenum Press, New York
—166—
Morgan,I.G., Zanetta,J.-F., Breckenridge,W.C., Vincedon,G. & Gombos,G.
(1973) Brain Res. 62, 405-411
Morgenroth,V.H., Boadle-Biber,M.C. & Roth,R.H. (1975) Mol. Pharmacol.
II, 427-435
Moskowitz,M.A., Rubin,D., Liebschutz,J., Munro,H.N., Nowak,T.S. & Wurtman,R.J. 
(1977) J. Neurochem. 28, 779-782
Nathanson,J.A. (l977) Physiol Rev. 21» 157-256
Nicolson,J.L. & Altman,J. (1972) Science 176. 530-532
Nieto-Sampedro,M., Bussineau,C.M. & Cotman,C.W. (1981) Neurochem. Res.
6, 307-320
Nieto-Sampedro,M., Bussineau,C.M. & Cotman,C.W. (1982a) J. Neurosci. 4 »
722-734
Nieto-Sampedro,M., Hoff,S.F. & Cotman,C.W. (1982b) Proc. Natl. Acad. Sci. 
U.S.A. 12, 5718-5722
Ng,M.L. & Matus,A.I. (1979a) Neuroscience 4, I69-I8O
Ng,M.L. & Matus,A.I. (1979b) Neuroscience 4,1265-1274
Norton,W.T. (1976) in Basic Neurochemistry (Siegel,G.J., Albers,R.W.,
Katzman,R. & Agranoff,B.W., eds.), pp. 74-99» Little, Brown, New York
Oja,S.S. (1973) Int. J. Neurosci. 2» 31-33
Palay,S.L., Sotelo,C., Peters,A. & Orkand,P.M. (1968) J. Cell Biol. 38.
193-201
Patel,A.J., Rabie,A., Lewis,P.B. & Balazs,R. (1976) Brain Res. 104. 33-48 
Patel,A.J., Smith,R.M., Kingsbury,A.E., Hunt,A. & Balazs,R. (198O) Brain Res.
198. 389-402
Patrick,R.L. & Barchas,J .D. (1974) Nature 2 50. 737-739
Pfenninger,K.H. & Rees,R.P. (1976) in Neuronal Recognition (Barondes,S.H., 
ed.), pp. 131-178, Plenum Press, New York
Phillips,J.H. & Slater,A. (1975) FEES Lett. 4 6, 327-331
Raghupathy,E., Ko,G.K. & Petersen,N.A. (1972) Biochim. Biophys. Acta
2 §6, 339-349
—167“
Raisman,G. <& Field,P.M. (1973) Brain Res. 24» 1-29
Ramirez,G., Levitan,I.B. & Mushynski,W.B. (1972) J. Biol. Chem. 247. 5382-5390 
Rannels,D.B., Christopherson,R. & Watkins,C.A. (1983) Biochem. J. 210.
379-387
Rannels,D.B., Wartell,S.A. & Watkins,C.A. (1982) Life Sci. ^O, 1679-1690
Rees,H.D., Brogan,L.L., Bntingh,D.J., Dunn,A.J., Shinkman,P.G., Damstra- 
Entingh,T., Wilson,J.E. & Glassman,E. (1974) Brain Res. 68, 143-156
Reichardt,L.F. & Matthew,W.D. (1982) Trends Neurosci. 5, 24-31
Reith,M., Morgan,!.G., Gomhos,G., Breckenridge,W.C. & Vincedon,G.
Neurobiology 4 » 169-175
Rodriguez De Lorez Arnaiz,G., Alberici De Canal,M. & De Robertis,E. (1971) 
Brain Res. 31, 179-184
Roel,L., Schwartz,S., Weiss,B., Munro,H.N. & Wurtman,R.J. (1974) J. Neurochem.
2 2, 233-239
Restas,J.A,P., Kelly,P.T. & Cotman,C.W. (l977) Anal. Biochem. 80, 366-372 
Restas,J.A.P., Eelly,P.T., Pesin,R.H. & Cotman,C.W. (1979) Brain Res. I68.
151-167
Rothman,S.S. (198O) Am. J. Physiol. 238. G391-402
Rubin,C.S. & Rosen,O.M. (1975) Annu. Rev. Biochem. 44. 831-887
Ruiz-Marcos,A., Sanchez-Toscano,F.,Escobar del Rey & Morreale de Escobar, 
(1979) Brain Res. 462, 315-329
Sabatini,D.D., £reibich,G., Morimoto,T. & Adesniok,M. (1982) J. Cell Biol.
»
Sal vat erra, P.M. & Matthews,D. A. (198O) Neurochem. Rea. 2.» 181-195 
Satake,M., Abe,S. & Araki,S. (1974) Proc. Japan Acad. 22> 231-236 
Sawant,P.L., Shibko,S., Kumta,U.S. & Tappel,A.L. (1969) Biochim. Biophys. Acta
482, 265-273
Schaffer,A., Seregi,A. & Komlos,M. (1974) Biochem. Pharmacol.23. 2257-2271 
Schain,R.J. <& Watanabe,K. (1971) Pediat. Res. 2» 173-180
—168—
SchatZjG. & Mason,T.L. (1974) Annu. Rev. Biochem. 43. $1-87
Schimke,R. (1973) in Methods in Membrane Biology (Korn,E.D., ed.), vol. 3, 
pp. 201-236, Plenum Press, New York
Schotman,P., Rieth,M.E.A, & Gispen,W.H. (1977) Brain Res. Bull. 2, 83-87
Schulman,H. & Greengard,P. (1978) Nature 271. 478-489
Schwartz,J.H. (l979) Annu. Rev. Neurosci. 2» 467-504
Semiginovsky,B., Jakoubec,B., Kraus,M. & Erdossova,R. (l970) Brain Res.
22, 298-301
Seta,K., Sansur,M. & Lajtha,A. (1973) Biochim. Biophys. Acta 294. 472-480
Shuts,C.C.D. & Lewis,P.R. (1966) Z.Zellforsch. 42, 334-343
Silver,A. (1974) in The Biology of Cholinesterases, Frontiers of Biology 
(Gillier,A., ed.), vol. 36, pp. 355-388, North Holland Biomedical 
Press, Amsterdam
Simpson,D.L., Thorne,D.R. & Loh,H.H. (1978) Life Sci. 22,, 727-742 
A'P- A M J. rACuaxKc-rt». SS7-S<1/
Smith,R.M., Patel,A.J., Kingsbury,A.E., Hunt,A.E. & Balazs,R. (198O)
Brain Res. 4 9 8, 375-387
Sobue,K., Kanda,K. & Kakiuchi,S. (1982) FEES Lett. 150. 185- 19O
Sokoloff,L. (1971) in Handbook of Neurochemistry, V. Metabolic Turnover 
in the Nervous Sÿstem. Part B (Lajtha,A., ed.), pp. 525-549» Plenum 
Press, New York and London
Sorensen,R.G. & Mahler,H.R. (1981) J. Neurochem. 3%, 1407-1418 
Sorensen,R.G. & Mahler,H.R. (1983) J. Neurochem. 40, 1349-1365 
Stoughton,R.L., Kelly,P.T. & Akeson,R. (1983) Neurosci. Lett. 21» 215-220 
Swick,R.W., Reiroth,A.K. & Stange,J.L. (1968) J. Biol. Chem. 243. 3581-3590 
Tamir,H. Rapport,M.M. Roizin,L. (1974) J. Neurochem. 22, 943-949 
Therien,H.M. & Mushynski,W.B. (1976) J. Cell Biol. H ,  807-822 
Therien,H.M. & Mushynski,W.B. ( 1979a) Biochim. Biophys. Acta 585. 188-200 
Therien,H.M. & Mushynski,W.E. (1979b) Biochim. Biophys. Acta 585. 201-209
-169-
Tsukita,S. & Ishikawa,H. (1980) J. Cell Biol. 84, 513-530
Valcana,T. & Eberhardt,N.L. (l977) in Thyroid Hormones and Brain Development
(Grave,G.D., ed.), pp. 271-283, Plenum Press, New York
Valcana,T. & Timiras,P.S. (1969) J. Neurochem. 4 6» 935-943
Von Hungen,E., Mahler,H.R. & Moore,W.J. (1968) J. Biol. Chem. 243. 1415-1423
Waejpeldt,T.V. (1978) Proc. Eur. Soc. Neurochem. 4 , 32-47
Walter,U., Kanof,P., Schulman,H. & Greengard,P. (1978) J . Biol. Chem.
252. 6494-6500
Walters,B.B. (1976) Ph.D. Thesis, University of London
Walters,S.N. & Morell,P. (1981) J. Neurochem. 36. 1792-1801
Wang,Y.-J. & Mahler,H.E. (1976) J. Cell Biol. I4, 639-658
Wartell,S.A.R., Christopherson,R., Watkins,C.A. & Rannels,D.E. (1981)
Mol. Pharmacol. 42» 520-524
Waterlow,J.C., Garlick,P.J. & Millward,D.J. (1978) in Protein Turnover 
in Mammalian Tissues and the Whole Body (Waterlow,J.C., Garlick,P.J. 
AMillward,D.J., eds.), pp. 403-412, Elsevier/North Holland Biomedical 
Press, Amsterdam
Wasterlain,C.G. (1974) Neurology 24, 175-180
Wasterlain,C.G. & Plum,?. (1973) Arch. Neurol. 2g, 38-45
Wasterlain,C.G., ?ando,J.L. & Lieber,C.S. (1977) Neurology 2%, 385-397
Webster,J.C. & Klingnan,J.D. (1979) Neurochem. Res. 4 » 137-153
Wedege,E., Luqmani,Y. & Bradford,H.P. (l977) J* Neurochem. 527-537
Weiss,B.P., Munro,H. & Wurtman.R. (l97l) Science 173, 833-835
Weller,M. (l979) Mol. Cell. Biochem. 2%, 71-78
Westrum,L.E. & Gray,E.G. (1976) Brain Res. 105. 547-550
Wickner,W. (1979) Annu. Rev. Biochem. 48. 23-45
Willow,M. & Johnston,G.A.R. (1981) J . Neurosci. 4 , 364-367
LfBAAmY
“ 170“
Wood,J.G,, Wallace,R.W., Whitaker,J.N, & Cheung,W.Y. (198O) J. Cell Biol.
8£, 66-76
Yen,S.-H., Liem,R.K.H., Kelly,?.T., Cotman,C.W. & Shelanski,M.L. (1977) 
Brain Res. 132. 172-175
Zanetta,J.P., Morgan,I.G. & Gombos,G. (1975) Brain Res. 337-348
